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PCR is widely used as a research tool for SNP detection because it offers a simple, 
sensitive and robust platform. Its wider use within clinical diagnostics and drug 
development requires the development of assay formats that are inexpensive, 
rapid, and ideally use a single-tube for the detection of a bi-allelic SNP. A single 
tube adaptation of allele-specific PCR that identifies allele-specific amplicons 
according to size was developed for detection of the SNP responsible for the sickle 
cell anaem ia phenotype. Com bined with an effective optimisation strategy, 
previously described for maximising yield in PCR tests, this format reduces the 
reagent costs associated with running the test whilst improving throughput.
The assay was further rationalised to provide a homogenous reaction format that 
had significant cost and throughput benefit. Incorporation of the universal double 
strand DNA specific binding dye, SYBR® Green I, into the PCR reaction mixture 
enabled real time detection of amplification and identification of allele-specific 
products using melt curve analysis. A further adaptation of this assay involved the 
use of sequence-specific real time PCR probes to detect specific PCR products, 
introducing sem i-sequence specificity to the test. The utility of the test was 
demonstrated using different real-time PCR instruments with a range of detection 
modalities and reagent systems.
Allele-specific PCR methods are currently the method of choice for routine 
laboratory analysis of DNA samples for mutations linked to sickle cell anaemia, and 
hereditary haemochromatosis. These were the model systems used for the 
development of the assay formats described here. In a preliminary clinical trial, 
genotyping results for the detection of sickle cell anaemia were 100% concordant 
with RFLP data. For the detection of the two mutations associated with hereditary 
haemochromatosis, C282Y and H63D, results were 97% and 92%  concordant with 
data from a reference laboratory. The mistyped samples were attributable to sample 
mix-ups during transitions between laboratories.
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The detailed kinetic aspects of allele-specific PCR tests were investigated  
quantitatively using a novel model describing the PCR process. This model 
assumes that PCR becomes limited by high substrate, high substrate inhibition, and 
good degree of correlation was achieved. Kinetic parameters including V ^ ,  K M 
and K t were estimated for extension of matched and mismatched primers, 
generating data directly applicable to the design of rapid-cycle PCR-based SNP  
detection tests. The model was also used to determine the cycle threshold in a PCR  
reaction curve, providing quantitative estimations of known and unknown template 
concentration. The model was validated by accurately estimating the concentration 
of twelve samples of unknown initial concentration by comparison to an external 






The understanding of genetic information has witnessed a huge progression over 
the past 100 years, starting with the first established cellular basis of heredity: the 
chromosomes and genes (Morgan, 1910). In 1953, Watson and Crick deciphered 
the molecular basis of this heredity by determining the double helical structure of 
DNA (W atson and Crick, 1953). This enabled the elucidation of biological 
mechanisms by which the cells read information contained in genes and the 
development of molecular biology methodologies that have allowed scientists to 
repeat these systems in vitro. Now, we are in the era of sequencing genes, and 
entire genomes to enable further advancements in the understanding of molecular 
mechanisms. To date, the genome sequences of 599 viruses and viroids, 205  
naturally occurring plasmids, 185 organelles, 31 eubacteria, seven archae, one 
fungus, one plant, and two animals, including the human genome have been 
elucidated (The International Human Genome Sequencing Consortium, 2001).
One of the greatest challenges for molecular biology post the Human Genom e  
Project is to map the extensive genetic diversity that exists between individuals, and 
between species. The most abundant source of this variation is the randomly 
distributed single base changes in DNA sequence known as single nucleotide 
polymorphisms (SNPs). Recent studies have identified as many as 1.42 million 
single nucleotide polymorphisms distributed throughout the genome at an average 
density of 1 SNP every 1.9 kilobases (The International SNP Map Working Group, 
2001). This dense set of highly stable markers opens up the possibility of 
association studies, identifying markers important in generating complex genetic 
traits. For example, disease loci may be pinpointed along with ‘functional variants’ in 
which the nucleotide change alters the function or expression of a gene that directly 
influences a disease state or drug response (Ingram, 1957). The study of the 
distribution of SNPs, particularly between different populations, is also a valuable
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tool for investigating molecular events that underlie evolution, namely genetic drift, 
mutation, recombination and selection (Freeland and Hurst, 1998).
SN Ps are defined as single base pair positions wherein different sequence  
alternatives (alleles) exist between individuals within a single population, or 
between individuals within different populations. Such polymorphisms must have an 
allelic frequency of 1% or greater within the test population to be considered as 
SNPs. Polymorphisms with iower frequencies are generally classified as ‘rare 
mutations’ (Brookes, 1999), although the definition used in this thesis encompasses 
disease predisposing single base variants of low frequency, or risk associated  
alleles as well.
Depending on the locality of a SNP within certain sequences, it can have different 
effects at the phenotype level. Generally, phenotype-influencing SNPs are termed 
‘functional’ (nonsynonymous or missense) SNPs since they result in altered amino 
acids in the primary protein sequence. SNPs that do not alter the resulting amino 
acid due to the degeneracy of the genetic code are termed synonymous SNPs, e.g. 
a change of CCA mRNA codon to CCG does not change the designation of the 
amino acid proline (Lewin, 1995).
SNPs occurring in the coding regions of genes (cSNPs) have been identified as the 
root cause of a number of recessively and dominantly inherited disorders (Section 
1.1), and different drug responses in individuals by altering the primary structure of 
proteins involved in drug metabolism (Section 1.2; Ginsburg and McCarthy, 2001). 
More commonly, SN Ps interact with environmental factors and other genetic 
variants from multiple genes causing complex disorders such as late onset 
Alzheim er’s disease (linked to mutations in the apolipoprotein E gene on 
chromosome 19, Davignon et al., 1988; Wilson e t a l ,  1996), and thromboembolism 
(linked to the factor V  Leiden mutation in the coagulation Factor V gene and the 
PTG202ioa mutation in the prothrombin gene, Bertina et al., 1994; Voorberg et al., 
1994). SNP markers are used today as the basis of clinical assays to screen 
individuals for key inherited diseases.
2
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SNPs can also occur within sequences with regulatory function (rSNPs) and within 
splice sites. Potentially these SNPs can disrupt gene expression and so contribute 
to an increased risk of developing certain diseases. For example, SNPs in the 
promoter regions of cytokines, namely tumour necrosis factor (TNF), interleukin 4, 
interleukin 6 and interleukin 10 (e.g. genes that coordinate the immune response), 
have been associated with a range of infectious and autoimmune disorders, 
including tuberculosis (Cooke and Hill, 2001) and arthritis (Taylor et al., 2001). This 
trend suggests that small differences in the regulation of key genes by the presence 
of a SNP can amplify or suppress a biological pathway such as a host response to 
a pathogen, causing the diversity in response to such disorders (Modiano, 1996).
Approximately 60,000 functional SNPs have been reported (The International SNP  
MAP Working Group, 2001; Pirmohamed and Park, 2001), these are a small 
fraction of the 1.42 million total SNPs identified. The remaining SNPs occur in non­
coding regions of the genome and are not associated with known phenotypes 
(Taylor eta!., 2001).
SNPs have long been the marker of choice for studies in genetic variation. Initially, 
these polymorphisms were known as ‘restriction fragment length polymorphisms’ 
(RFLPs). In this form, SNPs were identified according to their ability to create or 
abolish scission sites for restriction enzymes (Murayam a, 1966). Subsequently, 
SNPs as short tandem repeats (STRs) or microsatellites replaced RFLPs as 
markers for variability studies (Botstein et al., 1980) due to their high level of allelic 
variation but, since the completion of the human genome sequence, SNPs have 
been rediscovered as the marker of choice for variability studies. They provide a 
highly abundant genetic marker with greater stability than STRs due to their low 
mutation frequency. SNPs have an additional advantage in that STR  loci are 
markers in the sense that the polymorphism in the STR  is used to locate an 
adjacent functional variant that contributes to the disease state; variation in the STR  
itself rarely has a direct causative effect on the phenotype. Like STRs, SNPs can be 
used as a marker for a nearby functional variant, but since SNPs can occur in the 
coding or regulatory regions of genes, they can have direct functional 
consequences (Gray et al., 2000).
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SN Ps can also be inherited in highly conserved, interactive blocks called  
‘haplotypes’. A particular pattern or combination of sequential SNPs found on a  
single chromosome that tend to be inherited together with little genotypic variation is 
often referred to as a haplotype (haploid genotype). The study of SNP haplotypes 
may help stream line the analysis of genetic factors responsible for complex 
diseases, because without prior knowledge of the functional variant, genomic 
regions can be evaluated for association with disease outcomes. Subsequently, the 
functionally significant SNPs can be identified by a closer examination of regions 
identified by haplotype-based studies (Taylor eta l., 2001; Emahazion eta l., 2001).
The two principal strategies used currently by researchers for genetic association 
studies are ‘linkage analysis’ and ‘association analysis’ (or ‘candidate gene  
approach’), summarised in Figure 1.1 (Taylor e ta l., 2001). Linkage analysis relies 
on linkage disequilibrium (LD) or non-random pattern of co-inheritance between  
genetic markers within close proximity to each other. Generally, familial-based  
studies are employed in which disease inheritance can be compared to patterns of 
linkage over large genom ic regions. Through LD, associations found with 
anonymous markers can identify a region of the chromosome that may harbour a 
susceptibility gene without any a priori assumptions about what or where the 
susceptibility gene is (Kruglyak, 1999). However, linkage analysis rarely uncovers 
the specific mutation responsible for the disease outcome, rather a genetic marker 
within megabase resolution of where the disease gene is located. In addition, for 
human studies it is often difficult to collect multi-generation families of sufficient size 
or number to successfully apply these methods (McCarthy and Hilfiker, 2000).
For effective linkage, the mutation that is sought after must be a strong predictor of 
the disease phenotype, ideally necessary and sufficient to cause the disease. 
Linkage methods have enabled the identification of monogenic disorders because 
rare disease alleles show strong linkage with surrounding markers (Nowotny et al., 
2001). However, linkage analysis is not optimal in the detection of genes  
responsible for the aetiology of complex disorders such as Alzheimer’s disease, 
thromboembolism, osteoporosis (G iguere and Rousseau, 2000), cardiovascular
4
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and inflammatory diseases (Humphries et al., 2001), psychiatric diseases and most 
cancers (Kim et al., 2000; Bennett et al., 1999) where it is often the combined 
effect of several SNPs in key genes and environmental factors that determine  
whether an individual develops a disease (Allen etal., 1988).
Association studies are the preferred route for mapping complex disease genes 
because they use a priori knowledge of biological function to nominate candidate 
genes that are likely to have a role in the disease aetiology (Emahazion et al., 
2001). Typically, association studies use a case-control or cohort strategy involving 
unrelated subjects, overcoming the problems encountered in gathering enough 
subjects for family-based linkage studies. If a SNP or genetic variation is more 
prevalent in patients with a particular disease compared to unaffected controls, an 
association is inferred. In principle, sequences conferring only a fractional increase 
in disease risk can be detected, and the actual marker involved in the disease can 
be located, as well as genetic markers that are themselves in linkage disequilibrium 
with alleles of the associated marker (Taylor eta l., 2001).
The number of SN P markers required to detect ‘functional’ single gene variants 
within large populations is greater for effective linkage studies than candidate gene 
analysis (Kruglyak, 1999). Estimates vary from 1 million to 30,000 SNPs in at least 
1000 individuals, which realistically exceeds the capabilities of current technologies 
(Syvanen, 2001). The use of pooled samples, comprised of equal amounts of 
genomic DNA from up to 1000 individuals, is one of the strategies employed as a 
means of reducing the number of genotyping reactions required (Breen et al., 2000; 
Germer et al., 2000; Chen et al., 2002). The candidate gene approach represents a 
more achievable target given that smaller numbers of SNPs are required and the 
scale is no longer random and genome-wide. For example, the genotyping of 20  
SNPs in 50 candidate genes in 1000 samples represents a more reasonable goal of 
1 million genotypes. Both strategies would benefit from improved genotyping 
















Analyse candidate genes 




Validate variation in 
clinical trials and 
in vitro correlation
Figure 1.1: Two principle approaches to associating genetic variation with contribution to 
disease cause and susceptibility. In the Linkage analysis method, a genome-wide 
association approach is used, which requires a dense set of genetic markers (SNPs or 
STRs) distributed across the genome. A genetic marker is localised to a region of the 
chromosome if a sufficiently high correlation is observed. That region is then scanned to 
locate the actual susceptibility variation. In the Association analysis (or candidate gene 
approach), candidates SNPs are selected on the basis of biological knowledge or genetic 
observations. The candidate gene only is mapped, reducing the scale of the initial scan. 
‘ Denotes informative genetic marker.
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1.1 Targets for SNP Screening
Approximately 1600 diseases characterised in the Online Mendellian Inheritance in 
Man (O M IM ) database are caused by a single point mutation (monogenic 
disorders). These represent targets for genomic screening in addition to the 
thousands of characterised SNPs underlying common multifactorial disorders and 
variabilities in drug response. In this work, three clinically significant polymorphisms 
discussed below are used as ‘model SNPs’ for rapid genomic screening.
Sickle cell anaem ia (or p-thalassaemia major) was the first trait to reveal that a 
single point mutation can change protein structure and lead to a disease phenotype 
(Ingram , 1957). At the molecular level, the sickle cell anaem ia mutation is 
characterised by a single A -» T  missense transversion in the sequence encoding 
codon 6 of the human p-globin gene causing the substitution of the amino acid 
glutamine to valine (Murayama, 1966; Bookchin et al., 1970). This single molecular 
defect forms a mutant haemoglobin chain (known as HbS), which in the 
deoxygenated state has a tendency to polymerise and aggregate (Figure 1.2). The  
polymerisation is thought to cause a reversible increase in red cell (erythrocyte) 
membrane permeability that then triggers a chain of events where two constitutive 
transporters of the erythrocyte membrane become activated (a C a2+- sensitive K 
channel and an electroneutral K:CI cotransporter) leading to sickle cell dehydration. 
The extent of red blood cell dehydration and density has been correlated with the 
clinical severity of the disease (Bookchin and Lew, 2002).
Physiologically, the sickled erythrocytes become trapped in the microcirculation, 
depriving organs of essential oxygen, causing pain and chronic anaemia. The life 
span of sickled erythrocytes in the circulation is significantly shortened to 10-12  
days in most patients compared to normal erythrocytes (120 days). Sickle cell 
carriers (heterozygotes) are clinically normal, although their erythrocytes will sickle 
when subjected to very low oxygen pressure in vitro (Bookchin and Lew, 2002).
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Normal red blood cell
Sickled red blood cell
Figure 1.2: Normal and sickle cells. Electronmicrographs reproduced with kind permission 
from Dan Sartin at Action Research UK (www.actionresearch.co.uk).
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Homozygous HbS is common among, but not confined to, peoples of African 
American origin. Individuals in parts of Europe, South America and the Middle East 
are also commonly affected. In the UK, sickle cell disease affects approximately
10,000 people (Bookchin and Lew, 2002), some 3,000 more individuals than cystic 
fibrosis, which has regular screening programmes in place (Davies et al., 2000). In 
certain areas of the UK, individuals are tested for sickle cell anaem ia depending 
upon their ethnicity. With increased immigration and mixed race parenting, ethnicity 
may no longer be a sufficient criterion on which to select screening candidates. The  
aim is to implement a more widespread screening program for this disease in the 
UK (Davies et al., 2000), with a view to preventing morbidity and mortality by the 
administration of penicillin, in addition to genetic counselling programmes for the 
parents of affected children (Serjeant, 1997).
Hereditary haemochromatosis (HH) is the second disease selected as a target for 
genomic screening in this thesis. HH is one of the most common human genetic 
diseases, characterised by iron overload, in which iron is mostly deposited in 
parenchymal cells in the liver, pancreas, heart, and other organs causing 
malfunction (Andrews, 1999). At the molecular level, two single point mutations are 
associated with the development of HH. The first and more clinically significant 
(occurring in 90%  of HH patients; Townsend and Drakesmith, 2002) is a G-to-A  
transition at nucleotide position 845  of the open reading fram e of the 
haemochromatosis (H FE) gene. The resulting HFE protein exhibits a change from 
cysteine to tyrosine at amino acid position 282 (known herein as C282Y). The  
homozygous C 282Y  mutation found is 90%  of patients with HH. Heterozygous 
inheritance of C282Y also exhibits minor abnormalities in iron overload (Townsend 
and Drakesmith, 2002).
The link between the C 282Y  mutation and the iron overload characteristics of HH  
has been hypothesised, based on findings that the C282Y mutation inhibits HFE/02- 
microglobulin binding. In normal iron metabolism, association of HFE to 02- 
microglobulin is necessary for intracellular trafficking and incorporation of the HFE  
protein in cell membrane. The HFE protein then associates with the transferrin
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receptor at the cell surface, inducing activation of the transferrin receptor by 
phosphorylation. This activation reduces receptor affinity and impairs endocytosis of 
iron-saturated transferrin, with a decrease in cellular iron uptake as a result 
(Carlson and Olsson, 2001 ). The C 282Y  mutation is proposed to remove an 
essential cysteine residue, which normally participates in a disulphide bond, forming 
a structural conformation of the HFE protein that is capable of interaction with (32- 
microglobulin. The disruption of this important cell signalling interaction means that 
transferrin receptor affinity for iron-saturated transferrin is not reduced when  
required, and iron overload ensues (Feder eta l., 1997).
The second mutation in the H F E  gene, H63D , can cause the disease when  
inherited with a single C 282Y  mutation (the so-called ‘compound heterozygote’ 
state). H63D represents a C-to-G transversion at nucleotide position 187 of the 
open reading frame of the H F E  gene, causing a change from histidine to aspartic 
acid at amino acid position 63 in the resulting HFE protein (Ugozzoli et al., 2002). 
Increased susceptibility to HH is observed in 38%  of compound heterozygotes. The  
specific role of the H63D mutation may be in altering the affinity of the HFE protein 
for another ligand involved in iron metabolism, or alter the manner in which the 
mutant protein interacts with other proteins in the cell membrane (Feder et al., 
1997), although the exact role is, as yet, unproven.
The C282Y and H63D mutations are common in people of Northern European 
origin, affecting approximately 1 in 200-300 people, and more prevalent than sickle 
cell anaemia among the African American population (Baty et al., 1998). Morbidity 
and mortality in individuals affected with HH could be significantly reduced if the 
disease were diagnosed prior to the onset of hepatic, cardiac, or endocrine 
dysfunction. Therefore, screening of these SNP markers is important because an 
effective therapy is available through periodic phlebotomy to remove excess iron in 




It is widely anticipated that the study of SNP markers will also provide the ability to 
understand the “cause and  effect” of individual variation, allowing prediction of 
disease susceptibility or drug response. SNP genotyping is already performed on a  
routine basis to screen for monogenic diseases, as well as “susceptibility” genes in 
the complex diseases. Increasing interest surrounds the use of SNP markers to 
predict an individual’s response to therapeutic treatment, which may facilitate 
preventative medicine or the tailoring of specific treatm ent according to an 
individual’s predisposition to disease (Wieczorek and Tsongalis, 2001).
This informed approach to “personalised medicine” is broken down into two main 
disciplines: pharmacogenomics, the hereditary differences that dictate drug 
behaviour, and pharmacogenetics, the variability in drug response and metabolism 
due to hereditary d ifferences (Ginsburg and M cCarthy, 2 0 0 1 ). Basically, 
pharmacogenomic studies involve the analysis of a single drug, and its effect on a 
population of genomes (people), whereas pharmacogenetics involves the study of a  
single genome (person) and the effects of many drugs on the individual (Klaus 
Linderpainter, Personal Communication 2002). Confusingly, the terms are generally 
used interchangeably.
The two parallel approaches described for disease analysis (Figure 1.1, pg. 6), can 
also be applied to map the variety of individual responses to therapeutics. Although 
age, diet and physiological factors are important, much of the variation observed in 
drug response between patients is thought to be attributable to the underlying 
genetic variation of the human population (W ieczorek and Tsongalis, 2001). It is 
hoped that pre-treatment screening for these alleles will allow doctors to predict a  
patient’s response to therapy, improving the safety and efficacy of therapeutics by 
avoiding adverse drug reactions (ADRs). ADRs remain a major clinical problem, 
with some estimates putting ADR as the fourth cause of death in the US, 
representing US$75 billion in healthcare costs annually. Also, ADRs are considered
Chapter One
one of the most common factors that contribute to drug withdrawal, representing a 
significant financial burden to the healthcare industry (Pangas and Woodruff, 2002).
As a result, a large amount of research has been undertaken to investigate links 
between SNPs and drug response, revealing that the majority of polymorphisms 
identified so far are located in the drug metabolising enzymes, or drug receptors 
and transport proteins (L iljedahl and Syvanen, 2 0 0 2 ). Today routine  
pharmacogenetic analyses focus on typing drug metabolising genes belonging to 
the cytochrom e P450 (C Y P ) gene fam ily, which contain many of these  
polymorphisms. Over 30 different isoforms of cytochrome P450 enzymes exist, and 
it is estimated that more than half of all currently used drugs are metabolised by 
these enzymes. Polymorphisms in P450 enzymes have been shown to lead to poor, 
normal or ultra-rapid metabolism of drugs. For example, SNPs in the CYP2D 6 gene 
affect individual responses to a large number of commonly used drugs such as p- 
blockers, antidepressants, and codeine. Also, a poor metabolising variant of the 
enzym e encoded by the C Y P 296  gene causes life-threatening bleeding in 
individuals exposed to the anticoagulant warfarin (Furuya eta l., 1995).
To improve efficacy and general acceptance, drug developers try to avoid 
com pounds w hose m etabolic pathw ays are significantly influenced by 
polymorphisms in the P450 enzymes (Pirmohamed and Park, 2001). By moving on 
from the current pharmaceutical model of “one-size-fits-all” prescription of drugs, 
and moving towards a tailored prescribing of “personalised medicine” using 
pharmacogenomic techniques, more drugs may be moved forward in the drug 
discovery pipeline.
Elucidation of these pharmacogenetic effects will have beneficial consequences in 
many other areas of healthcare (Figure 1.3). With the availability of clinical tests for 
key SNPs, the options for drug developers will increase, not only determining the 
appropriate drug to be prescribed, but also the optimal dosage to administer. To 
satisfy the potential volume of genotyping tests that such a system would require, 
improved assays with reduced costs and improved throughput are a necessity.
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Figure 1.3: A schematic outlining the healthcare areas benefiting from applied genomics (pharmacogenomic and pharmacogenetic information). 
Information extracted from (Wieczorek and Tsongalis, 2001; Pirmohamed and Park, 2001).
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1.3 Detecting Genetic Variability
SN P genotyping (SNP analysis) has become a generalised term encompassing a 
broad range of methods used to detect genetic variability within individuals. The 
three main stages of SNP analysis are SNP discovery (or SNP identification), SNP  
validation, and SNP scoring (genotyping, calling, or typing; The International SNP  
Map Working Group, 2001).
For SNP discovery, the aim is to screen SNPs in DNA samples from as many 
individuals from as many populations as possible, ideally with an ultra-high 
throughput solution. Currently, Sanger’s dideoxy method for DNA sequencing 
(Sanger eta !., 1977), as used in the Human Genome Project (Lander eta !., 2001; 
Venter et a i ,  2001), provides a large screening capacity. To improve throughput 
parallel sequence reactions’ on multiple sequence platforms were used. Although 
sequencing remains the gold standard method of SNP discovery (The International 
Human Genome Sequencing Consortium, 2001), it is relatively slow and expensive 
on a large scale.
To validate a SNP, confirming that a candidate SN P is not the product of 
experimental error, a gene harbouring a ‘candidate SNP’ is generally re-sequenced. 
A SN P map location (actual position within the human genome) and allele 
frequencies are then assigned. To increase throughput for SNP validation, high- 
density microarray technology is often used allowing the genotyping reactions to be 
multiplexed. Typically, a m icroarray carries tens or even hundreds of 
oligonucleotide probes for each SNP to be analysed immobilised on a solid platform 
(e.g. GeneChip from Affymetrix). The probes include all possible sequences at the 
SNP site, and a stretch of nucleotide sequence that flanks the SNP. Specialised 
software is used to interpret the patterns arising from a matched hybridisation to 
assign the genotypes (Lipshutz e ta i ,  1995; Syvanen, 2002).
The final stage, SNP scoring, has been described as the “post-genomic” era of SNP  
analysis, since it utilises the genomic information revealed by discovery and
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validation stages discussed above (Kwok, 2001). SNP scoring uses the known DNA  
sequence information as a basis on which to design assays for the detection of a 
characterised genetic variation within the genomic sequence. Usually the variant 
has been associated with a particular clinical phenotype. Effective detection of 
genetic variability within individuals requires assays that are inexpensive and rapid 
without compromising on accuracy, even in sub optimal conditions. In addition, the 
test should involve minimal manipulation to reduce the opportunity for sample mix- 
ups and contamination. The key attributes sought in the development of clinical 
genotyping assays for SNP scoring is summarised in Figure 1.4.
Underlying any genotyping assay is a biochemical principle that is used to locate a 
SN P generating a ‘detectab le ’ signal in its presence. The most important 
biochem ical principles em ployed in SNP-genotyping platforms today are  
summarised in Figure 1.5. In general, they employ hybridisation with sequence 
specific oligonucleotide probes, or DNA modifying enzym es, such as DNA  
polymerases and ligases (Syvanen, 2001). These biochemical reactions have been 
multiplexed, automated and adapted to suit a range of detection methods to identify 
the specific biochemical signal generated in the presence of a target nucleic acid 
sequence. The most common detection modality is monitoring light emission since 
there are many ways to do so, including direct fluorescence (Figure 1.6A), 
fluorescence resonance energy transfer (FRET; Figure 1.6C), fluorescence  
polarisation (FP; Figure 1 .6D) and luminescence (Figure 1.6 E). Mass spectrometry 
is becoming increasing popular since it offers the most direct method of detection 
i.e. molecular weight measurement. It also takes just milliseconds to analyse each 
sample, and moderate multiplexing is possible. However, the analyte needs to be of 
very high purity to eliminate a noisy signal, which has been the main drawback to 
date (Figure 1.6 B; Jackson et al., 2000 ). Novel methods exploiting the 
electrochemical properties of DNA for SNP detection have also been described in 
which oligonucleotide probes are deposited on an electrode. The electrical property 
of the probe is altered when the complementary DNA is annealed to it (Figure 1.6 F; 
Kelley et al., 1999). Som e refining of electrochemical methods is required to 















i.e. in a closed vessel 
with minimal steps
Rapid Automation
to enable high throughput should be possible
Inexpensive • ) Robust
marker specific even if DNA samples are
reagents and optimisation sub-optimal
Figure 1.4: Key attributes to consider for the development of a “perfect assay” for SNP genotyping.
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Figure 1.5: Six biochemical reaction principles underlying SNP genotyping assays (based on 
information from Kwok et al., 2001, Syvanen, 2001). The grey panel demonstrates a C-to-A 
polymorphism. Probes shown are designed to detect the wild-type allele. [A] Allele-specific 
hybridisation: Usually, two oligonucleotide probes are used, one complementary to the wild 
type allele, and the other complementary to the mutant sequence. The variable position is 
usually designed to lie in the centre of the probe for maximal destabilisation in the presence 
of a mismatch. The probes will hybridise to target DNA under optimised conditions where a 
match is strongly favoured over a mismatch. [B] Allele-specific primer extension: Two 
primers are designed such that the 3 ’ terminus ends on the mutation site. The 3 ’ base of 
each primer is designed to match either the wild type or the mutant sequence. Under 
optimised conditions, Taq DNA polymerase will only extend a perfectly matched base. [C] 
Single nucleotide primer extension (Minisequencing): One primer that anneals to its target 
sequence immediately adjacent to the mutation site is extended by DNA polymerase with a 
single nucleotide that is complementary to the mutation site. The base at the mutation site 
can be inferred by identifying the nucleotide by which the primer was extended. [D] Allele- 
specific oligonucleotide ligation: Two adjacent oligonucleotides are included in a reaction 
with DNA ligase. The two oligonucleotides will be ligated together, only if the 
oligonucleotides perfectly match the template at the junction. The presence of a SNP can be 
inferred by determining whether ligation has occurred. [E] Invasive cleavage (Invader 
assay): Allele-specific oligonucleotide probes are designed base to match the wild type or 
mutant DNA sequence. The oligo sequence 5’ of the mutation site is unrelated to the target. 
An upstream oligonucleotide (the Invader) is included, with complementarities to the 5’ end 
of the allele-specific oligonucleotide. If an allele-specific oligonucleotide is perfectly matched 
to the target sequence, it is displaced by the Invader oligonucleotide, and the overlapping 
complex formed is specifically recognised by a FLAP endonuclease, which cleaves and 
releases the 5 ’ end of the allele-specific oligonucleotide. Detection of the released 5 ’ portion 
of the oligo will determine the nature of the allele present. [F] Restriction digestion: The 
presence of SNP may create or abolish a scission site for a particular restriction enzyme. 
Incubation of DNA with a restriction enzyme with known properties will either cleave or 
remain uncleaved. Determining the size of fragments following incubation will allow allele 
nature to be inferred.
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Figure 1.6: The main detection modalities employed in genotyping assays today. The list is 
not intended to be comprehensive. [A] Direct fluorescence using dyes that specifically bind 
double-stranded DNA (dsDNA). Upon binding and excitation by a light source, an increase 
in detectable fluorescence is observed (Singer, et al., 1997); [B] Mass spectrometry. 
example shows Matrix-assisted laser-desorption-ionization and time-of-flight (MALDI-TOF) 
where sample molecules are co-crystal I ised with the matrix and a laser beam is used to 
desorb and ionise the analyte. Desorption produces ionised sample molecules, which are 
accelerated by an electric field. The molecules travel along the TOF drift tube in a vacuum; 
the ions with larger mass-to-charge ratios travel more slowly than those with smaller mass- 
to-charge ratios. The time taken for ions to traverse the distance from source to the detector 
is accurately measured and equated to the mass-to-charge ratio of the ion (Jackson et al.,
2000); [C] Fluorescence polarisation (FP) is based on the observation that when a 
fluorescent molecule is excited by plane-polarised light, it emits a polarised fluorescent light 
into a fixed plane if the molecules remain stationary between excitation and emission 
(Perrin, 1926). At constant temperature and viscosity, FP is directly proportional to the 
molecular weight of the molecule to which the fluorophore is attached. If the fluorescent 
molecule is large (with high molecular weight), it rotates and tumbles more slowly in space 
and FP is preserved, providing a polarised signal at the detector. If the molecule is small 
(with low molecular weight), it rotates and tumbles faster and FP is largely lost, generating a 
depolarised signal at the detector (Chen et al., 1999); [D] Fluorescence Resonance Energy 
Transfer (FRET) is a photophysical effect where energy that is absorbed by a donor 
fluorescent molecule (A) is transferred non-radiatively to an acceptor fluorescent molecule 
(B). Fluorophore A absorbs light at 440 nm and emits at 480 nm. Fluorophore B absorbs 
light at 500 nm and emits at 520 nm. When the fluorophores are brought within close 
enough proximity to each other (the Forster distance), energy transfer can occur. 
Fluorophore A Is excited by absorbing light of 440 nm and transfers the energy to 
fluorophore B. Now fluorophore A is excited and falls back to its ground state, thereby 
emitting light at 520 nm. Thus, when A and B are in close proximity the emission at 480 nm 
is decreased and the emission at 520 nm is increased (Stryer and Haugland, 1967); [E] 
Luminescence: Step 1 shows a polymerisation reaction catalysed by DNA polymerase, in 
which a dNTP is incorporated into the DNA strand, accompanied by the release of inorganic 
pyrophosphate (PPi) in a quantity equimolar to the amount of incorporated nucleotide. Step 
2 the quantitative conversion of PPi to ATP, by ATP sulfurylase in the presence of 
adenosine 5’ phosphosulfate (APS). This ATP drives the luciferase-mediated conversion of 
luciferin to oxyluciferin that generates visible lights in amounts that are proportional to the 
amount of ATP. Thus, each light signal is proportional to the number of nucleotides 
incorporated (Lundin et al., 1976); [F] Electrochemical detection: A single example is shown 
here, DNA sequences containing a match or mismatch to the complementary probe were 
produced, and immobilise onto a gold electrode surface. Electrode surfaces modified with 
the duplexes were interrogated in chronocoulometric analyses at -3 5 0  mV with 0.5 pM 
methylene blue as the intercalated catalyst and 2.0 mM [Fe(CN)6]3‘ as the solution-borne 
substrate. The diminished DNA-mediated electron-transfer efficiency as a result of local 
base stack perturbation caused by the mismatch is demonstrated by a decrease in charge 
signal (Boon etal., 2000).
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The earliest methods of SNP scoring were developed for the diagnosis of sickle cell 
anaem ia in the DNA of affected individuals. The genotyping method used was 
RFLP based on the linkage of the sickle cell allele to Hpa I restriction site (Figure 
1.5F; Kan et al., 1972). The single base alteration in the scission site of Hpa I gave 
a different DNA fragment pattern following digestion, than an unaltered site in 
unaffected individuals. Therefore, by visualising the resulting DNA fragment 
patterns, by electrophoresis, Southern blotting (Southern, 1975) and specific 
hybridisation to a cloned gene or oligonucleotide probes, the genotype was inferred. 
Later it was shown that the sickle cell mutation itself affected the cleavage site for 
Dde I (G eever et al., 1981) and M st  II (Chang and Kan, 1982) and could be 
detected directly using enzymatic cleavage. Direct allele-specific oligonucleotide 
(ASO; Figure 1.5A) hybridisation methods were also described for the detection of 
the same mutation (omitting the RFLP step) in which differential hybridisation of 
allele-specific radioactive probes could be detected by autoradiography (Conner et 
al., 1983). However, all of these methods are not widely used nowadays since they 
are laborious, difficult to implement, use radioactive probes (entailing complex 
safety precautions) and have very low sensitivity (Chehab et al., 1987; Wu et al., 
1989).
It wasn’t until the polymerase chain reaction (PCR) was invented in 1985 (Mullis 
and Faloona, 1986; Saiki et al., 1985), that it became possible to design sensitive 
assays to detect SNPs in genomic DNA. PCR is a nucleic acid amplification 
technique in which short oligonucleotide sequences (primers), usually between 10 
and 40 base pairs long, are designed to anneal to complementary sequences 
flanking either side of a ‘target region’ (Figure 1.7). These primers are added in 
excess to the target sequence DNA (or template). A suitable buffer, magnesium  
chloride ions, a thermostable polymerase and free nucleotides are also added. A 
process of thermal cycling is used to amplify the DNA several million-fold. The 
target DNA is initially denatured at 95°C and then cooled to generally between 40°C 
to 60°C to enable sequence-specific annealing of the primers to the separated  
strands. The tem perature is then raised to the optimal tem perature of the 
polymerase, generally 72°C, which then extends the primer, copying the target 
sequence. This series of events is repeated (usually 20 to 40 times), wherein during
21
Chapter One
the first few cycles, copies are made of the target sequence, and then during 
subsequent cycles, copies are made from copies, which increases target amplicon 
yield exponentially prior to DNA detection/visualisation (Figure 1.8).
Few technologies other than PCR have had such a revolutionary effect on how 
molecular studies are conducted (Erlich et al., 1991). The impact on genotyping has 
been immense, since almost all genotyping performed today requires a PCR step of 
the region surrounding the mutation to provide the required sensitivity and 
specificity for distinguishing between heterozygous and homozygous genotypes.
In 1989, PCR itself was adapted for mutation detection in a method based on allele- 
specific primer extension (Figure 1.5B) called allele-specific PCR (AS-PCR), also 
referred to as the amplification refractory mutation system (ARMS; Newton et al., 
1989), allele-specific amplification (ASA), or preferential amplification of specific 
alleles (PASA; Sommer et al., 1992). In conventional AS-PCR, two PCR primers 
are designed with the 3 ’-terminal nucleotide complementary to either nucleotide of a 
SNP (wild type or mutant), used in combination with a common reverse primer to 
selectively amplify the SNP alleles in two separate PCR tests (Newton et al., 1989). 
By using a Taq DNA polymerase lacking 3 ’-» 5 ’ proof-reading activity, specificity is 
maintained since, under optimised conditions, Taq DNA polymerase will not extend 
a primer with a 3 ’ mismatch. Therefore, a single product will indicate homozygous 
inheritance of a particular allele, whilst a product in both reactions indicates 
heterozygosity. An internal control set of primers is used to amplify a region 
spatially separated from the target region, ensuring that a negative result is 
attributable to the absence of a specific allele, and not a failure of the PCR.
The traditional approach used for analysing AS-PCR products is by electrophoretic 
size separation of DNA fragments on a gel matrix, followed by staining with a 
fluorescent double-strand DNA (dsDNA) specific binding dye such as ethidium  
bromide (Markovits et al., 1979; Figure 1.6A). Ethidium bromide (2,7-diam ino-10- 
ethyl-9-phenylphenanthrid in ium  brom ide) has a planar structure allowing  
intercalation into approximately every second base pair of dsDNA.
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Figure 1.7: A schematic representation of PCR dynamics, showing the three temperature 
stages of a PCR cycle, including denaturation, annealing and extension.
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Figure 1.8: Simplified representation of the exponential amplification of nucleic acid during a 
PCR test.
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W hen ethidium bromide is bound to DNA and excited by UV light, it exhibits a 
greater fluorescence enhancement than when free in solution, allowing ethidium  
bromide: DNA complexes to be readily visualised (Sharp et al., 1973). The 
fluorescent enhancement is thought to result mainly from two factors: immobilization 
of the dye molecule in a planar conformation (allowing extensive electron  
delocalisation to occur) and exclusion of solvent (water) from interactions with the 
dye that might otherwise quench fluorescence (Mason, 1999; Cosa etal., 2001).
In 1992, a pioneering application of ethidium bromide was published in which the 
dye was incorporated directly into a PCR reaction mixture to visualise DNA  
amplification in real time by directing excitation illumination through walls of the 
amplification vessel before or after, or even continuously, during thermal cycling 
(Higuchi et al., 1992). This work was pivotal in revealing the shape and  
characteristics of a PCR reaction curve (Figure 1.9), prompting the development of 
PCR instruments with integrated optics systems allowing continuous monitoring of 
DNA amplification in a closed reaction vessel.
This advancement was in line with the synthesis of new dyes (unsymmetrical 
cyanine dyes) including SYBR® Green I, YOYO®, YO-PRO®, and SYBR® Gold 
(Tuma et al., 1999), which exhibit more favourable properties for DNA analysis than 
ethidium bromide, principally because they are less mutagenic (Lunn and Sansone, 
1987). As a group, the unsymmetrical cyanine dyes are characterised as having low 
intrinsic fluorescence, large fluorescent enhancements upon binding to nucleic 
acids, and high fluorescence quantum yields when complexed with nucleic acids. 
These features combine to produce excellent signal-to-background noise ratios. In 
combination with their apparently high binding affinities for nucleic acids, and 
greater sensitivity than ethidium bromide, these dyes are a favourable option for 
inclusion in PCR reaction mixes for real-time monitoring of PCR (Lay and Wittwer, 
1997) and quantitative PCR strategies (Rasmussen et al., 1998; Section 1.3). 
Although the mechanism of binding is still unknown for these dyes, it is thought to 
























Figure 1.9: The five phases of a typical real-time PCR curve. Phase 1- Baseline, where 
increases in fluorescence are below noise level. Often this is used to derive the ‘cycle 
threshold’ value, defined as the fractional cycle number at which the fluorescence passes a 
fixed threshold. A fixed threshold can also be set above the baseline. Phase 2- Log-linear or 
exponential phase, where the reaction proceeds at maximum efficiency displaying an 
exponentia l increase in product accum ulation (doubling per cycle). Phase 3- linear 
amplification phase, where the reaction no longer exhibits an exponential amplification, 
rather a linear increase in product. Phase 4- exponential decay, where the reaction 
efficiency is decreased and a slower production of product ensue. Phase 5- plateau phase 
where there is no detectable increase in amplification, possibly due to high substrate 
inhibition (Kainz etal., 2001) or a reduction in the availability of critical reaction components.
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Double-strand specific DNA binding dyes also enable the real-time monitoring of a 
methodology called DNA melting curve analysis, which allows product amplification 
a n d  identification in the sam e reaction vessel. ‘DNA melting’ describes the 
denaturation of DNA from a double-stranded to single-stranded state. The specific 
temperature at which the DNA is 50%  single stranded and 50%  double stranded is 
known as the “DNA melting temperature” (Tm; Ririe e ta l., 1997). Conventionally, 
DNA melting is monitored by changes in optical density as a sample temperature is 
slowly elevated. The principle behind this is the ability of the heterocyclic rings of 
the bases to adsorb light strongly in the ultraviolet range (with a maximum close to 
260 nm). W hen DNA is in its double helical state the electron systems of the 
heterocyclic rings overlap, made possible by their stacking in the parallel array of 
the double helix. This reduces their ability to absorb UV light. During DNA melting, 
the electron systems are freed from the constraints of base pairing and have the 
ability to absorb UV light. This is known as the ‘hyperchromic’ effect. Any departure 
from the duplex state of DNA is immediately reflected by a decline in the 
hyperchrom ic effect, exhibiting an increase in optical density toward the 
characteristic of free bases (Chamberlin and Berg, 1963).
Continuous fluorescence monitoring of a PCR mixture containing DNA and a 
dsDNA specific dye, whilst slowly elevating the temperature shows a rapid loss of 
fluorescence at a particular temperature where the helical dsDNA is denatured to 
single strands and the dye can no longer bind. A plot of fluorescence vs. 
temperature is called a “melt curve” (Figure 1.10A), which is converted to a “melt 
peak” by plotting the first negative derivative of fluorescence loss, F ,  with respect 
to tem perature, T  ( - d F / d T ;  Figure 1.1 OB). Melt peaks allow easy visual 
interpretation of melt curve data, allowing the identification of a PCR product (Ririe 
et al., 1997). The shape and position of the melt curve is mainly influenced by base 
composition, length and sequence of DNA strand (i.e. G C /A T ratio), allowing 
products of a similar size to be differentiated in a reaction mixture (Ririe et al.,
1997). Although the dynamic range of discrimination using melt curve analysis is 
limited, greater product differentiation can be achieved using smaller amplicons (50- 
150 bp). More-refined temperature measurement by instrumentation may allow a 
wider discrimination of T m (Ririe e ta l., 1997).
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Figure 1.10: [A] Typical melt curve in which the sample is slow ly heated to complete 
denaturation. The rapid loss of fluorescence occurs at the specific melting temperature of 
the PCR amplicon where the dsDNA binding dyes can no longer bind. [B] Typical melt peak, 
where the first negative derivative of the fluorescence (F1) data in [A] with respect to the 
temperature, T, is plotted versus temperature. Grey band demonstrates where the most 
rapid loss of fluorescence occurs, translating into the melt peak by differentiation. In addition 
to factors described in text, position of melt peak can be influenced by ionic strength 
(Schildkraut and Lifson, 1965), concentration of fluorescent dye, number of products in 
reaction mixture, and temperature gradient used to perform melt analysis (Ririe etal., 1997).
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The information obtained from a melt curve analysis is not strictly “sequence  
specific” and therefore artefactual amplification products can interfere with the data. 
Often these artefacts melt at a lower temperature than a specific product, and show 
a broader melt peak allowing their differentiation. Even so, using SYBR® Green I to 
monitor PCR reactions remains a popular choice among researchers, and has been 
used for a range of novel assays including McSNP® genotyping (Figure 1.5F; Akey 
eta l., 2001), and homogenous allele-specific primer extension tests (Table 1.1).
An established alternative to allele-specific primer extension methods for 
distinguishing between SNP alleles is to monitor a PCR reaction by allele-specific 
hybridisation (Figure 1 .5A) of real-time PCR probes. Critically, these probes employ 
hybridisation of the target nucleic acid sequence to its complement; unlike dsDNA  
binding dyes this adds sequence specificity to genotyping assays. The assays are 
based on the same biochemical principle as the original allele-specific hybridisation 
publications introduced earlier (Wallace e ta l., 1979; Chang and Kan, 1982), but the 
advancements in reagents, protocols and instrumentation have contributed to the 
progression of hybridisation formats. Instead of using lengthy dot-blot assays the 
hybridisation event is usually reported by FRET mechanisms (Figure 1.6D).
FRET is a distance-dependent interaction between the electronic excited states of 
two dye molecules in which energy is transferred from a donor molecule to an 
acceptor molecule without emission of a photon. For efficient FRET, there must be 
sufficient spectral overlap between donor emission and acceptor absorption 
wavelengths (Figure 1.11). Also, donor and acceptor transition dipole orientations 
must be approximately parallel (Stryer and Haughland, 1967). The efficiency of 
energy transfer (E) is defined as the number of quanta transferred to the acceptor, 
divided by the number of quanta absorbed by the donor. It is described by the 
expression:










Figure 1.11: A specific requirement for FRET to occur is that there is sufficient spectral 
overlap between the donor fluorescence wavelength, and the acceptor absorption 
wavelength.
Primer extension Based on the selective extension of oligonucleotides by Taq DNA polymerase
Reference Method Concept Advantages Disadvantages PCR step
Newton etal., 1999 Gel
electrophoresis
Allele-specific PCR performed in 
solution phase, and products 
identified by electrophoresis
Inexpensive Time consuming, multiple steps Yes
Germer and Higuchi, 
1999
Intercalating dyes Allele-specific PCR performed in a 
single tube, one allele-specific 
primers has a GC tail to increase the 
Tm of the specific product.
Rapid, homogenous, inexpensive Minimal multiplexing capacity Yes
Myakishev et al., 
2001
FRET primers Allele-specific PCR probes used to 
report a mismatch by maintaining 
FRET
Simple, allows multiplexing Expensive probes, complex design rules Yes
Waterfall and Cobb, 
2002
Intercalating dyes Single tube adaptation of allele- 
specific PCR where primers are 
arranged in bi-directional manner 
around the SNP. Products identified 
by different Tms.
Rapid, homogenous, inexpensive Minimal multiplexing capacity Yes
Table 1.1: Common genotyping assays based on allele-specific primer extension. The list is not intended to be extensive due to the number of 
similar assays, but rather provide details of a range of assays.
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where R is the distance between the donor and acceptor (in A) and R0 (in A), the 
distance at which energy transfer is 50%  efficient, also called the Forster radius 
(Forster, 1946; Forster, 1948).
This formula shows that the rate of energy transfer is inversely proportional to the 
sixth power of the distance between the donor and acceptor fluorophores. 
Therefore, the efficiency of the transfer rapidly declines to zero at distances larger 
than the Forster radius. The Forster radii have to be experimentally measured for 
each specific donor-acceptor pair, but generally for FRET to occur, the donor and 
acceptor molecules have to be within 1-10 A of each other.
If the acceptor is a fluorescent dye itself, the transferred energy can be emitted as a 
fluorescence characteristic of the acceptor. If the acceptor is not fluorescent, the 
energy is ‘quenched’ through equilibration with solvent, and the acceptor is then 
known as a ‘quencher’. A quencher is a molecule that absorbs or dissipates energy 
from an excited fluorophore (the reporter), returning it to the ground state without 
any fluorescent emission by that fluorophore (Didenko, 2001).
Common probe mechanisms utilising FRET for real time PCR monitoring and SNP  
detection are summarised in Figure 1.12. The most popular probe configuration for 
real-time PCR monitoring is the 5 ’ fluorogenic nuclease probe (commercially known 
as TaqMan® probe; Figure 1.12A). A TaqMan® probe is an oligonucleotide labelled 
with a reporter dye and a quencher dye, protected from extension by Taq DNA  
polymerase by phosphorylation at the 3 ’ end (Livak, 1999). During the extension 
phase of a typical PCR run, the 5 ’ nuclease activity of Taq DNA polymerase 
hydrolyses the probe in the 5 ’ to 3 ’ direction, liberating the reporter dye from the 
quencher dye, disabling FRET. A cumulative increase in reporter fluorescence 
indicates that the probe-specific target has been amplified (Holland et al., 1991). 
TaqMan® probes represent a category called ‘hydrolysis’ probes, named as such 
because the probe is hydrolysed to release the reporter dye (consumed by the 5 ’ 
nuclease activity of DNA polymerase).
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Figure 1.12: Principles for homogenous SNP genotyping by real-time PCR. This list is not 
intended to be comprehensive. The grey panel demonstrates a C-to-A polymorphism. 
Probes shown are designed to detect the wild-type allele. [A] Fluorogenic 5 ’ nuclease 
(TaqMan®) probes: Two allele-specific oligonucleotide probes are labelled with two 
fluorescence reporter dyes emitting at different detectable wavelengths. Probes blocked 
from extension by Taq by a 3 ’ phosphorylation. Hydrolysis of the probe by the 5 ’ nuclease 
activity of Taq only occurs if the probe is specifically hybridised to a perfectly matched target 
sequence. Liberation of the reporter dye from the quencher prevents FRET, providing a 
fluorescent signal characteristic of the specific probe (Livak, 1999). [B] Molecular beacons: 
Two allele-specific probes, labelled with fluorophores emitting at different detectable 
wavelengths, are designed such that a perfectly matched probe-target hybrid will be 
energetically more favourable than the stem-loop structure. A mismatched probe-target 
hybrid favours the stem-loop conformation. A perfectly matched sequence enables 
hybridisation to the DNA sequence, preventing FRET quenching, and emitting light at a 
characteristic wavelength (Tyagi et al., 1998) [C] Dual hybridisation probes: Two probes are 
included, one is 3 ’-labelled with either a donor or acceptor dye, and the other is 5 ’-labelled 
with either a donor or reporter (acceptor) dye. Probes are PCR-blocked at the 3’ end by 
phosphorylation. Perfectly matched probes are in close enough proximity enabling FRET, 
giving a signal characteristic of the acceptor dye. A mismatch causes one of the probes to 
melt off at a detectably lower temperature (De Silva et al., 1998). [D] Universal Energy- 
Transfer Labelled probes (Amplifluor®): An allele-specific primer is designed with a 5’ tail 
sequence (Z) that is not complementary to the target. Probe consists of a molecular beacon 
with no specificity for the target product, attached to a primer with a sequence (Z ’) 
complementary to the Z  sequence of the allele-specific primer. The area between the primer 
and beacon is not PCR-blocked. During amplification, the complement sequence of the 
beacon is amplified allowing product and probe to anneal. This opens the beacon structure, 
preventing FRET quenching. Using beacons with different Z ’ sequences and allele-specific 
primers with different Z sequences allows product identification by characteristic 
fluorescence emissions (Myakishev et al., 2001). [E] Scorpion primer: Two allele-specific 
probes are labelled with fluorescent dyes emitting at different detectable wavelengths. 
Variant base can be designed at the 3 ’ end of the primer portion of the probe, using allele- 
specific PCR as the discrimination mechanism (as figure), or by detecting a mismatch within 
the stem loop portion as [B]. After extension, during PCR, the specific probe sequence binds 
to its complement within the same strand of DNA, opening the stem-loop and disabling 
FRET. An increase in signal is observed. In the allele-specific probe embodiment, a 
mismatch prevents amplification of complementary sequence, for loop to bind to. If the 
mutation is in the stem-loop portion, a mismatch will cause FRET to remain active by 
favouring the closed conformation (Whitcombe etal . ,  1999). [F ] HyBeacon® probes: 
Oligonucleotide probes complementary to the wild type or mutant sequence, internally 
labelled with a specific fluorophore. Probes are blocked from PCR extension at the 3 ’ end by 
phosphorylation. Increased florescence is observed when the probe is bound to a perfectly 
matched sequence (French et al., 2001). [G] Resonsense® probes: An oligonucleotide 
probe is labelled with a single fluorophore and blocked at the 3 ’ end from extension. An 
exonuclease deficient Taq is used to prevent hydrolysis during the PCR. Probe is designed 
to hybridise to a perfectly matched target sequence generating a product probe duplex for a 
DNA intercalater to bind (SYBR® Gold). The intercalater is used as the donor moiety to 
fluoresce when bound to dsDNA and excite the fluorophore on the probe by FRET. [H] 
Angler® probes: Similar to [G] except that the probe is chemically linked to the primer 
bringing it spatially close to the extended primer for sequence specific self-probing of 
product. In this case, the 3’ end of the primer is not protected from extension (Lee et al.,
2001). [I] PNA-based Light-Up probes: Probes are made up of peptide nucleic acids labelled 
at the amino-terminus with a Thiazole orange moiety. When the probe is bound to perfectly 
matched DNA, the dye fluoresces (Wolffs etal., 2001).
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The hybridisation aspect of TaqMan® probes is apparent during SNP detection 
where cleavage of the probe only occurs if the probe is specifically hybridised to its 
target sequence (Livak, 1999). By including two probes complementary to each 
allele labelled with different fluorescence reporter dyes at the 5 ’ end with detectably 
different emission wavelengths (usually FAM, 6-carboxy-fluorescein, >.max 535 nm, 
and JOE, 6-carboxy-4\5’-dichloro-2’,7’-dimethoxyfluorescein, ^max 557 nm) into a  
single PCR test, only the matched probe will produce a significant measured signal 
increase because a matched conformation provides the desired substrate for 5 ’ 
nuclease activity (Figure 1.13). A mismatch between the probe and target greatly 
reduces hybridisation and cleavage efficiency because this specific recognition 
structure is disrupted.
Although the TaqMan® assay is an established technique for genotyping, conditions 
that distinguish between probes with a single nucleotide difference can be difficult to 
obtain (Sevall, 2000). A necessary requirement is that the TaqMan® probe is bound 
to the template at temperatures where T aq  polymerase is optimally extending  
primers (60-72°C ). This usually requires an oligonucleotide length of 2 5 -40  
nucleotides which is generally too long for most SNP detections given that the 
difference in Tm between a perfectly matched duplex 25 bp long and a similar 
duplex with a single mismatch is usually only about 3°C  (Walburger et al., 2001). 
Without careful optimisation of probe sequence and PCR conditions it can be 
difficult to detect SNPs with an acceptable signal-to-noise ratio for a robust clinical 
assay.
The remaining probe formats described in Figure 1.12 report changes in the 
proximity of reporter and quencher dyes by FRET directed by a hybridisation event, 
not hydrolysis. During each cycle, the probes hybridise to the target sequence  
present to give a signal that corresponds to the amount of PCR product in each  
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Blocked from extension 
5 , jabe| by 3' phosphorylation
Displaced fork-like structure 
DNA polymerase
Figure 1.13: The substrate for Taq DNA polymerase in TaqMan® probe assays. This 
substrate is a forked structure occurring at the phosphodiester bond joining the displaced 
region with the base-paired portion of the strand (Figure 1.13; Holland etal., 1991).
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For dual hybridisation probes (Figure 1 .12C) the perfect hybridisation of two 
labelled probes enables FR E T to occur. Following excitation of the fluorophore 
attached to the donor probe by a light source, the fluorophore attached to the 
reporter probe can be excited by FRET mechanisms, generating a signal that is 
characteristic of the reporter dye. As described in Figure 1.11, the emission 
wavelength of the donor dye must have sufficient spectral overlap with the 
excitation wavelength of the reporter dye for efficient FR ET to occur. It is the 
reduced hybridisation stability of a mismatched probe, which causes it to melt off at 
a detectably lower temperature than a match (disabling FRET excitation of the 
acceptor probe) that enables efficient SNP detection. A similar concept is employed 
in Resonsense® and Angler® probe formats (Figure 1.12G and 1.12H, respectively; 
Lee et a l ,  2001) where the fluorescence emission of a dsDNA specific binding dye 
(SYBR® Gold) is used to excite a sequence-specific reporter probe, as opposed to 
an adjacent sequence-specific donor probe.
A popular configuration used in the design of hybridisation probes is a stem-loop 
structure (or hairpin), commercially referred to as a molecular beacon (Figure 
1.12B). Molecular beacons are stem-loop structures labelled at the end of the 5 ’ 
arm with a reporter dye, with a quencher dye attached to the end of the 3 ’ arm. 
W hen free in solution, the molecular beacon adopts the stem-loop structure that 
brings the reporter dye and quencher into close proximity, allowing FR E T  
quenching. In the presence of a complementary sequence, hybridisation to the 
target is therm odynam ically more favourable than the closed stem -loop  
configuration, which increases the distance between reporter and quencher dyes 
such that efficient quenching by FR E T cannot occur. A fluorescent signal 
characteristic of the reporter dye ensues. It follows that in the presence of a 
mismatched sequence, the stem-loop structure is energetically favoured and  
quenching by FRET is maintained (Tyagi eta l., 1998).
Certain probe systems have combined the molecular beacon structure with allele- 
specific primer extension to introduce ‘sem i’ sequence specificity to A S-PC R  
methods. One example, the Amplifluor™ system, involves PCR amplification of 
genomic DNA with two allele-specific primers that have a 5 ’ tail sequence attached.
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The specific tail sequences contain primer-binding sites for two differentially labelled 
molecular beacon primers called ‘universal energy-transfer-labelled primers’. In the 
presence of a matched sequence, the appropriate allele-specific primer will be 
extended, and the specific 5 ’-tail sequence becomes part of the PCR product. 
Therefore, the corresponding universal energy-transfer-labelled primer can 
hybridise to the PCR product, opening the stem-loop structure, preventing FR ET  
quenching. A signal characteristic of the reporter dye will ensue. It follows that Taq 
will not extend the m ism atched allele-specific primer, and therefore the 
complementary 5 ’ tail will not be amplified. With different 5 ’ tail sequences, semi­
sequence specificity is introduced into the assay (Figure 1.12D; Myakishev et at., 
2001).
A further example of combining molecular beacons and allele-specific PCR is 
scorpion primers. Here, a molecular beacon is directly attached to an allele-specific 
oligonucleotide (Figure 1.12E). The beacon is designed with complementarities to 
the sequence upstream of the SNP site. In the presence of a matched sequence, 
the allele-specific oligonucleotide portion of the probe is extended, and a 
com plem ent to the stem -loop structure is produced in the PCR product. 
Consequently, the beacon portion will hybridise to this sequence, disabling FRET  
quenching and a characteristic signal ensues. A mismatch at the 3 ’ end of the 
allele-specific portion of the probe will prevent extension of the primer, and the 
complementary sequence for probe hybridisation is not formed. Therefore, the 
scorpion maintains its stem-loop structure without generating a signal (Whitcombe 
et a!., 1999). Scorpion probes have also been designed with the base variant 
occurring in the stem-loop portion of the probe, exploiting the thermodynamic 
properties of this structure, as described for molecular beacons (Thelwell et a i ,
2000).
More recently, probe systems have been described that rely on alterations in 
detectable fluorescence caused by hybridisation of a singly labelled probe to their 
complement. These include HyBeacons® (French et a i ,  2001; Figure 1.12F), 5 ’- 
Labelled Oligonucleotide probes (Crockett and Wittwer, 2001) and Light Up® probes 
(Wolffs eta!., 2001; Figure 1.121). For HyBeacons®, a single fluorophore is attached
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to an internal T  residue of an oligonucleotide probe. An elevation in fluorescence is 
observed on hybridisation to its complimentary sequence within the PCR amplicon. 
H ere, the proposed mechanism stems from fluorescence quenching by the 
nucleotide residues in the probe (in particular purine bases) when in solution; this is 
likely to be a result of base-dye stacking and electron transfer events (French et a i,
2001). This is analogous to Light Up® probes except the oligonucleotide is replaced 
by a peptide nucleic acid (PNA) backbone, which has an extremely high affinity for 
DNA (Nielsen et a i ,  1991). Conversely, the 5 ’-labelled oligonucleotide probe 
(Crockett and Wittwer, 2001), exhibits a fluorescence quenching activity when 
bound to its complementary target.
All three single-labelled  probe systems rely on the inherent quenching  
characteristics of nucleotides themselves, resulting in different alterations in 
measurable fluorescence. The advantage of these probes is that they contain a 
single fluorophore lowering the overall cost of reagents and synthesis. However, the 
effectiveness of the probe is highly influenced by the surrounding or complementary 
sequence. HyBeacons® require an internal T  nucleotide on which to attach the 
fluorophore, and the 5 ’ labelled probe exhibits greater effects during hybridisation to 
‘G ’-rich amplicons (Crockett and Wittwer, 2001). This may not be possible in all 
sequences containing SNPs.
Probe-based systems have increased the multiplexing opportunities for SNP  
detection due to the commercial availability of a huge variety of fluorophores with 
detectable differences in their emission wavelengths. These probes can be 
rationally designed using specific rules to recognize and detect any desired target 
with almost any desired degree of specificity by varying length, sequence, and 
hybridisation conditions. However, often the probe design rules can be complex and 
prohibiting, requiring specialised software (Tapp eta l., 2000). In addition, the actual 
cost of real-time PCR probes is high in comparison with simple intercalating dyes. 
With the increased commercial availability of novel probes, these costs could be 
driven down by virtue of competition.
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So far, the use of allele-specific probes in a solution phase has been described. 
Alternatively, probes can be immobilised on a solid-support in high throughput 
microarray formats. Microarrays vary according to the solid support used (such as 
glass or filters), the surface modifications with various substrates, the type of 
nucleic acid fragments on the array (such as cDNA, oligonucleotides or genomic 
fragments), whether the gene fragments are pre-synthesised and deposited, or 
synthesised in situ, and the machinery used to place the fragments on the array 
(such as ink-jet printing, spotting, or in situ  synthesis; Holloway et ai., 2002). 
However, the basic concept behind all microarrays is the precise positioning of the 
nucleic acid probes onto a solid support such that they can act as molecular 
detectors. The specific hybridisation of nucleic acid from a single sample, to 
thousands of these molecular detectors (or probes), can be monitored using a 
range of different methods (Figure 1.6), generating a great deal of information from 
a single sample simultaneously.
For SNP detection, the thermal stability of a hybrid formed between an allele- 
specific oligonucleotide (ASO) probe and its corresponding SNP-containing target 
sequence is determined by the stringency of the reaction conditions and the 
surrounding sequence of the SNP. Therefore, it is very difficult to establish 
conditions that are optimal for genotyping all SNPs. This limits the multiplexing 
capabilities. Using nucleotide analogues with a higher affinity for DNA than DNA  
itself, e.g. locked nucleic acids (LNAs) or peptide nucleic acids (PNAs; Figure 1.14), 
more robust genotyping can be achieved using shorter probes than natural ASO  
probes since a mismatch in either of these chemistries causes a greater disruption 
of hybridisation than a simple DNA-DNA mismatch (Orum et a i ,  1999; Jensen et 
ai., 2001). Details of other allele-specific hybridisation methods are summarised in 
Table 1.2.
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A. DNA B. RNA C. LNA D. PNA
Figure 1.14: [A] DNA monomer, [B] RNA monomer, [C] Locked Nucleic Acid (LNA) monomer, and [D] Peptide Nucleic Acid monomer. The LNA 
monomer is a bicyclic compound in which the 2 ’ and 4 ’ positions of the furanose ring are linked by an O-methylene (oxy-LNA), S-methylene (thio- 
LNA) or NH-methylene (amino-LNA) moiety, represented by X in [C]. This linkage restricts the conformational freedom of the furanose ring, 
conferring high thermal stability when hybridised to a complementary DNA (or RNA) sequence (Koskin et ai, 1998, Singh et ai, 1998; Orum et ai, 
1999). The PNA polynucleotide has a 2-aminoethylglycine backbone in lieu of the deoxyribose phosphate backbone of DNA. Like LNAs, PNA- 
DNA duplexes are also more sensitive to mismatches than DNA-DNA mismatches (Orum etal., 1993).
Hybridisation Based on the thermal stability of a hybrid formed by an allele-specific probe and a SNP-containing target sequence
Reference Method Concept Advantages Disadvantages PCR Step
Livak, 1999 TaqMan probes 
(ABI)
Solution phase, homogenous, real­
time PCR assay. Probe hybridises 
between primer annealing sites.
Simple assay format uses 5’ 
nuclease activity of Taq to digest a 
fully matched probe, disabling 
FRET quenching





As above, except probe has a 
hairpin stem-loop structure.
Simple assay. Matched probe 
hybridisation disables FRET 
quenching.
Probes are expensive, complex design 
considerations
Yes
Orum etal., 1999 LNA probes 
(Genset)
A replacement for phosphodiester 
oligonucleotide probes attached to 
an array to capture complementary 
sequences.
More specific than phosphodiester 
probes, shorter than 
oligonucleotide probes.
Limited availability, slightly more expensive 
than simple phosphodiester oligonucleotide 
probes.
Yes
Saikietal., 1989 Reverse dot blot Based on hybridisation between 
ASO probes that have been 
immobilised on a membrane, and 
PCR products in solution.
One of the original genotyping 
methods used, multiplexing 
possible
Prone to low signal-to-noise ratio, time 
consuming
Yes




Solid support genotyping on a high 
density chip
Very high probe density, excellent 
multiplexing capabilities
High failure rates, expensive for design and 
manufacture of chip, set of markers cannot be 
changed quickly or arbitrarily, long protocol
Yes
Howell etal., 1999 DASH
(Dynametrix Ltd.)
Typically a solid support assay, 
looks for the melting temperature 
differences of allele-specific probe 
when hybridised to a matched or 
mismatched target
Inexpensive labelling using 
intercalater dyes, uses biotinylated 
PCR product to maintain single 
stranded nature for capturing
Complex design rules, specialised 
instrumentation required, single reporter 
means two reactions must be run in parallel 
per SNP
Yes
Table 1.2: Common genotyping assays based on allele-specific hybridisation. The list is not intended to be exhaustive due to the number of similar 
assays, but rather provide details of a range of assays.
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A further principle in which the specific properties of DNA polymerases are used is 
in allele-specific nucleotide incorporation (Figure 1.5C; Table 1.3), or single base 
extension (minisequencing) methods. These are becoming the reaction principle of 
choice for high throughput SNP genotyping projects because of the high accuracy 
of nucleotide incorporation by DNA polymerases. The primer extension reaction is 
robust, and allows genotyping of most SNPs without a large variation in reaction 
conditions. These features are advantageous for high throughput projects involving 
SNP validation, because the effort required for assay design and optimisation are 
minimised. A range of detection methods is available for single base extension 
assays, including mass spectrometry (Figure 1.6 B), FP (Figure 1.6 C) and FRET  
(Figure 1.6 D). Generally, a PCR-step is required to achieve sufficient target 
sequence for SNP detection.
DNA ligases have also been in genotyping assays, based on the ability of the 
enzyme to discriminate against mismatches at the ligation site in two adjacently 
hybridised oligonucleotides (Figure 1.5D; Table 1.4). This reaction principle has 
been described with multiplex detection using fluorescently labelled oligonucleotide 
probes in the template dye-incorporation assay (TDI, Figure 1.15; Chen et a i ,
1998), and combined with colourimetric detection of hybridised probes in microtiter 
plates (Lizardi et at., 1998). Ligase-mediated genotyping is also used in the dye- 
labelled oligonucleotide ligation (DOL) assay, with detection by FRET or FP (Figure 
1.16; Chen e ta l ., 1999).
The genotyping methodologies introduced during this chapter have all required a 
specific amplification step, which is invariably PCR, to achieve the required 
sensitivity. In addition, PCR allows accurate DNA quantification (Section 1.3), a 
procedure that is highly valuable to clinical laboratories assaying viral loads, gene 
copy numbers or bacteria concentration in human specimens. The progress in PCR  
instrumentation has also allowed the development of homogenous assays that 
combine amplification and detection in a single tube, offering huge advantages to 





The distinction between genotypes is based on the high accuracy of nucleotide incorporation by Tag DNA polymerase
Reference
Nikiforov et ai., 1994
Dubiley et ai., 1999 
Ronaghi et ai., 1996
Rossetal., 1998
Sauer et ai., 2000
Method Concept
SNPstream Incorporated hapten-labelled
(Orchid), GBA nucleotide analogues recognised by
antibodies. Enzymes conjugated to 
antibodies catalyse formation of a 
coloured product
Multiplex Fluorescently labelled
minisequencing dideoxynucleotides used in
SnaPShot minisequencing reactions.
(ABI)
Pyrosequencing Inorganic pyrophosphate (PPi)
(Pyrosequencing released from a nucleoside
AB) triphosphate during DNA chain
elongation, detected by a 
luminescence assay
MassEXTEND, Primers of different lengths used
MassARRAY with mixtures of dNTPs and ddNTPs
(Sequenom) yield allele-specific primer extension
products with detectable differences 
in molecular mass.
Advantages
Inexpensive, robust, automated 
HTP process (384-well)
Multiplexing capacity by using 
primers modified with 5’ tails of 
varying lengths, compatible with 
capillary DNA sequencers.
Sequencing of up to 50 bases, 
operates in 96-well or 384-well 
format
High multiplexing capacity, high 
resolution, uses MALDI-TOF to 







Expensive, difficult to multiplex, dedicated 
instrument
Expensive instrumentation, requires purified 





GOOD Assay A primer extension reaction that
generates alkylated allele-specific 
PCR products- alkylation can be 
more sensitively detected by MS
Sensitive mass spectrometry 
detection eliminating the rigorous 
purification steps
Multi-step procedure Yes
Reference Method Concept Advantages Disadvantages PCR step
Chen et a i, 2000 Coded
Microspheres
(Luminex)
Multiplex allelic discrimination 
reaction performed in solution using 
‘tagged’ primers. ‘Tagged’ PCR 
products separated by flow 
cytometry using complementary 
‘tagged beads’.
Good multiplex potential Multiplex PCR and multiplex primer extension 
reaction are difficult to optimise, and 
performed in solution separate from solid 
phase flow cytometry sorting reaction.
Yes





assay (TDI) using 
FP or FRET
Donor dye-labelled primer extended 
using AS-PCR, and acceptor dye 
labelled ddNTPs. A match/mismatch 
can be detected using FRET since 
fluorophores are brought within 
close enough proximity for the donor 
to excite the acceptor.
Direct fluorescence detection, 
cheaper probes, good multiplexing 
potential, adaptable for FP 
detection since extension of the 
donor labelled probe will increase 
the molecular weight of the 
fluorophore changing its 
polarisation properties.
Non-specific products increase noise in the 
signal.
Yes
Schmaker et a i, 





Primer covalently immobilised on 
microscope slide. Following 
extension using fluorescent 
dideoxynucleotides, array analysed 
by fluorescence scanning
Potential for HTP, uses one 
detection primer per SNP, ten-fold 
increase in discrimination potential 
compared with ASO probe-based 
array formats.
Requires microarray instruments Yes
Table 1.3: Common genotyping assays based on allele-specific nucleotide incorporation. The list is not intended to be exhaustive due to the 
number of similar assays, but rather provide details of a range of assays.
Oligonucleotide Based on the discrimination by DNA ligases against mismatches at the ligation site in two adjacently hybridised oligonucleotides
ligation
Reference Method Concept Advantages Disadvantages PCR step
Lizardi et a i, 1998 Rolling circle 
amplification
Circular DNA ligation products (such 
as padlock probes) serve as 
template for a RCA
Signal amplification, yields product 
many times the size of the original 
circle. Adapted to SNPgenotyping.
Steric hindrance on solid phase, PCR not 
required in principle
No
Baneretal., 1998 Padlock probes Linear oligos with ends 
complementary to target. When 
perfectly hybridised, probes are 
circularised by ligation, acting as 
templates for RCA.
Localised detection, avoids a PCR 
step, adapted for SNP genotyping 
where a mismatch prevents oligo 
ligation.
Probes difficult to design No
Whiteley et al„ 1989 Ligase chain 
reaction (LCR)
Two oligonucleotide probes adjacent 
to a SNP site are ligated in the 
presence of a matched sequence, 
forming targets for later cycles
Eliminates a PCR step in principle, 
yet still accomplishes exponential 
amplification
Often used in combination with PCR to 
achieve the required sensitivity (CCR).
No




Consists of denaturation, annealing, 
extension and ligation, relying on a 
mismatch at the 5’ end of a primer to 
prevent ligation. Uses thermal stable 
DNA ligase and DNA polymerase.
Used for SNP detection Requires post-CCR separation steps on a gel. Yes
C h en eta i, 1998 Dye-labelled 
oligonucleotide 
ligation (DOL)
When an allele-specific oligo 
labelled with an acceptor dye is 
ligated to an oligo bearing a donor 
dye, FRET is observed. Cycling 
conditions are manipulated such that 
a signal is observed depending on 
the ligated extended probes.
Performed in a closed tube format 
with PCR and ligation reactions 
thermally isolated, made possible 
by careful primer design, very 
specific
All 3’ ligation probes are labelled with dyes, 
high reagent cost
Yes
Table 1.4: Common genotyping assays based on allele-specific oligonucleotide ligation. The list is not intended to be exhaustive due to the 
number of similar assays, but rather provide details of a range of assays.
PCR amplification of target region





Add dye-primer, allele-specific 
dye terminators and DNA 
polymerase
ddA- ft d d A -Q
Wild type allele T 1 Mutant allele C  M
d d G #  d d G -#
FRET Emission
wavelength 'R' FRET Emission
wavelength T'
— f .   3 ' c-
Target DNA ^  FAM-labelled primer ddA-(£| ROX-labelled ddNTP
Genomic DNA —► PCR primer ddG- t  TET-labelled ddNTP
Figure 1.15: The template-directed dye-terminator incorporation (TDI) assay. Target genomic DNA is first amplified by PCR. Excess PCR primers 
and dNTPs are degraded by E. coli exonuclease I and shrimp alkaline phosphatase. Following heat inactivation of these enzymes, the TDI 
reaction mix is added to the PCR products. An allele-specific primer extension reaction mediated by DNA polymerase occurs in which the donor 
dye-labelled primer is extended by a single base using a matched acceptor dye-labelled dideoxy terminators. A fluorescent signal characteristic of 
the reporter labelled ddNTP ensues (Chen and Kwok, 1999).
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FRET Emission wavelength T’
# 3' 3'
Target DNA #  FAM-labelled primer A $  ROX-labelled allele-specific A'primer
Genomic DNA ► PCR primer G •  TET-labelled allele-specific'G'primer
Figure 1.16: Dye-labelled oligonucleotide ligation (DOL) assay with FRET detection. Detection of a T to C SNP is shown in the diagram. A PCR 
amplification step of the SNP-containing target region achieves the required sensitivity of the assay. This is performed in the presence of 
sequence-specific dye-labelled probe portions. Upon hybridisation of the allele-specific portion of the probe (two are present, differentially labelled 
with ROX=R and TET=T), ligation to the FAM (F) labelled portion occurs, bringing the FAM and reporter dye in close enough proximity for FRET to 
occur. A signal characteristic of the allele-specific portion of the probe ensues allowing allele identification (Chen and Kwok, 1999).
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But PCR does have some disadvantages. These include the fact that many clinical 
laboratories may not have the proper facilities to conduct PCR-based genotyping. 
Amplicon contamination is a significant and often overlooked limitation for PCR- 
based techniques. The continual amplification of the same target within a clinic or 
surgery environment, leads to a significant risk of false positives from air borne 
amplicon requiring careful disposal of end-point material (Johnson and Johnson, 
personal communication). In a clinical diagnostic laboratory false positives are 
highly undesirable, but with the correct controls in place it is possible to recognise 
contamination should it occur. Physical methods to control contamination can be 
implemented such as the spatial separation of reagent storage and PCR reaction 
set-up, sample preparation, PCR reaction mix assembly (i.e. template addition), and 
PCR-product analysis, each with dedicated equipment (Neumaier et a i ,  1998). In 
addition, a licence fee is required to use PCR for diagnostic testing (US Patent No. 
4683195 by Cetus Corporation, now owned by Roche).
Consequently, clinical genotyping assays have been developed that can avoid a  
PCR step, by utilising enzymatic functions other than polymerisation by Taq DNA  
polymerase. A homogenous isothermal (without temperature cycling) reaction 
format using DNA ligation has been developed for genotyping SNPs, called the 
ligase chain reaction (LCR, Figure 1.17; W hiteley et a i ,  1989). Here, two pairs of 
oligonucleotide probes are used in cyclic ligation reactions, together with a 
thermostable DNA ligase for exponential amplification of genomic DNA. In practice, 
DNA ligases are used in combination with PCR to attain the required sensitivity 
(Combined chain reaction, CCR; Bi and Stambrook, 1997). A summary of other 
novel isothermal amplification techniques can be found in Table 1.5.
Out of all the nucleic acid amplification techniques described, PCR remains the 
most widely used and sensitive approach to DNA analysis. Consequently, PCR is 






Strand denaturation @ 95°C
3' 5'
Oligonucleotide annealing @ 55-65°C
Ligation of adjacent oligonucleotides 
by DNA ligase
Target DNA ijqase   Oligonucleotides complementary
to the whole target sequenceGenomic DNA -------------
Figure 1.17: The ligase chain reaction (LCR). In LCR, two pairs of probes complementary to 
the entire target sequence anneal at adjacent positions on the denatured DNA strands. 
Matched probes will be ligated together by DNA ligase, serving as targets for subsequent 
cycles leading to exponential amplification (Lee, 1996).
Chapter One
Table 1.5: Common genotyping assays based on isothermal amplification. The list is not 
intended to be extensive due to the number of similar assays, but rather provide details of a 
range of assays.
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Isothermal assays DNA amplification without the need fora PCR step
Reference Method Concept Advantages Disadvantages PCR step
Compton, 1991; 





Uses reverse Transcriptase, RNAse 
H and 17  RNA polymerase, in 
concert with two primers for 
isothermal amplification at 40°C.
Can give quantitative information 
about the target gene
Low temperature can result in non-specific 
primer interactions, not successfully adapted 
to SNP detection
No




Uses DNA polymerase and 4 special 
primers to amplify DNA by auto- 
cyciing strand displacement DNA 
synthesis at 60°C.
Can be performed in a laboratory 
incubator, sensitivity of detection is 
6 copies of target gene
Not yet adapted for SNP detection, separate 
analysis steps
No








Uses chimera primers (3’ end RNA, 
5’ end DNA), DNA polymerase with 
strand displacement activity, a 
ribonuclease that can cut the 
chimeric primer, and dNTPs, in a 
template switching reaction.
Has been applied to a chip-based 
format, takes place at 50-65°C
Not yet adapted for SNP detection No
Wharam e ta i, 2001 Signal mediated 
amplification of 
RNA technology 
(SMART) with a 
three Way 
Junction (3WJ)
Target dependent signal generated 
by 3WJ by activation of T7 RNA 
polymerase promoter. RNA signal 
measured by enzyme linked oligo- 
sorbent assay (ELOSA), or real time 
using molecular beacon.
Assay can be quantitative, 
requires same reagents regardless 
of assay and can be used to 
detect most SNPs.
Complicated probe design, requires 
improvement in sensitivity
No
Lyamichev et ai., 






A 5’ invading oligonucleotide and a 
partially overlapping 3’ signal 
oligonucleotide form a specific 
structure when bound to a 
complementary sequence. A flap 
endonuclease cleaves the structure, 
releasing the 5’ flap from the probe.
Assay is adaptable for a range of 
detection methods including mass 
spectrometry, FRET and FP by 
labelling the 5’ end of the allele- 
specific oligonucleotide.
Large amount of genomic DNA required to 




1.4 Real-time Quantitative PCR methods
Quantitative PCR (qPCR) is a term used to identify any PCR technique that allows 
determination of the quantity of a specific nucleic acid target in a biological sample. 
The traditional approach to qPC R  is quantitative-competitive PCR (Q C -PC R ; 
Becker-Andre and Hahlbrock, 1989), where a competitor amplicon would typically 
be constructed that contained identical primer binding sites as the target amplicon, 
yet would be differentiable by size on an agarose gel. The identical binding sites are 
intended to ensure that the amplification efficiency of both target and competitor 
amplicons are the same. A known amount of competitor DNA would be spiked into 
the same reaction, and the assumption made that amplification efficiencies of both 
amplicons were identical; the ratio of target to competitor should remain the same 
throughout the PCR test. By determining the ratio of target to competitor at the end 
of the reaction and knowing the starting amount used to spike the reaction, the 
starting amount of target can, in theory, be calculated.
f
There are several drawbacks to this Q C -P C R  approach. Firstly, quantitative 
measurements of amplicon are made at the end of a PCR test. Small differences in 
target concentration, quality and concentration of enzym e, dNTPs, magnesium  
chloride, primers, cycle length and number, annealing temperature, etc. can greatly 
affect the amplification efficiency, and subsequently final accumulation of PCR  
products. This means that even in the best experimental conditions, this and similar 
end-point approaches can only give a semi-quantitative or qualitative estimation of 
a nucleic acid template. The dynamic range of a Q C -PC R  assay is limited to a 
target-to-competitor ratio of 1:10 or 10:1 meaning that several dilutions must be 
tested to find a suitable ratio. Further, a suitable competitor requires construction 
and characterisation for every target to be quantitated (Bustin, 2000).
Quantitative PCR was revolutionised by the advent of real-time PCR (Figure 1.9, 
pg. 26; Higuchi e t a /., 1993). In this pioneering research, ethidium bromide was 
used as a reporter dye but instead of obtaining end-point measurements a kinetic 
PCR analysis was performed by exciting the PCR tests with UV transillumination,
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and taking a video image of the PCR test during each annealing and extension 
phase using a charge coupled diode (CCD) camera. By monitoring the amplification 
reactions containing a dilution series of initial starting template and plotting the 
increase in fluorescence versus cycle number, the quantitative performance of the 
assay was assessed. It was found that the larger the concentration of starting 
tem plate copies in the reaction, the earlier the rise in fluorescence above  
background occurs. This system produces amplification plots that provide a more 
complete picture of the PCR process than assaying product accumulation after a 
fixed number of cycles, and allows quantification over a large dynamic range.
PCR instrumentation with the ability to continuously monitor thermal data, combined 
with sensitive dyes and accurate data analysis software, provide a sensitive 
platform on which to base homogenous qPCR experiments for a range of clinical 
applications (Table 1.6). With real-time monitoring, quantification can be performed 
using data generated during the log-linear (or exponential) phase of PCR (Figure 
1.9, Phase 2). During the log-linear phase, amplification efficiency is assumed to be 
constant, without limiting components, inhibition, or interference from noisy 
background fluorescence levels. In addition, replicate reactions produce uniform 
and reproducible results (Rasmussen, 2001).
Monitoring the log-linear phase of a PCR reaction offers significant improvements 
over methods collating data from plateau phases, which is where most end-point 
measurements are made. As described earlier, any slight difference in a limiting 
com ponent can have a drastic effect on the final amount of product, and  
reproducibility is poor. During the plateau phase, the reaction curve exhibits little or 
no net increase in PCR product (Figure 1.9, Phase 5). This is thought to be caused 
by numerous events including depletion of reaction components (dNTPs, enzyme, 
primers), thermal inactivation of DNA polymerase, inhibition of enzyme activity by 
increasing pyrophosphate production, reduction in the denaturation efficiency per 
cycle, destruction of product due to enzyme 5 ’-3 ’ exonuclease activity, product to 
product reannealing (Wittwer e t a i ,  1997), the chelation of critical metal ions by the 
amplicon depriving the enzyme of a cofactor (Wharton and Eisenthal, 1981), or high 
substrate/amplicon inhibition (Dimitiov and Apostolova, 1995; Kainz, 2000).
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Fluorescence readings acquired during the log-linear phase can be used for 
quantifying nucleic acids in a sample by two basic methods, absolute and relative 
quantification. For both methods, the generation of reproducible and reliable 
estimates of nucleic acid concentration relies partly on the accurate measurement 
of a ‘cycle threshold’ (CT) value. The CT value defines a particular cycle or position 
of the amplification curve, derived from the point at which the fluorescence signal 
rises above background noise (Figure 1.9). Identical DNA samples at identical 
concentrations should produce similar cycle threshold values. The different 
methods used for defining the C T using two real-time PCR instruments is 
summarised in Figure 1.18.
Absolute quantification methods use CT values to form a standard curve, and target 
values are usually expressed as an absolute value (copy number or grams). 
Generally, separate PCR (or reverse transcriptase PCR; RT-PCR, Figure 1.19) 
tests are run consisting of serial dilutions of known target concentrations (Figure 
1.20A), alongside sam ples of the sam e target of unknown DNA (or RNA) 
concentration. The standards are amplified in different reaction vessels, but within 
the same PCR run (external standards). Hlguchi et a i  (1993) showed that a plot of 
the log of initial target copy number (or concentration) for a set of standards, versus 
the cycle threshold is a straight line (Figure 1.20B). Therefore, the cycle threshold 
value of the unknown can be determined by interpolation from the linear regression 
of the appropriate external standard curve to estimate the initial DNA (or RNA) 
concentration.
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Application Advantages Disadvantages Main considerations
Clinical, Food and 
Veterinary Microbiology
e.g. viral load, bacterial 
load, fungal load
Similar sensitivity to classical methods 
but faster, less labour intensive, and 
higher sample throughput.
Detects nucleic acids from live and dead organisms, 
classical methods only quantify live organisms. It remains 
unknown which parameter is most useful in deciding the 
relevant factor i.e. disease induction, virulence of pathogen.
Infectious agents have high mutation rate, 
which can influence viral load estimates if 
primers cannot bind due to mismatches. 
Therefore, where possible, choose highly 
conserved regions for assay development.
Clinical Oncology
e.g. minimal residual 
disease, chromosomal 
translocations, SNPs
High technical sensitivity of <5 copies 
per reaction.
Does not entail the primer design 
issues associated with infectious 
agents.
Sensitivity is key to minimal residual disease monitoring or 
transmission of endogenous pathogens during 
xenotransplantation; therefore maximal input of DNA into the 
PCR is the limiting step.
Sensitivity and discriminatory abilities are the 
two main considerations here.
The aspects concerned with SNP detection are 
discussed throughout this Chapter.
Gene Expression and 
Gene Therapy
e.g. cytokines, receptors 
etc. or gene transfer 
estimates, biodistribution 
of vectors
Reproducibility of an optimised RT- 
PCR assay is nearly as good as a 
real-time PCR assay.
Using the comparative quantitative 
method one can use relative 
quantification without generating RNA 
standards.
Need to test and confirm the reproducibility of the 
housekeeping gene before reliable data can be obtained.
Loss of RNA during extraction or storage is common- spiking 
the sample with a control RNA can test for this problem. 
Comparative degradation of sample and spiked RNA adds a 
further issue.
Choice of housekeeping gene and sample 
preparation is critical.
Ensure that DNA does not contaminate the 
RNA sample otherwise inaccurate gene 
expression levels will be obtained.
Table 1.6: Selected applications of real-time qPCR including advantages, disadvantages, and main considerations. This list is not intended to be 






















Figure 1.18: [A] LightCycler Fit Points Method of defining the cycle threshold (called the 
‘crossing point’, Cp, by Roche). The user manually sets a baseline (green) above the 
background noise. Points are selected on the log-linear portion of the curve, and a straight 
line of y = mx + c is drawn through the points. The crossing point is the fractional cycle 
number at which an interpolation of the linear curve crossed with the manually set threshold. 
[B] ABI Prism 7700 Sequence Detection System software automatically performs a baseline 
correction above the background noise to set a baseline (green line). The fractional cycle 
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Figure 1.19: Reverse-transcriptase PCR (RT-PCR) for the quantification of RNA (for gene 
expression studies). An RNA template is transcribed into cDNA by reverse transcriptase. 



























Figure 1.20: Real-time qPCR with external standards using a standard curve and mono­
colour detection. [A] Typical amplification profile of product accumulation, monitored using a 
dsDNA binding dye. Fluorescence readings are acquired at a frequency of once per cycle. 
For relative quantification, the standards do not have concentration values. Target 
amplifications are compared with the standard curve from a reference gene (see text) and 
quantities are given as an n-fold increase in product compared to the reference. [B] A cycle 
threshold (see Figure 1.15) is defined for each cycle, representing the same point of the 
PCR curve for each starting DNA concentration. The cycle threshold is plotted vs. the log 
concentration or log copy number to generate a standard curve from which the 
concentrations of unknown standards can be interpolated.
Chapter One
There are two key considerations when designing experiments for the absolute 
quantification of nucleic acid. Firstly, the amplification efficiency of the standards 
and target DNA must be the same during the run, and between runs (Bustin, 2000). 
This can be achieved if the targets are identical, or ligated into a plasmid vector 
meaning the targets have identical binding sites (similar to Q C -PC R  strategies). 
However, since the size of the template can also affect PCR efficiency, this could 
introduce error if genomic DNA samples are being quantified. Secondly, a set of 
standards containing a defined number of targets is required. Since the ‘absolute’ 
numbers are always calculated relative to a standard, the accuracy of the number 
largely depends on the accuracy of the standard used (Klein, 2002).
Absolute qPC R  using external standards can be subdivided into ‘mono-colour’ 
detection, or ‘dual-colour’ detection. The former is accomplished by using a dsDNA  
specific binding dye (which can be used to monitor all qPCR reactions) or a single 
real-time PCR probe (introducing sequence-specificity), to monitor the reaction. 
Using a dsDNA specific binding dye is the least expensive approach, and has a 
high dynamic range, although there is no control for PCR inhibitors influencing 
efficiency. W hen monitoring the test using a dsDNA binding dye, the fluorescence 
signal may be contributed to by primer dimer amplification as opposed to target. 
Primer dimer amplification occurs more readily where template concentrations are 
very low due to the lack of target DNA, and therefore highly optimised reactions are 
required for sensitive assays (Klein, 2002).
For dual-colour detection, reactions are monitored with an internal control 
amplification using sequence-specific real-time PCR probes. As with mono-colour 
detection, the method uses external standards to determine the concentration of the 
target sam ple, except the target is co-amplified with a heterologous control 
amplicon spatially separated from the target. The control is used to measure the 
PCR performance and test for inhibitors, or inefficient nucleic acid extraction. The  
control is a desirable attribute to assays used in a clinical setting where the reason 
for a negative signal cannot be ambiguous (Neumaier, 1998).
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Another methodology in qPCR experiments is relative quantification. Relative  
quantification approaches are used to compare differences in nucleic acid targets 
among different samples compared to a reference gene, such as monitoring gene 
expression levels. A reference gene, often called a housekeeping gene or 
calibrator, is a nucleic acid that is present at a near constant concentration or copy 
number in all samples being compared. The reference gene may be endogenous, 
usually a gene that is naturally present in the sample material at constant levels 
such that the regulation of the target species can be relatively quantified using a 
second set of primers, or it may be exogenous, an internal reference that is added 
to the sample at known concentration and is co-amplified with the target nucleic 
acid using a second set of primers..
Relative quantification may be performed using external references with a standard 
curve (similar to absolute qPCR methods). In this case, separate tubes are run and 
the quantity is expressed as an n-fold difference relative to the reference. Instead of 
an absolute value, for all experimental samples the target quantity is determined 
from the standard curve and divided by the target quantity of the calibrator 
(Rasmussen et al., 1998). A typical application of this method would be monitoring 
drug effects on gene expression using reverse transcriptase PCR (RT-PCR) where 
an untreated control would be the calibrator and samples isolated from patients 
using the drug would be compared against this (Klein, 2002).
Alternative methods of relative quantitative PCR are generally designed for the 
specific software that accompanies particular PCR instruments, using novel 
algorithms to model the PCR and elim inate the need for standard curve  
construction. PE Applied Biosystems instruments (Forster City, CA, USA) present a 
method called the comparative-relative PCR (AACT). The method is based on the 
fact that the difference in threshold cycles (ACT) between the gene of interest and 
the housekeeping gene is proportional to the relative expression level of the gene of 
interest (Livak and Schmittgen, 2001). Therefore, the target gene quantity can be 
inferred. The LightCycler™ (Roche Molecular Biochemicals, USA) uses a similar 
approach, except the relative gene expression ratio is calculated from the real-time
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PCR efficiencies and the crossing point (Cp) deviation of an unknown sample 
versus a calibrator (ACp; Pfaffl, 2001).
A pre-requisite for all relative quantification methods is that the PCR efficiency of 
the target is identical in the reference and sample. In addition, the selection of the 
reference gene is critical to the success of the assay. For example, in m RNA  
quantification, a ‘housekeeping’ gene is used which is a non-regulated gene in the 
same sample that is constitutively expressed at an identical level to all samples to 
be analysed. However, even housekeeping genes do not have constant expression 
levels and as yet, there is no universally accepted method for normalisation using 
housekeeping genes (Bustin, 2001).
The work described in this thesis builds upon the PCR process to develop assays 
for the detection of well-characterised SNPs in diagnostic testing. In addition, the 





All oligonucleotide sequences (Appendix I) were designed using PrimerCalc®  
software (Q-Biogene; Carlsbad, CA, USA), and supplied by Sigm a Genosys  
(Gillingham, UK) with a reverse phase cartridge purification step.
2.0 PCR Amplifications
2.0 . 1 G e n e ra l p ro toco l using on MJ PTC-100 C yc ler
For all amplifications performed using a PTC-100 MJ Thermal Cycler (GRI, Essex, 
UK), Promega (Madison, USA) supplied the reagents. Each PCR was performed in 
a sterile 0 .8  ml polypropylene tube containing 10x M g-free PCR buffer, 
oligonucleotides, Taq DNA polymerase, magnesium chloride, dNTPs and template 
DNA. The total reaction volume was made up to 25 pi using PCR-grade water 
(Sigma Genosys, UK). Component concentrations varied for each experiment, and 
are stated throughout.
A general thermal cycling program consisted of an initial denaturation step at 95°C  
for 2 min, followed by 30 amplification cycles of denaturation at 95°C  for 30 s, 
annealing at 60°C  for 30 s, and extension at 72°C  for 30 s. Holding the sample at 
72°C for 3 min constituted a final extension step. Protocols deviating from this 
general program are stated throughput. Samples were visualised on an agarose gel 
according to Section 2.5.4.
2.0.2 G e n e ra l p ro toco l using a  LightCycler™
For all amplifications performed using the LightCycler™  instrument (Roche  
Molecular Biochemicals, Lewes, UK), Roche Molecular Biochemicals supplied all 
reagents and consumables. Each PCR was performed in glass capillary, containing 
DNA Master FastStart SYBR® Green I mixture (10x; Taq DNA polymerase, reaction 
buffer, magnesium chloride, dNTPs, and SYBR Green I dye), oligonucleotides,
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additional magnesium chloride, and template DNA. The total reaction volume was 
made up to 20 p,l using PCR-grade water. Component concentrations varied for 
each experiment, and are stated throughout.
A general thermal cycling program consisted of a 10-minute initial denaturation step 
(to activate the Taq  DNA polymerase) at 95°C, followed by 40 amplification cycles 
of 1 s denaturation at 95°C, 5 s annealing at 60°C, and an extension phase at 72 °C  
for 5 s. A single fluorescence reading was acquired at the end of the extension 
phase. All temperature transitions were 20 °C .S '1 and fluorescence gains (used to 
set sensitivity of the LightCycler™) were F1-1 throughout. Protocols deviating from 
this general program are stated throughout.
2.0.3 M elt curve analysis using a  LightCycler™
Following each amplification, a melt curve analysis was performed in the same 
closed glass capillary with a denaturation step at 95 °C, followed by a cooling step 
to 5°C above primer annealing temperature (ensuring all fluorescence originates 
from product-to-product re-annealing) and a slow denaturation phase to 95°C at a 
rate of 0.1°C.s'1, with continual fluorescence acquisition. Amplicon denaturation was 
observed as a rapid loss of fluorescence near the calculated melting temperature 
(T m). These data were converted into melting peaks by the LightCycler™ Data 
Analysis Software (Version 3.0; Roche Molecular Biochemicals), by plotting the first 
negative derivative of fluorescence loss, F ,  with respect to tem perature, T  




2.1 Plasmid DNA Library Construction
A small library of four plasmids was prepared to model a “susceptibility” gene. Each 
plasmid is identical apart from the presence of a single nucleotide polymorphism (G, 
C, A or T) at identical base positions. Prom ega supplied all reagents unless 
otherwise stated.
2.1.1 Am plification o f fa rg e t sequences con ta in ing  polym orphism
PCR tests were performed on the LightCycler™ according to Section 2.0.2, except 
an extension time of 10 s was used. Amplification was directed by primers ACT BF 
and ACT BR generating a 374 bp insert from human genomic DNA. Primers were 
included at a concentration of 0 .6  pM  each, at a final magnesium chloride 
concentration of 3 mM. Human genomic DNA template was included at 15 ng total. 
A melt curve analysis (Section 2.0.3) generated a single peak at 88 °C, confirming 
specificity of the product.
PCR amplicons were purified using Wizard® PCR Preps DNA Purification System  
(Section 2.3.1), and subsequently used as template DNA in PCR reactions directed 
by primers AC T BF and ACT BRX (where X is G, C, A or T), according to test 
conditions described above. Primer A C T BRX was designed with a single 
polymorphism at a defined position in a 5 ’ tail, to incorporate a SNP at the same 
position in the four resulting amplicons. Amplicons were purified, and stored at 
-2 0 °C  until use.
2 .1.2 Ligation o f PCR fragm enfs into p lasm id ve c to r
Ligations were carried out using the pGEM®-T Easy Vector System II. The  
linearised vectors have a 3 ’ terminal thymidine residue at both ends complementary 
to the poly ‘A’ tail added to PCR amplicons synthesised by Taq  DNA polymerase. 5 
pi of 2X Rapid Ligation Buffer was added to 1 pi of pGEM®-T Easy Vector (50 ng), 1 
pi of T4 DNA Ligase (3 Weiss units.pl'1), and 7 pi of purified PCR product. A positive 
control and background control were prepared by replacing PCR fragments with 
Control Insert DNA or PCR-grade water, respectively. All reactions were mixed by
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pipetting, and incubated for 1 hour at room temperature. Figure 2.1 displays the 
plasmid map. The position and sequence of the cloned insert is described in detail 
in Appendix II. The position of the polymorphic sequence was verified by 
sequencing using BigDye Terminator Cycle Sequencing Ready Reaction Kits on an 
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Figure 2.1: Plasmid map of the pGEM-T® Easy Vector Plasmid System II. The (3-actin DNA 
insert is in the multiple cloning site at position 52. Actual sequence is shown in Appendix II. 




2.2 Preparation and Transformation of Competent 
Eschericia coli Cells
All chemicals and reagents were supplied by Sigma Aldrich (Dorset, UK) and were 
of analytical grade unless otherwise stated. Becton Dickinson and Company (New  
Jersey, USA) supplied all media chemicals unless otherwise stated.
2.2. 1 Preparation o f fresh or frozen c o m p e te n t E. co li cells 
Com petent E. coli cells were routinely prepared from a frozen stock (stored at 
-7 0 °C  in 15% sterile glycerol) by streaking the E. coli cells onto the surface of a  
Luria-Bertani (LB media: 10 g.l'1 Bacto®-tryptone, 5 g.l'1 Bacto®- yeast extract, 5 g.l'1 
NaCI) agar plate (15 g.l'1 agar; Oxoid, Hampshire, UK) using a sterile platinum wire. 
The plates were incubated for 12-16 hours at 37°C.
5 ml LB media (10 g.l'1 Bacto®-tryptone, 5 g.l'1 Bacto®- yeast extract, 5 g.l'1 NaCI) 
was inoculated with a single well-isolated colony of 1-2 mm diameter, and grown for 
3 hours at 37°C. Cells were transferred aseptically into sterile, ice-cold 50 ml 
polypropylene tubes and cooled to 0°C by storing on ice for 10 min. Cells were  
recovered by centrifugation at 4000 rpm for 10 min at 4°C . Media was decanted  
from the cell pellets, and tubes were inverted for 1 min allowing the last traces of 
media to drain away. Pellets were resuspended in 20 ml (per tube) of ice-cold 
transformation buffer (TFB; 10 mM MES [pH 6.3], 45 mM MnCI2.4 H 20 , 10 mM 
C a C I2.2 H 20 ,  100 mM KCI, 3 mM Hexamminecobalt chloride). When frozen 
competent E. coli for storage at -7 0 °C  were prepared, FSB (10 mM Potassium  
acetate [pH 7.5], 45  mM MnCI2.4 H 20 ,  10 mM CaCI2.2 H 20 ,  100 mM KCI, 3 mM  
Hexamminecobalt chloride, 10% glycerol) was used in place of TFB. Resuspended 
cells were stored on ice for 10 min, and recovered by centrifugation at 4000 rpm for 
10 min at 4°C . The supernatant was decanted and tubes were inverted for 1 min to 
remove the last traces of buffer. The pellet was resuspended in 4 ml (per tube) of 
ice-cold TFB or FSB.
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To prepare fresh competent cells, 140 pi of DnD solution (1.53 g dithiothreitol, 9 ml 
DMSO, 100 pi 1 M potassium acetate [pH 7.5], H20 to 10 ml) was added to each 
suspension and mixed gently by swirling; the suspension was stored on ice for a 
further 15 min. Aliquots of the suspensions were dispensed into chilled, sterile 
polypropylene tubes, and stored on ice before use.
To prepare frozen stocks of competent cells, 140 pi of DM SO  was added per 4 ml 
of resuspended cells. Tubes were mixed gently by swirling and stored on ice for 15 
min. An additional 140 pi of DM SO was added to each suspension and mixed 
gently before returning the suspensions to an ice-bath. 400 pi aliquots were  
dispensed into chilled, sterile microfuge tubes and immediately snap-froze in liquid 
nitrogen prior to storage at -7 0 °C  until required.
2.2.2 Transformation o f fresh or frozen c o m p e te n t E. co li cells 
Plasmid DNA was added to 10 pi of thawed (from frozen stock) or fresh competent 
E. coli cells (prepared in Section 2.2.1). Tubes were gently swirled several times to 
mix their contents and stored on ice for 30 min. The volume of DNA solution did not 
exceed 5%  of the volume of competent cells. Two controls were incorporated 
including competent bacteria that receive a known amount of the standard  
preparation of supercoiled plasmid DNA and competent bacteria that receive no 
plasmid DNA at all.
Tubes were heat-shocked to 42°C  in a water bath for exactly 2 min, and rapidly 
transferred to an ice bath to chill for 2 min. 1 ml of LB media was added to each 
tube before being placed in a shaking incubator set at 37°C  for 45 min, allowing 
bacteria to recover and express the antibiotic resistance marker encoded by the 
plasmid (ampicillin resistance). Cells were concentrated by centrifugation (4000 rpm 
for 10 min at room temperature) and the supernatant was discarded. The pellet was 
resu sp en d ed  by g en tle  p ipetting  read y  for co lony se lec tio n  by 
insertional inactivation (Section 2.2.3).
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2.2.3 Testing b a c te r ia  for insertional inactivation
40 pi of a stock solution of X-gal (20 mg.ml'1 in dimethylformamide) and 4 pi of a 
solution of isopropylthio-p-D-galactodise (IPTG ) (200 mg.ml'1) were added to an LB 
agar plate containing 50 pg.ml'1 of ampicillin. A sterile glass spreader was used to 
spread the solutions over the agar surface and plates were incubated at 37°C until 
the fluid had disappeared. The supplemented LB plate was inoculated with 200 pi of 
the suspension to be tested, and left until the inoculum had been absorbed. The  
plate was incubated in an inverted position for 12-16 hours at 37°C.
Plates were stored at 4°C for several hours until the blue colour had fully 
developed. All colonies were transformants since they contained the active 
antibiotic resistance gene. The ability of the p-galactosidase to form blue colonies in 
the presence of IPTG shows that the lacZ  gene was not interrupted by successful 
ligation of the PCR insert. Positive white colonies demonstrated that the insert was 
present. Single colonies were picked and spread onto fresh LB X.I.A  agar plates, 
and grown overnight at 37°C to confirm that colonies are actually white and not slow 




Buffer contents from DNA Purification Kits are disclosed, unless information is 
proprietary to the Supplier.
2.3.1 Wizard® PCR Preps for DNA purification
The Wizard® PCR Preps DNA Purification System (Promega) was used to isolate 
PCR amplicons from non-specific artefacts including primer dimer. 50 j l l I  of 
completed PCR test was added to a clean 1.5 ml microcentrifuge tube containing 
100 pi of Direct Purification Buffer (50 mM KCI, 10 mM Tris-HCI [pH 8.8], 1.5 mM  
M gCI2, 0.1% Triton® X-100). The mix was vortexed briefly. Guanidinium chloride 
contain resin (1 ml) was added and vortexed briefly three times over a 1-minute 
period. For each PCR product, one Wizard® Minicolumn was prepared with the tip 
inserted into a vacuum manifold. The resin/DNA mix was pipetted into the syringe 
barrel, and a vacuum was applied to draw the resin/DNA mix through the 
Minicolumn. The column was washed by drawing 2 ml of 80%  isopropanol through 
the syringe barrel under vacuum, and dried by drawing a vacuum for a further 30  
seconds after the solution had been pulled through. The syringe barrel was  
transferred to a 1.5 ml microcentrifuge tube and residual isopropanol was removed 
by centrifugation at 4000 rpm for 2 min. The Minicolumn was transferred to a new  
centrifuge tube. 50 pi of PCR-grade water was applied to the Minicolumn and left to 
stand for 1 min before centrifugation at 4000 rpm for 20 seconds to elute the DNA  
fragment. The purified DNA was stored at 4°C until use.
2.3.2 QiAprep® Spin M in iprep Kit pro toco l
The QIAprep® Spin Miniprep Kit (Qiagen Sciences, Maryland, USA) was used to 
purify the plasmid DNA. Overnight cultures of transformed E. coli were prepared by 
inoculating 5 ml of LB media containing 50 pg.ml'1 of ampicillin with a single positive 
colony (prepared as described in Section 2.2.3). Solutions were incubated for 12-16 
hours at 37°C. Bacterial cells were concentrated by centrifugation at 10000 rpm for 
2 min. The media was discarded and the bacterial pellet was resuspended in 250pl 
Resuspension Buffer (Buffer P1; 50 mM Tris.CI, pH 8.0, 10 mM EDTA, 100 pg.ml'1
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Rnase A) to weaken the bacterial cell wall. The suspension was transferred to a 1.5 
ml microfuge tube and 250 pi Lysis Buffer (Buffer P2; 200 mM NaOH, 1% SDS w/v) 
was added. The solution was mixed gently by inversion. The alkaline conditions 
completely lysed the phospholipids and protein components of the cell membrane.
350 pi Buffer N3 (containing 25-50%  guanidinium chloride and 10-25%  acetic acid) 
was added and tubes inverted 4-6 times, until the solution became cloudy. This 
neutralised the whole lysate causing chromosomal DNA to denature forming an 
insoluble network, whilst protein-SDS complexes and high molecular weight RNA  
precipitated. Samples were centrifuged at 4000 rpm for 10 min until the supernatant 
containing plasmid DNA was clear and a compact white pellet of the contaminating 
macromolecule was formed. Supernatant was removed by gentle aspiration and 
applied to the QiAprep® spin column. Tubes were centrifuged for 1 min and the 
flow-through was discarded. Buffer PB (0.5 ml containing 25-50%  guanidinium  
chloride and 25 -50%  propan-2-OI) was added to the column, followed by 
centrifugation for 1 min to remove trace nuclease activity.
The QiAprep® spin column was washed by adding 0 .75 ml Buffer PE (containing 
ethanol) and centrifuging for 1 min. Flow-through was discarded, and an additional 
centrifugation step (1 min) removed residual wash buffer. Finally, the QiAprep® 
column was placed in a clean 1.5 ml microfuge tube and DNA was eluted by adding 
50 pi PCR-grade water to the centre of each column. Columns were left to stand for 
1 min prior to centrifugation at 4000 rpm for 1 min.
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2.4 Plasmid DNA Quantitation
Plasmid DNA was quantified following purification. It is essential that concentrations 
are identical in order to validly compare results obtained using each plasmid DNA  
template. Since spectrophotometric analysis (Section 2 .4 .2 ) often overestimates 
DNA yield and can be slightly variable, concentrations were refined by real-time 
quantitative PCR methods (Section 2.4.3).
2.4. I Agorose G e l Electrophoresis
10 pi of Lambda DNA (Promega) concentration standards (5 to 50 ng.pl'1) with 2 pi 
bromophenol blue gel loading buffer were separated electrophoretically alongside 
unknown DNA samples on a 1 % agarose gel (Molecular Biology Grade Agarose; Q- 
Biogene) containing 0.5 pg.ml'1 ethidium bromide (Sigma Aldrich). Electrophoresis 
was performed in 1x TBE (5x TBE stock solution; 0 .445 M Tris-borate, 10 mM  
EDTA, [pH 8.3]) at 30 mA constant current. Products were visualised by UV  
transillumination (305nm) using a High Performance Ultraviolet Transilluminatior 
(Ultra-Violet Products Limited; Cambridge, UK) and images captured. Maximal band 
optical density (O D max) was measured using LabWorks™ Gel Analysis Software 
(Version 3.0; Ultra-Violet Products Limited) and plotted as a standard curve, 
allowing estimation of unknown DNA concentrations.
2.4.2 S pectrophotom etric  Analysis
DNA was quantified by spectrophotometric analysis using a Cary-100 Bio UV- 
Visible Spectrophotometer (Varian; Surrey, UK). 150 pi of PCR-grade water was  
added to a microcuvette with a path length of 0.5 cm and baseline absorbance 
readings were obtained between 260 nm and 280 nm. Purified plasmid DNA  
(Section 2.3.2) was diluted into PCR-grade water up to 150 pi, and added to a clean 
quartz microcuvette. Absorbance readings from 260 nm to 280 nm were taken 
using the baseline correction. The reading at 260 nm was recorded and used to 
calculate the concentration of nucleic acid in the sample since 1 OD corresponds to 
~ 50 p g .m l1 (average extinction coefficient) for double stranded DNA. Absorbance
75
Chapter Two
readings below 0.05 at 260 nm were considered insignificant and the OD26o/OD28o 
value assessed DNA purity, which was > 1.7 in each case (Sambrook etal., 1989).
2.4.3 Q uan tita tive  PCR (qPCR) M ethods
Plasmid concentrations estimated by spectrophotometric methods (Section 2 .4 .2), 
were refined using real-time qPCR methods. Primers ICF and ICR were used to 
direct the amplification of a 223 bp fragment from plasmid DNA, spatially separated 
from the DNA insert and variant nucleotide. Each PCR was performed on the 
LightCycler™ according to Section 2.0.2, containing 0.5 |iM  each primer, and a final 
concentration of 3 mM MgCI2. External standards consisted of 2 jxl of plasmid 
preparation (with variant nucleotide G) at an initial estimated concentration of 10 
ng.pJ'1, and 10x dilutions (1:10, 1:100, 1:1000, and 1:10000). These were amplified 
alongside tests containing 2pl of plasmid preparations C, A, and T. Following PCR, 
a melt curve analysis was performed (Section 2.0.3), to confirm product specificity. 
The Fit Points Method (LightCycler™ Data Analysis Software; Version 3.0) was 
used to estimate initial concentrations of plasmids relative to the external standard. 
All plasmids were then diluted to the same concentration as the standard.
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2.5 Human Genomic DNA Isolation and Restriction
Buffer contents from DNA Isolation Kits are disclosed, unless information is 
proprietary to the Supplier.
2.5.1 Isolation from B uccal C ell Sw ab
Human genomic DNA was isolated from buccal cell swab using the Puregene® DNS 
Isolation Kit (Gentra Systems, Minneapolis, USA). Buccal cell samples were 
collected by scraping the inside of mouth with a sterile nylon cytology brush. The 
collection brush was dipped up and down 10 times in a 1.5 ml microfuge tube 
containing 300 pi Cell Lysis Solution, and incubated at 65°C  for 60 min. 1.5 pi of 
RNAse A solution was added to the cell lysate followed by mixing by inversion 25 
times. The sample was incubated at 37°C for 15-60 min. The sample was cooled to 
room temperature and 100 pi of Protein Precipitation solution was added to the cell 
lysate. The tube was placed in an ice bath for 5 min before centrifugation at 10 000 
rpm for 3 min. The supernatant containing the DNA was poured into a clean 1.5 ml 
microfuge tube containing 300 pi 100% isopropanol and 0.5 pi Glycogen solution 
(20 mg.ml'1). The sample was mixed by inversion 50 times and incubated at room 
temperature for 5 min. The sample was centrifuged at 10000 rpm for 5 min and the 
DNA was visible as a small white pellet. The supernatant was discarded, and the 
tube drained on clean absorbent paper. 300 pi of 70%  ethanol was added to wash 
the DNA followed by centrifugation for 1 min. The ethanol was carefully poured 
away and the tube left to air-dry for 15 min. 20 pi of DNA Hydration Solution (10 mM 
Tris, 7 mM EDTA [pH 7.0-8.0]) was added and incubated for 1 hour at 65°C to 
disperse the DNA. DNA was stored at 4°C until use.
2.5.2 Requesting DNA sam ples from external laboratories
DNA sam ples isolated from patients with sickle cell anaem ia or hereditary 
haemochromatosis were obtained from external laboratories. A letter was sent to 
potential suppliers (Figure 2 .2), for approval by the Ethical Committee of the 
appropriate institution. Samples were assigned a number and these were the only
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details given to ensure patient confidentiality. The sample genotypes according to 
the source laboratory were only supplied following in-house tests.
2.5.3 DNA restriction, A garose G e l Electrophoresis
1 pig DNA was restricted with 20 units restriction enzyme in One-Phor-AII Plus 
buffer (Amersham Pharmacia, Little Chalfont, UK) made up to a final volume of 30 
pi with PCR-grade water. Samples were incubated for 1 hour at the appropriate 
tem perature followed by an enzym e deactivation step for 15 min. Digestion 
products (10 pi) were added to bromophenol blue gel loading buffer (2 pi) and 
separated electrophoretically on agarose gels (0.7%  to 2.5% ) containing 0.5 pg.ml'1 
ethidium bromide. Electrophoresis was performed in 1x TBE at 30 mA constant 
current. Products were visualised by UV transillumination on a High Performance 
Ultraviolet Transilluminatior (305nm ). Gels were photographed and analysed by 




Re: DNA samples for SNP detection
Further to our telephone conversation on the 7th February, I am writing with a request for some DNA 
samples to be used for research purposes only.
I am a final year PhD student at the University of Bath, sponsored by Molecular sensing pic, working on the 
development of novel assays for single nucleotide polymorphism {SNPs) detection. My work so far has 
culminated in the development of a PCR-based assay enabling the rapid identification of sickle cell 
anaemia from human genomic DNA samples (provided by Dr. John Old at the National 
Flaemoglobinopathy Reference Service, Oxford, UK).
Flowever, I have been advised that for a more thorough evaluation of this test, I need to demonstrate its 
applicability to other polymorphisms/deletions, such as those contributing to diseases such as cystic 
fibrosis, hereditary haemochromatosis, familial hypercholesterolaemia, and other genetic disorders. 
Therefore, I am writing to ask if you could kindly spare a small amount of DNA from approximately 10-15 
patients with a disease from the list above (or any other clinically relevant SNP), which I could use for the 
purpose of assay validation to help in my PhD research.
On the advice of the Cytogenetics laboratory at Southmead, I have contacted Simon Ramsden at St. 
Marys Flospital, Manchester, to check the regulations for sending DNA samples between laboratories prior 
to sending this request. He advised that currently this is not a problem, but within the next few months a 
restriction will be put in place. He could not see any problems for DNA to be transferred at this time.
I have enclosed details of my two PhD supervisors below such that they can be contacted if appropriate. 
Also, I would be more than happy to visit your laboratory to discuss my request further.
Please do not hesitate to contact my supervisors or me if you have any queries and many thanks in 
anticipation of your help.
Yours sincerely
Christy Waterfall




Optimisation of Allele-Specific PCR (AS-PCR) 
for SNP Genotyping
3.0 Introduction
Prior to polymerase chain reaction development (Chapter One; Mullis and 
Faloona, 1987, Saiki et a l ,  1985), diagnostic tests for the detection of single 
base polymorphisms were restricted, primarily due to a lack of sensitivity and 
labour-intensive analyses (Chang and Kan, 1982). Typically, each test required 
approxim ately 250  ng of genomic as DNA starting material to acquire 
informative results, which represents the upper level of most extraction  
techniques. PCR allows the exponential amplification of specific regions of DNA  
copies from a single genomic copy, delivering the desired sensitivity and 
specificity for a range of genotyping tests including traditional RFLP-based  
assays (Figure 1.5F, pg. 18) to contemporary sequence-specific detection using 
oligonucleotide probes (Figure 1.5A ). Consequently, the majority of all 
genotyping tests developed to date involve a PCR step, either front-end, back­
end or integral to the test (Tables 1.1-1.5 inclusive, pgs. 30, 44, 46, 47, 54 and 
58).
In 1989, PCR itself was modified for SNP detection in a technique called allele- 
specific PCR (AS-PCR), also referred to as the amplification refractory mutation 
system (ARMS; Newton et al., 1989), allele-specific amplification (ASA; Nichols 
et al., 1989), or preferential amplification of specific alleles (PASA; Sarkar et al.,
1990). A schematic of conventional AS-PCR is shown in Figure 3.1. The design 
of conventional AS-PCR tests is simple. Typically two separate PCR tests are 
required to genotype a bi-allelic system. One test contains an allele-specific 
primer with complementarities to the wild type DNA sequence and the other 
contains an allele-specific primer with 3 ’ terminal complementarities to the 
mutant DNA sequence. Given that Taq DNA polymerase initiates synthesis from 
the 3 ’ end of a primer and lacks a 3 ’-» 5 ’ proofreading activity, a mismatched 
primer is refractory to extension under optimised conditions, resulting in poor 






Genomic DNA Newly-synthesized DNA ► Matched primer r  Mismatched primer
Figure 3.1: Schematic representation of conventional allele-specific PCR for the detection of a C to A polymorphism. [A] The allele-specific primer (with 3’ 
terminal G) and common primer (CP) will amplify from genomic DNA samples homozygous for the wild type ‘C’ allele. A newly synthesised DNA strand of a 
pre-defined size will be produced. [B] Genomic DNA samples homozygous for the mutant allele ‘A’, genomic DNA will not be amplified efficiently due to a 
mismatch at the 3’ end of the wild type allele-specific primer. The genotype can be inferred by performing two separate PCR tests incorporating the same 
template DNA containing each allele-specific primer complementary to the wild type or mutant allele. Heterozygotes will synthesise the correct amplicon in 
both reactions since both alleles are present.
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The inclusion of a common reverse primer, designed to lie at a pre-defined distance 
from the SNP site, allows the user to identify the allele-specific products, typically by 
size separation of DNA fragments methods and subsequent staining with a DNA  
binding dye such as ethidium bromide (Figure 1.6A, pg. 20; Markovits eta l., 1979). 
The genotype can be inferred from amplicon profiles of the two separate PCR tests. 
The wild type primer is refractory to extension in the presence of mutant DNA, yet 
forms a product of the correct size in the presence of wild type DNA, and the mutant 
primer is refractory to extension in the presence wild type DNA, yet forms a product 
of the correct size with mutant DNA. In the case of heterozygous inheritance of a 
particular SNP, products of the pre-defined size are amplified in both tests. An 
internal control set of primers (non-allele specific and spatially separated from the 
region of interest) is typically included in both PCR tests to ensure that a negative 
result is solely caused by a mismatched primer, and not by a PCR inhibitor or 
insufficient starting DNA for example (Bottema and Sommer, 1993).
This chapter describes the development of a single-tube AS-PCR test. The test, 
called bi-directional PCR, combines two allele-specific primer sets in the same tube, 
arranged in a bi-directional orientation around the SNP site, with complementarities 
to either wild type or mutant alleles. Outer primers are positioned at different 
distances from the polymorphic site to allow genotype identification by size  
discrimination on an agarose gel. Other single tube adaptations of AS-PCR have 
recently been described (Table 3.1). They differ from the bi-directional PCR assay  
described here by employing varied design features to achieve specificity and  
detect the amplicons.
AS-PCR tests are simple to design from known sequence information, satisfying a  
criterion for the “perfect assay” for genotyping (Figure 1.4, pg. 16). However, it can 
be challenging to establish conditions that are truly discriminatory for all SN P  
combinations. This is particularly significant where end-point measurements are  
used for product analysis since a single misextension event will generate a matched 
template for subsequent cycles. The complementary template can be amplified to 
plateau phases in just a few cycles meaning that match- and mismatch- primed 
amplicon profiles are indistinguishable, causing failure of the genotyping test.
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Table 3.1: A comparison of the single-tube allele-specific PCR assays published to date that 
do not utilise fluorogenic probes. These include competitive oligonucleotide priming (Gibbs 
et al., 1999), tetra-primer PCR (Ye et al., 1992), Bi-PASA (Lui et al., 1997), Tm-shift 
genotyping (Germer and Higuchi, 1999), SAS-PCR (Sasvari-Szekely et al., 2000), Tetra- 
primer ARMS-PCR (Ye et al., 2001), and PCR-CTPP (Hamajima, 2001). These are 
compared to bi-directional PCR (Waterfall and Cobb, 2001) shown in bold type. AGE 
represents agarose gel electrophoresis.
83
Method COP Tetra-primer Bi-PASA Tm-shift SAS-PCR Tetra-primer PCR-CTTP Bi-directional
PCR genotyping ARMS PCR PCR
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The method used for optimisation and improved discrimination should be quick and 
easy to implement to reduce the overall costs associated with the genotyping test. A  
common approach to improving the likelihood of discrimination is the incorporation 
of additional mismatches at the antepenultimate 3 ’ position of the allele-specific 
primer to further weaken hydrogen bonding with the tem plate. Generally, a  
mismatch at this position will not be sufficiently disruptive to prevent primer 
extension if the 3’ terminal base is matched, but in the presence of mutant template 
where both positions are mismatched, severe destabilisation of the primer-template 
duplex can occur, preventing extension (Sommer et al., 1992; Hezard et al., 1997). 
Table 3.2 summarises data from published reports employing this approach to 
detect all SN P combinations. Frequently mismatch extension was prevented, 
however only one group out of the seven report conditions in which all S N P  
combinations were effectively discriminated (Bottema eta!., 1993).
Indeed, the ability to define discriminatory conditions is highly dependent upon a  
number of physical param eters including PCR annealing temperature, primer 
length, instrumentation (Table 3.3), PCR enhancers (Table 3.4), and the reagents 
and enzyme system used. A significant improvement in the quality of primer and  
enzym e systems has occurred over the past decade, primarily due to new  
purification and synthesis methods (Linz et al., 1990). In particular, the advent of 
“hot start” enzyme systems has dramatically improved reaction specificity. Hot Start 
systems are designed to eliminate the spurious amplification caused by Taq 
polymerase activity occurring at ambient temperatures during reaction set up. 
Primers can non-specifically anneal to the template below the temperature for 
specific annealing and cause failure of genotyping tests. Numerous methods have 
been described to prevent this non-specific extension, mainly by debilitating the 
enzyme at low temperatures (<40°C; Table 3.5).
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Table 3.2: Summary of Prior Studies reporting effects of Primer 3 ’ nucleotide mismatches on 
the efficiency of amplification by Taq DNA polymerase in PCR. For purposes of comparison, 
data has been interpreted in a roughly quantitative way by a scale of (+++++) for equivalent 
to a matched amplification, to (-) for no amplification. For Newton et al., 1989, results were 
given as ‘refractory’ represented by (-), or not refractory, represented as the equivalent of a 
match (+++++). NC denotes No Comment on this particular combination. Allele-specific 
PCR was used, followed by gel electrophoresis with subsequent ethidium bromide staining. 
Band intensities were qualitatively compared. For Kwok et al., 1990, HIV I model system 
was used in allele-specific PCR tests, quantified by ethidium bromide staining following gel 
analysis. Where relative amplification efficiencies were the same as match (+++++) was 
used; a twenty-fold reduction in relative efficiency is shown as +++; less than a 100-fold 
relative efficiency is shown as (+). For Huang et al., 1992, the quantitative reduction in Taq 
polymerase extension of mismatches primer: template duplexes are represented by (+) 
when primer extension was reduced by less thanlO'6 fold; (++) represents a reduction of 10‘6 
fold; (+++) represents 10‘3 to 10'5 fold; (++++) represents less thanlO'2 fold; and (+++++) 
represents the equivalent level of amplification as a match. Allele-specific PCR was used, 
followed by gel electrophoresis with subsequent ethidium bromide staining, followed by 
autoradiography for quantifying band intensities. For Bottema and Sommer, 1993, displayed 
data that exhibited reliable discrimination in all SNP combinations using allele-specific PCR, 
followed by electrophoresis and ethidium bromide staining. Significant optimisation was 
used, and the relative levels of amplification were not disclosed. For D’yachenko et al., 
1994, transversion mispairs exhibited lower amplification efficiency (+) than transitions 
(+++). Allele-specific PCR was used, followed by gel electrophoresis with subsequent 
ethidium bromide staining, followed by autoradiography for quantifying band intensities. For 
Day et al., 1999, if product was detected by ethidium bromide staining after 10 cycles of 
allele-specific amplification, it is shown as (+++++); after 20 cycles (+++); and after 30 
cycles (+). For Ayyadevara et al., 2000, a complex representation of percentage 
amplification was given for two different template sequences. For clarity, these have been 
represented as discriminatory conditions (-) or not discriminatory (+++++). Allele-specific 
PCR was used, followed by gel electrophoresis with subsequent ethidium bromide staining, 
followed by autoradiography for quantifying band intensities.
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Template Primer Mismatch Newton eta i., K w oketa l., Huang etal., Bottema et al., D'yachenko et Day et al., 1999 Ayyadevara et
base base Type 1989 1990 1992 1993 al., 1994 al., 2000
c G Match +++++ +++++ +++++ +++++ +++++ +++++ +++++
C T ransversion NC + + - + +++ -
A T ransition +++++ +++++ +++ - +++ +++++ +++++
T T ransversion NC +++++ ++ - + +++ -
G G T ransversion NC +++++ + - + +++ -
C Match +++++ +++++ +++++ +++++ +++++ +++++ +++++
A T ransversion NC + + - + + +++++
T Transition +++++ +++++ +++ - ++++ +++ -
T G Transition +++++ +++++ +++ - +++ +++++ -
C Transversion - +++++ ++++ - + +++ -
A Match +++++ +++++ +++++ +++++ +++++ +++++ +++++
T T ransversion - +++++ ++ - + +++ -
A G Transversion NC + + - + +++ -
C Transition +++++ +++++ +++ - +++ +++ -
A Transversion - +++ ++ - + + +++++
T Match +++++ +++++ +++++ +++++ +++++ +++++ +++++
Parameter Effect on reaction specificity in allele-specific PCR tests
Core component concentrations
Bottema and Magnesium, dNTPs, 
Sommer, 1993 primers, Taq DNA
polymerase, template.
Lowering the concentration of all core components in the test can sometimes increase specificity. Too low and the yield will be adversely 
affected, too high and spurious amplification will occur. Excess magnesium will aid non-specific primer annealing, excess dNTPs will aid 
non-specific extension, and excess primers or enzyme will aid non-specific amplification.
Bottema and 
Sommer, 1993
Template A starting template concentration that is too high can inhibit the PCR reaction. Too low, and primers will anneal to each other and form 
low molecular weight non-specific products by amplifying from themselves (primer dimers).
Cycling parameters
Rychlik et al., Annealing temperature 
1990
If the annealing temperature is too low, non-specific DNA fragments are amplified since the primers will anneal in random areas of the 
template. Too high and the yield of the desired product and sometimes the purity is reduced due to poor annealing of primers. It is 
generally recommended to set the annealing temperature to 5°C above the Tm of the primers.
Sommer et al., 
1992
Number of cycles Decreasing the number of cycles may reduce the detection of any minor amplification of the mismatched allele. However, this does not 
usually affect the specificity.
Oligonucleotide design
Rychlik, 1995; Length and stability 
Wu et al., 1991
Long primers have greater stability and therefore mismatches at the 3’ end are not destabilising. Shorter primers are recommended in 
AS-PCR. For optimal specificity, the 5’ portion of the primer should be G/C rich and the 3’ end should be A/T rich.
Sommer et al., 
1992
Position of mismatch Mismatches at the 3’ end of the primer can disrupt extension since Taq initiates DNA synthesis from there. Additional mismatches can be 




Spurious A high magnesium concentration can be used to promote spurious fragments that can serve as internal controls. Here, this is not advised 
since this is likely to disrupt the specificity where it is truly required. Plus the control band is not defined and constant.
Newton et al., 
1989
Additional primer set Provides a constant and defined internal control fragment, and improves specificity by providing another substrate for Taq polymerase.
Instrumentation
Wittwer et al., 
1993
T ransition times/ 
heating mechanism
Slow transition times often require longer times for PCR phase, increasing the opportunity for mismatch extension. Rapid cycling 
shortens the time for all phases of the PCR test, in particular, short extension times can prevent mismatch extension by decreasing 
opportunity for a mismatched primer annealed at the SNP site to be extended.
Table 3.3: Parameters for optimisation in AS-PCR tests. This list is not intended to be exhaustive.





Bovine Serum Albumin (BSA)
Kreader, 1996
N,N,N-trimethyglycine (Betaine)
Frackman et al., 2001
Tetramethylammonium chloride 
(TMAC)
Kovarova and Daraber, 2000  
Additive effects
Frackman etal., 2001, Nagai etal., 1998, 
Waterfall and Cobb (unpublished data)
Most commonly used PCR enhancer. Disrupts base pairing allowing complex secondary structure to be removed, which may normally 
prevent amplification. Good for GC rich templates. May affect the thermal activity if Taq polymerase and/or the extent to which strand 
separation of the amplified product is achieved at a particular temperature. Highly toxic substance.
Reported to work in a similar way as DMSO by preventing the formation of secondary structure during amplification, and affecting the 
thermal profile of the enzyme. Glycerol more suitable for PCR enhancement that DMSO since it is not toxic.
Thought to be useful in PCR tests where inhibitors may be present. Possibly protects Taq DNA polymerase from enzyme inhibitors.
Increase yield and specificity. Betaine is an isostabilising agent, equalising the contribution of GC- and AT- base pairing to the stability of 
the duplex. Therefore, useful in amplifying from templates which are GC-rich.
Used to eliminate non-specific priming and improve the stringency of hybridisation reactions.
PCR enhancers can often be used in combination and may exhibit additive effects. However, certain combinations and sub-optimal 
concentrations can completely inhibit the PCR. One such combination is glycerol and BSA.
Table 3.4: PCR enhancers used for improving the specificity and yield of PCR tests. This list is not intended to be exhaustive.










Barnes and Rowlyk, 2002
Double-stranded DNA fragment
Kainz et al., 2000
A reagent essential for amplification (i.e. Taq or MgCI2) is withheld until the reaction temperature is sufficient to allow specific 
annealing under stringent conditions (>55°C). Can become tedious with large reaction sets since tubes need re-opening to add 
component. This also increases opportunity of contamination.
A neutralising monoclonal antibody to Taq DNA polymerase specifically blocks the enzyme activity until the reaction components are 
heated. This denatures the antibody such that it can no longer bind. Inhibitory properties become permanently inactivated upon 
heating.
Aptamers are short single stranded DNA sequences that recognise Taq DNA polymerase with high affinity. They efficiently bind and 
inhibit the enzyme at lower temperatures (<40°C), but can be removed by heating, rendering the enzyme in its active form. The 
inhibitory effect is reversible.
Uses a modified forms of Taq DNA polymerase e.g. AmpliTaq Gold™, which is inactive at low temperatures. Inhibitory properties 
become permanently inactivated upon heating and a drop in pH.
Uses a novel buffer composition and reaction assembly protocol for PCR, including magnesium and phosphate combined at high 
concentrations in addition to standard buffer reagents. The magnesium containing precipitate is unavailable to DNA polymerase until 
thermal cycling occurs.
Short double stranded DNA fragments are included in the reaction to inhibit Taq DNA polymerase. The inhibition is not sequence 
specific, but exclusively dependent upon the melting temperature of the fragments.
Table 3.5: Common methods of implementing Hot Start PCR. The list is not intended to be exhaustive.
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These variable parameters should be optimised to accommodate the two non­
variable parameters for each SNP assayed, i.e. surrounding DNA sequence and 
base composition of the SNP site. SNPs can fall into two subsets depending on 
their base composition, namely tranversions and transitions; tranversions represent 
the substitution of a purine (A or G) with a purine, or a pyrimidine (T or C) with a 
pyrimidine, whilst transitions represent substitutions of a purine with a pyrimidine or 
a pyrimidine with a purine (Brookes, 1999). A transition mispair maintains a 
chemical structure similar to the matched base pair since the same number of 
hydrogen bonds takes part in base pairing. In transversion mispairs however, the 
hydrogen bond complement is incomplete, creating a less favourable substrate for 
Taq DNA polymerase (Goodman et al., 1993). It follows that a transversion SNP is 
generally more refractory to extension than a transition.
An obvious criterion that is often overlooked during optimisation of AS-PCR is the 
component interactions between core PCR reagents themselves (i.e. M gCI2, 
dNTPs, Taq DNA polym erase, and primers) and their effects on mismatch 
extension. Literature suggests that a magnesium and oligonucleotide titration (in 
combination with additional mismatches in the allele-specific primer) is sufficient to 
obtain discriminatory conditions, yet Table 3.2 would suggest that this is not the 
case for all SNP combinations. Designing and testing primers of different lengths 
and sequence can involve large and expensive reaction sets, which can be avoided 
by considering the complex component interactions in a PCR test (Figure 3.2).
M g C I2 and dNTPs have been shown to affect the efficiency of priming and 
extension by altering the kinetics of association and dissociation of primer-template 
duplexes at annealing and extension temperatures (Wolff e ta l. ,  1993). These  
components also alter the efficiency with which Taq  DNA polymerase recognises 
and extends such duplexes (Kwok et al., 1990; Huang et al., 1992). Of particular 
relevance to A S-PCR methods, the concentration of MgCI2 and dNTPs required 
depends largely on the target and primer sequences. The presence of excess 
magnesium may promote non-specific amplification products and insufficient 











K  /  II X /  /
L











Figure 3.2: Diagrammatic representation of key reaction component interactions in a PCR test.
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Also, dN TPs quantitatively bind Mg2+, so that any modification of dN TP  
concentration will require a compensatory adjustment of MgCI2 (Innis, 1990). Taq 
polymerase requires free Mg2+ as a cofactor so any excess of dNTPS can have a 
detrimental effect on product yield by chelating cofactor ions (Linz etal., 1990).
This chapter describes the use of a multifactorial optimisation strategy to define 
conditions allowing SNP discrimination regardless of base composition. The method 
is based on a process widely used for development trials during industrial process 
design where the aim is to generate enough information to establish optimal 
conditions for a particular process using the minimal number of experiments 
possible (Taguchi, 1986). In 1994, modified Taguchi methods were applied to 
optimising standard PCR, defining component concentrations that generate  
maximal yield and minimal spurious amplification. For standard PCR, ‘control 
factors’ are selected as the components most likely to exert greatest effect on the 
outcome of the test. Taguchi then uses a number of progressive trials to predict a  
combination of component concentrations that will lead to optimal performance 
(Cobb and Clarkson, 1994). If these results are satisfactory then further 
experiments are unnecessary. Further improvement may be achieved with 
subsequent trials using a narrower range of concentrations for each component.
Here, the Taguchi format is used to establish discriminatory conditions for SN P  
genotyping in a small number of reaction sets. The Taguchi method also facilitates 





3.1.1 C o n ven tio n a l a lle le-specific  PCR tests
A schematic of conventional allele-specific PCR is shown in Figure 3.1. Primers 
W T_C P _374 and ASA_1X (where X is G, C, A or T) were designed to direct the 
amplification of a 374 bp fragment from a p-actin gene segment inserted into 
pG EM -T Easy Vector-based plasmid DNA constructs (Section 2.1). Nine PCR  
reactions were performed for each optimisation set according to the general 
protocol described in Section 2.0.1, except the four components most likely to affect 
the outcome of the PCR (primers, Taq DNA polymerase, MgCI2 and dNTPs) were 
aliquoted according to an orthogonal array (Table 3.6; Cobb and Clarkson, 1994), at 
three different concentrations (Table 3.7). Internal control primers ICF and ICR  
(0.04 pM each) were added to amplify a 223 bp control fragment. Sixteen sets were 
performed in total, including the four matched PCR tests, and twelve possible 
mismatched tests.
PCR products were analysed by agarose gel (1.5% ) electrophoresis and maximal 
optical density (O Dmax) readings were obtained (Section 2 .4 .1). Gel images and 
corresponding O D max data are presented in Figure 3.3 and Table 3.8, respectively. 
Amplicon yields varied within sets according to component concentrations, and 
between sets according to base complementation. Yields were greater in perfectly 
matched than mismatched tests for all templates. The control fragment was present 
in all PCR tests.
A qualitative analysis of the amplicon yields allowed the selection of reaction 
conditions that amplified product in the presence of a matched nucleotide, yet under 
identical conditions, remained refractory in the presence of a mismatch. Conditions 
were elucidated for all SNP combinations and used in subsequent genotyping tests 
to confirm the optimal nature. All twelve polymorphisms were genotyped in triplicate 
(Figure 3.4). For each SNP combination, the conditions enabled amplification of a 
matched template, with little or no amplification in the presence of a mismatch.
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Reaction [1] 12] [3] [4]
1 A A A A
2 A B B B
3 A C C C
4 B A B C
5 B B C A
6 B C A B
7 C A C B
8 C B A C
9 C C B A
Table 3.6: Orthogonal array for testing four variables each at three levels. Variables [1], [2], 
[3] and [4] are primer set, Taq DNA polymerase, MgCI2 and dNTPs, respectively.
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Level A B C
BFR/ASA1X (|iM) 0.2 0.4 0.6
Taq (U) 0.5 1.25 2.5
MgCI2 (mM) 0.5 1 1.5
dNTPs (*iM) 80 120 200
Table 3.7: Concentration levels for components used in orthogonal array (Table 3.6).
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1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9
Figure 3.3: Typical gel images from optimisation tests covering all possible matched and 
mismatched base complementations. In each case, the DNA band is 374bp. No spurious 






1 2 3 4 5 6 7 8 9
C:G m 107.1 120.3 1 110.6 m 52.3 _ 119.3
C:C - - - - - - - - -
C:A - - 58.3 - 72.5 - - - 23.5
C:T - - 79.1 - 39.3 - - - 47.5
G:G - - - - 39.8 - - - 68.12
G:C - 100.0 99.4 71.6 109.0 - 110.8 - 111.5
G:A - - - - - - - - -
G:T - - 95.5 - 42.0 - - - 77.3
T:G . - 81.1 - 85.0 - - - 101.5
T:C - - - - - - - - -
T:A - 34.2 113.6 23.3 109.7 - 58.4 - 110.2
T:T - - - - - - - - -
A:G - - 25.9 - 42.0 - - - 53.7
A:C - - - - - - - - -
A:A - - - - - - - - -





Table 3.8: Product yields from allele-specific PCR tests covering all base complementations; 
represented as maximal optical density (ODmax) values. Numbers in bold type represent 
matched amplifications. A dash (-) represents no amplification. Corresponding gel image 
data is displayed in Figure 3.3.
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Figure 3.4: Typical gel images displaying triplicated reactions performed using the 
discriminatory conditions defined by the optimisation strategy. The target region is 374 bp in 
each case. Wells 1-3 contain wild type template with wild type primer amplifications; wells 4- 
6 represent wild type template with mutant primer; wells 7-9 represent mutant template with 
wild type primer; and wells 10-12 represent mutant template with mutant primer. The internal 
control fragment (223 bp) was present across the reaction set. Conditions defined by 
Reaction 7 were used to detect SNPs G-»C, G->A, G-»T, C-»A, C->T, A->G, A ^C  and 
T->C; Reaction 2 was used to detect C-»G; Reaction 5 was used for A->T and T->G; and 
Reaction 9 was used for detecting a T->A polymorphism.
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In certain cases, artefactual amplification was observed (experiments detecting 
S N P s G -> C , A ^ C , C ->G , C ->A , T -> C , and C ->T ). The size of this artefactual 
fragment is consistently -1 0 0 0  bp, which would be the approximate size of the 
fragment, formed by primers ICF and BFR (Appendix I). Alternatively, since a  
common factor in the experiments where this artefact occurs is the detection of 
base ‘C \ it is possible that the allele-specific primer has complementarities with 
another site on the plasmid sequence. This did not interfere with overall specificity.
3.7.2 Single tube gen o typ in g  o f sickle cell a n a e m ia  using b i-d irectional PCR  
A schematic of bi-directional A S-PC R  is shown in Figure 3.5. Two allele-specific 
primers were designed with complementarities to normal p-globin (SC_W T_AS) or 
sickle cell (SC_M UT_AS) genes. These were arranged in a bi-directional orientation 
such that both primers terminated on the SNP site. Primer SC_W T_AS has a single 
‘A ’ nucleotide at the 3’ end, matching the T  nucleotide on the non-coding strand of 
the p-globin gene. Primer SC _M U T_A S has a single ‘A ’ nucleotide at the 3 ’ end  
matching the T  base on the coding strand of the sickle cell gene. The wild type 
outer primer (W T_O P_517) was positioned 517 bp downstream on the opposite 
strand of SC_W T_AS. The mutant outer primer (M UT_O P_267) was placed 267 bp 
upstream of SC_M UT_AS. Internal control amplification was not required since any 
successful PCR will generate an allele-specific amplicon.
For optimisation, four critical components ([1] W T primer set, [2] M UT primer set, [3] 
MgCI2 and [4] dNTPs) were selected and aliquoted according to Table 3.3 with final 
concentrations according to Table 3.9. Two identical optimisation sets were run 
containing -1 0  ng of [A] wild type or [B] mutant control DNA (Figure 3.6/Table 3.7). 
Other reaction components included Mg-free PCR buffer, 0 .025 U.pJ'1 Taq DNA  
polymerase with HS TaQ UANT-O FF™  (Q-Biogene) and PCR-grade water to a total 
volume of 25p,l. Cycling conditions and product analysis were identical to those 
described in Section 3.1.1. Product yield varied considerably across the reaction 
sets according to varying component concentrations, and between reaction sets 
and according to template zygosity. The wild type 517 bp amplicon only was 
amplified in set [A], and the mutant 267 bp fragment only was amplified in set [B].
100
200 bp 100 bp
A. Wild type allele B. Mutant allele
Genomic DNA Newly-synthesized DNA ► Matched primer r  Mismatched primer
Figure 3.5: Schematic representation of bi-directional allele-specific PCR. Three possible fragments can be formed depending upon substrate 
DNA zygosity, as well as enzyme system and cycling parameters. The 200 bp amplicon defines the allele-specific product formed when wild type 
DNA is present, and only wild type primers are extended. The 100 bp amplicon defines the allele-specific product formed when mutant DNA is 
present and only the mutant primers are extended. A heterozygote is identified by the amplification of both PCR products. The target region (300 
bp) amplified by non-allele specific outer primers is shown in pale grey. The enzyme system selected was inefficient at amplifying longer 
sequences and in the presence of competition from a smaller fragment insufficient target region was amplified for visualisation on a stained gel.
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Level A B C
SC-WT-AS/WT-OP517 (p.M) 0.2 0.4 0.8
SC-MUT-AS/ MUT-OP267 (jiM) 0.2 0.4 0.8
MgCI2 (mM) 0.5 1.0 2.0
dNTPs (|iM) 80 120 200





2 67  bp
Figure 3.6: Typical gel image data of PCR optimisations. Outer lanes contain 100 bp ladders. Reactions 1 to 9 according to the orthogonal array 
(Table 3.6) are labelled accordingly. Set [A] represents reactions in which wild type template DNA was the substrate. Set [B] represents reactions 
in which mutant (HbS) template DNA was included. The 517 bp and 267 bp allele-specific fragments were generated in sets [A] and [B], 
respectively. Product yield varied across each reaction set. Table 3.10 represents with ODmax data of the amplicon bands, used as a 
representation of product yield/reaction score.
Rxn 1 2 3 4 5 6 7 8 9
[A] ODmax 5.13 90.83 80.30 63.40 63.70 - 132.27 - 160.67
[B] ODmax 113.6 172.53 169.20 108.73 161.13 183.67 144.80 - 165.93
Table 3.8: Product yield data (OD max) from optimisation sets [A] and [B] in Figure 3.6. Samples giving no product are designated by (-).
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Diagnostic conditions were selected by qualitative  analysis of PCR yields from 
optimisation sets [A] and Set [B]. Optimal conditions for zygosity determination are 
those that amplify each allele-specific amplicon at similar efficiencies, measured toy 
the intensity of specific bands on the gel. In this study, the conditions and 
interactions of Reaction 9 (Tables 3.6 and 3.9) satisfied these criteria, producing 
517 bp and 267 bp bands with O D max values of 160.67 units and 165.93 units 
respectively. A small trial was performed using these conditions in which 14 human 
genomic DNA sam ples of unknown zygosity were used as tem plate using 
considered optimal discrim inatory conditions (Figure 3 .7 ). The initial DNA  
concentration of each sample ranged from 5 to 25 ng.pl'1. Reactions generating the 
517 bp fragment only identified a normal genotype. The 267 bp fragment was 
amplified confirming a homozygous mutation and sickle cell carriers (HbA/S) were 
identified by the amplification of both amplicons. Genotypes were 100% concordant 





-  267 bp
Figure 3.7: Gel image data from a small-blinded trial. Fourteen human DNA samples of varying zygosity were selected and amplified under 
conditions specified by Reaction 9 (Table 3.6/Table 3.9). Diagnosed template zygosity is shown on the gel image. Three normal samples were 
identified by the amplification of the 517 bp products only. Six heterozygous samples were identified by the amplification of both 267 bp and 517 
bp fragments. For heterozygotes, the 267 bp band was slightly more intense than the 517 bp band, likely to be due to staining disparity between 
optimisation sets [A] and [B]. Five homozygous sickle cell samples were identified by the amplification of the 267 bp amplicon only.
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3 . 7.3 R eaction co m p o n en ts  a ffec tin g  p ro d u c t yield (SNl analysis)
Amplicon yields from optimisation sets A and B were “scored” by obtaining O D max 
data from gel images (Table 3.10). Those giving non-allele specific fragments or no 
amplification at all were given a score of 1. The ‘yield scores’ were used in a simple 
downstream mathematical analysis to determ ine which components exerted  
maximal effect on product yield at a particular concentration. Generally, the 
theoretical target of the PCR test in the presence of a matched template is to 
increase the product yield so that it is as large as possible. Under these  
circumstances, the Taguchi method recommends the quadratic loss function,
S N l = -  lOlog
1 n 1
I "  y< )
(3.1)
assuming that variable, y, denotes the product yield measured for a particular 
combination of factor settings in a given experim ent (total of n repeated  
measurements per experiment). The signal-to-noise ratios (SN L) for each parameter 
at each concentration level tested (Table 3.11) were plotted versus concentration 
for each component, and refined by polynomial regression to obtain curves whose 
maximum represent the reaction optima (Figure 3.8; Cobb and Clarkson, 1994).
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Variable Level- Gel A Level- Gel B
A B C A B C
WT primers 18.94 4.77 4.77 43.12 42.93 4.77
MUT primers 18.95 4.77 4.77 41.01 4.77 44.73
MgCI2 1.68 39.94 38.12 4.77 42.88 43.94
dNTPs 18.94 4.77 4.77 42.94 44.32 4.77
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Figure 3.8: Effects of reaction components on the SNL ratios for the amplification of a wild type 517 bp amplicon from wild type DNA (solid line); 
and a mutant 267 bp amplicon from HbS DNA (broken line). Increased SNL value represents a larger effect on product yield than a low SNL value.
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3.2 Discussion
In AS-PCR methods, reaction conditions are identified that give a good yield for 
matched genotypes, yet under identical conditions give no amplification in the 
presence of a mismatch. Importantly, both products should be amplified in the 
presence of heterozygous DNA. The traditional methods of achieving high 
discrimination were discussed previously, the most common of which is to introduce 
an additional mismatch to the 3 ’ end of the allele-specific primer. Using this 
approach, multiple primers may require design and testing, because the nature of 
the base composition of the additional mismatch and surrounding sequence can 
sometimes render the primer refractory to extension, even in the presence of a 
matched template. This can prove costly and lead to large reaction sets, especially 
if combined with a sequential magnesium and oligonucleotide titration, and  
annealing temperature optimisation.
Here, it is shown that an optimisation based on the core PCR component 
interactions can quickly establish discriminatory conditions in a small trial, without 
the need for additional mismatches and design considerations. Conventionally, a 
sequential investigation of the effects and interactions of four reaction components 
each at three concentration levels would require an experiment with 81 (i.e. 34) 
separate reactions. Using the Taguchi method the same trial was carried out in just 
nine reactions with wild type and mutant control templates (Cobb and Clarkson, 
1994).
The core components considered most likely to affect the outcome of the PCR were 
selected and varied according to an orthogonal array. Where 3 concentration levels 
are tested for each reaction component, the number of experiments ( E ) is 
calculated from the equation E  =  2k +  l ,  where k  is the number of factors to be 
tested (Cobb and Clarkson, 1994). Therefore, just nine reactions per optimisation 
set were required to test four components. For conventional allele-specific PCR, 
these were primers, magnesium chloride, dNTPs, and Taq DNA polymerase. For bi­
directional PCR, these were magnesium chloride, dNTPs, wild type and mutant
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primer sets. The primer concentrations within each set were equimolar since there 
is no evidence to suggest that using a different ratio of forward and reverse primers 
has a beneficial effect in PCR (Henegariu etal., 1997).
The optim isation strategy was applied to conventional A S -P C R  w here  
discriminatory conditions were established for the detection of all SNP combinations 
using a pG EM -T Easy Vector plasmid template with a single variant nucleotide 
(Figure 3.3), and verified by running triplicated tests (Figure 3.4). This shows a 
significant enhancement to AS-PCR methods when compared to the data in Table  
3.2.
In addition, a gel-based single tube adaptation of allele-specific PCR was 
developed (Figure 3.5), where allele-specific amplicons were identified by size 
discrimination. The test was combined with the multifactorial optimisation strategy, 
taking into account the core component interactions in the PCR, and additional 
mismatches or PCR enhancers were not required to achieve discrimination (Figure 
3.6). Conditions were quickly established for the detection of an A -»T  polymorphism 
causing sickle cell anaem ia by taking into account the fact that at equimolar 
concentrations, amplification by the two primer sets might be weak or strong at a 
given locus. This event is dependent upon primer stabilities, binding efficiencies, 
priming competition, product size and concentration of other reaction components. 
Unique to bi-directional PCR, each primer is complementary to a different part of 
the DNA sequence, introducing additional variability to the reaction.
The optimal nature of the conditions was subsequently verified in a small-blinded 
trial where results were 100%  concordant with RFLP data from the source 
laboratory (Figure 3.7). Importantly, these conditions discriminated the transversion 
A: A and T: T  mismatches designated by the sickle cell polymorphism which was 
not the case in earlier reports (Kwok et al., 1990; Huang et al., 1992). However, 




An informative downstream application of Taguchi optimisation is the ability to 
quantitatively study the biochemical basis of component interactions and priming 
competition using regression analysis. Product yield data from optimisation sets 
was used to satisfy a quadratic equation where the theoretical target is to generate 
the highest amplicon yield possible. The specific SNL ratios mathematically penalise 
small deviations from the theoretical target, generating a value that is the highest 
possible average with the lowest standard deviation (Table 3.9). Optimal conditions 
are those giving the largest SNL value (Cobb and Clarkson, 1994).
The SN l analysis using equation 3.1 was applied to bi-directional PCR, revealing 
that the optimal magnesium requirement for the generation of maximal product yield 
and specificity was 1.5 mM irrespective of template zygosity. Likewise, the optimal 
concentration of dNTPs in sets A and B were similar, with lower concentrations 
being favoured. Excess dNTPs may chelate the magnesium co-factor ions of Taq 
decreasing processivity, or reduce yield and specificity.
The regression profiles of primer sets generated by wild type and mutant DNA  
samples demonstrated variation in primer stabilities, efficiencies and competition 
(Figure 3.8). For wild type DNA the aim is to direct amplification of the 517 bp 
fragments only. The lower concentration of the wild type primer set tested gave the 
largest S N L value relating to product yield. Intermediate concentrations decreased 
the SNL, and the upper concentration showed an incremental increase in SNL. An 
identical profile was observed with the mutant primer set, optimally redundant in the 
presence of wild type DNA. It is possible in the presence of low primer set 
concentrations, i.e. conditions of minimal competition, wild type primers can direct 
amplification of the 517 bp fragment. When the mutant allele is present, the aim is 
to direct amplification of the 267 bp amplicon only. The optimal concentration of the 
mutant primer set was predictably at the upper level. The inclusion of lower 
concentrations of wild type primers allowed maximal amplification of the mutant 
fragment, wherein the wild type set was exhibiting least competition, demonstrating 
the significant role of primer interactions in bi-directional amplifications.
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In accordance with previous experiments (data not shown), the conditions selected 
for the blinded trial (0.8 pM each primer, 1 mM MgCI2 and 80 pM dNTPs) were not 
in accordance with optimal component levels calculated by SNL values, due to the 
different objectives of each enquiry. The theoretical target is to define conditions 
amplifying a maximum yield. This differs from the practical target of specifying 
conditions where each allele is specifically amplified with equal efficiency. In order 
to achieve this, sub-optimal conditions for the amplification of one allele may be 
combined with optimal conditions for amplification directed by a less efficient primer 
set.
Bi-directional amplifications were performed using an antibody-based Hot-Start Taq 
DNA polymerase. The enzyme demonstrated high fidelity, only amplifying allele- 
specific products with minimal spurious artefacts. Additionally, the enzyme was 
inefficient at amplifying larger fragments (>600 bp) when in competition with a 
smaller fragment, thus the non-allele specific fragment spanning the whole target 
region was not amplified. In similar studies, this larger fragment has been used as 
an internal control to avoid the incorporation of a distal primer pair conventionally 
required for diagnostic tests (Liu et a l ,  1997). However, bi-directional PCR reaction 
will always yield a fragment, serving as an internal positive control for the PCR. 
Here, the processivity of Taq directed toward generating allele-specific products 
only, generating high amplicon yields without spurious amplification.
Testing the effects of four reaction variables simultaneously reduced the time taken 
to optimise the test, lowering the associated reagent costs. When combined with 
the single-tube bi-directional assay, twice as many samples can be genotyped in a 
single PCR run compared to other gel-bases analyses, addressing throughput 
issues. In both cases, additional mismatches in allele-specific primers were not 
required and a standard annealing temperature was used in all tests. This suggests 
that the need to examine the more costly variables, such as primers of different 
length and sequence, can be overridden by considering the classical interactions of 
core PCR components. If conditions are not established, alternative methods to 
improve discrimination can then be used. The optimisation strategy may also be 
applied to other molecular biology assays to establish optimal conditions according
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to a theoretical target, including the effects of different additives on a PCR test, and 
combinations of additives (data not shown).
The utility of gel-based single tube adaptation of A S-PC R  in clinical testing is 
recognised by very recent publications describing similar methods (Brightwell et a l, 
2002). However, the rate-limiting step of these assays is the necessity for size 
discrimination of the resulting allele-specific PCR products using agarose gel 
electrophoresis. Chapter four describes the application of melt curve analysis and 
real time detection to bi-directional PCR, to provide rapid SNP genotyping.




Rapid SNP Genotyping using Fluorescent Bi­
directional PCR and Melt Curve Analysis
4.0 Introduction
In 1992, Higuchi et al. published pioneering research in which the advent of ‘real­
time’ PCR was presented. A dsDNA specific binding dye, ethidium bromide, was 
incorporated directly into a PCR reaction mixture to visualise DNA amplification in 
real time by directing excitation illumination through walls of the amplification vessel 
before or after, or even continuously, during thermocycling (Higuchi et al., 1992). 
This work was pivotal in revealing the shape and characteristics of a PCR reaction 
curve (Figure 1.9), and increased the utility of PCR methods for clinical application, 
i.e. quantitative PCR and mutation detection.
This prompted the development of PCR instruments with integrated optics systems 
allowing continuous monitoring of PCR amplification in a closed reaction vessel 
(Table 4.1). Concurrently, a new class of dyes (unsymmetrical cyanine dyes) was 
synthesised including SYBR® Green I, PicoGreen, SYBR® Green II, YOYO®, YO- 
PRO®, and SYBR® Gold (Tum a et al., 1999), which exhibit more favourable 
properties for DNA analysis than ethidium bromide. As a group, the unsymmetrical 
cyanine dyes are characterised as having low intrinsic fluorescence, large 
fluorescent enhancements upon binding to nucleic acids, and high fluorescence 
quantum yields when complexed with nucleic acids, producing large signal-to- 
background ratios. In combination with their apparently high binding affinities for 
nucleic acids, and greater sensitivity than ethidium bromide, these dyes are 




Double-strand specific DNA binding dyes also allow sim ultaneous product 
identification in the same closed reaction vessel by DNA melting curve analysis. 
Introduced in Chapter One, ‘DNA melting’ describes the denaturation of DNA from 
a double-stranded to single-stranded state (ssDNA). The specific temperature at 
which the DNA is 50%  single stranded is known as the “DNA melting temperature” 
(Tm). The transition from dsDNA to ssDNA can be observed in real time by including 
a dsDNA specific reporter dye (e.g. SYBR Green I) into the PCR mixture, and 
continuously monitoring fluorescence as the temperature is slowly elevated (c.f. 
0 .1 ° C .s ‘1) from low (~60°C ) to high tem peratures (~95°C ). A rapid loss of 
fluorescence is observed at the specific melting tem perature of the DNA, 
characterised by the inability of the dsDNA specific dye to remain bound. The read­
out from such monitoring is called a “melt curve” (Figure 1.10A, pg. 28), which is 
converted to a “melt peak” (or series of melt peaks) by plotting the first negative 
derivative of fluorescence loss, F ,  with respect to temperature, T  ( - d F /d T v s. T \  
Figure 1.1 OB). Since the shape and position of a melt peak depends markedly on 
the G C /AT ratio, length and sequence of the amplicon, products of a similar size 
can be differentiated in a reaction mixture (Ririe eta l., 1997).
The LightCycler™  PCR instrument, used in these experim ents, delivers an 
additional advantage of speed. Previously, the bi-directional PCR test was based on 
slow Peltier-effect heat block thermal cycling, the platform upon which most thermal 
cyclers are based (Table 4.1). Peltier elements operate essentially by applying a 
current through two conductors with dissimilar electron densities causing heat to be 
absorbed on one side and released on the other- by controlling the direction of 
electron flow, such a device can act as both a heating and cooling mechanism  
(Pierce, 2002). Using this mechanism, a typical DNA amplification may require in 
excess of 3 hours, although 2-hour amplifications are possible if adjustments to 
minimise sample denaturation and annealing times are made (Wittwer et al., 1993). 
The LightCycler™ displays improved temperature control by alternating heated and 
ambient air as the medium for heat transfer. The low mass of air means that very 
rapid temperature exchange rates can be achieved within the thermal chamber 
(20.0 °C .s‘1; W ittwer et al., 1997). Also, glass-capillary tubes are used in place of 
plastic tubes with a large surface-to-volume ratio, further improving the thermal
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properties for heat exchange. Consequently, 30 PCR cycles can be completed in 
less than 30 minutes using the LightCycler™ platform, delivering higher throughput.
The assay described in this chapter describes rapid cycle bi-directional PCR  
combined with melt curve analysis using SYBR Green I, to eliminate a major 
bottleneck in this type of diagnostic test, predominantly due to the relatively limited 
throughput of gel electrophoresis systems. The integrated system introduces 
homogeneity to a previously heterogeneous system, and a higher throughput 
suitable for a clinical environment. Detecting the three clinically relevant SNPs  
described in Section 1.1 validated the test.
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Figure 4.1 shows a schematic representation of the fluorescent bi-directional PCR  
test. Primer sets were designed to detect three clinically relevant SNPs. The A->T  
mutation in codon 6 of the (3-globin gene related to sickle cell disease was chosen 
as a SNP target. Primers SC_W T_AS and SC _W T_O P were designed to direct the 
amplification of an 86 bp product from the normal p-globin gene, with a calculated 
T m of 87.0°C  (wild type primer set). SC_W T_AS has an ‘A’ nucleotide at the 3 ’ end 
matching the T  base on the coding strand of the normal p-globin gene. Primers 
SC _M UT_AS and SC_M UT_OP were designed to amplify a 112 bp fragment from 
the mutant DNA, with a calculated Tm of 85.0°C  (mutant primer set). SC_M UT_AS  
has an ‘A’ nucleotide at the 3’ end, matching the T  base on the coding strand of 
the sickle cell mutation. The sequence of interest and primer alignments is shown in 
Figure 4.2.
Secondly, primers were designed for the detection of the most common 
polymorphism in the H F E  gene related to hereditary haemochromatosis (HH), 
namely the G ->A  polymorphism at nucleotide position 845 of the open reading 
frame (Ugozzoli et al., 2002). The resulting HFE protein exhibits a change from 
cysteine to tyrosine at amino acid position 282, referred to as ‘C 282Y ’. Primers 
C 282Y_W T_A S and C282Y_W T_O P were designed to direct the amplification of a 
76 bp product from the normal H F E  gene, with a calculated T m of 87.0°C (wild type 
primer set). C282Y_W T_AS has a ‘G ’ nucleotide at the 3 ’ end matching the ‘C ’ base 
on the non-coding strand of the H F E  gene. C282Y_M UT_AS and C282Y_M UT_O P  
amplify a 72 bp fragment from homozygous mutant DNA, with a calculated T m of 
84.0°C  (mutant primer set). C282Y_M U T_A S has a T  nucleotide at the 3 ’ end, 
matching the ‘A ’ polymorphic base on the coding strand. The sequence of interest 
and primer alignments is shown in Figure 4.3.
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Primers were also designed for detection of the less common missense C —»G 
transversion in the H F E  gene at nucleotide position 187 of the open reading frame, 
also linked to increased susceptibility to HH when inherited with the C 282Y  
mutation (Ugozzoli et al., 2002). This causes an amino acid change in the HFE  
protein from histidine to aspartic acid at position 63, known herein as H63D. 
Prim ers H 6 3D _W T _A S  and H 63D _W T _O P  w ere designed to direct the  
amplification of a 121 bp product from the normal H F E  gene, with a calculated T m of 
86.0°C  (wild type primer set). H63D_W T_AS has a ‘C ’ nucleotide at the 3 ’ end 
matching the ‘G ’ base on the non-coding strand of the H F E  gene. H63D_M U T_A S  
and H 63D _M U T_O P amplify an 89 bp fragment from homozygous mutant DNA, 
with a calculated Tm of 84 .0°C  (mutant primer set). H 63D _M U T_A S has a ‘C ’ 
nucleotide at the 3 ’ end, matching the ‘G ’ polymorphic base on the coding strand of 
















MUTAS WT OP 
< —
Tm X°C
A. W ild type allele
Tm Y°C
B. Mutant allele
Genomic DNA Newly-synthesized DNA Matched primer Mismatched primer
Figure 4.1: A schematic representation of ‘fluorescent bi-directional PCR’. In a single PCR reaction with two allele-specific primer sets, genomic 
DNA will be amplified by either set depending upon template zygosity, yielding allele-specific amplicons. [A] Samples homozygous for the wild 
type allele will be amplified by WT_AS and WT_OP giving an amplicon with a pre-defined Tm of X°C. [B] Samples homozygous for the mutant 
allele will be amplified by MUT_AS and MUT_OP generating an amplicon with a pre-defined Tm of Y°C. The difference between X and Y must be 
2°C for adequate discrimination using instruments available currently. Heterozygous inheritance will be diagnosed by amplification of both allele- 
specific PCR products.
5 ’ . . .  agggctgggc ataaaagtca gggcagagcc a tc ta ttg c t ta c a tttg c t tctgacacaa ctg tgttcac
3 ’ . . .  tcccgacccg ta t t t tc a g t  cccgtctcgg tagataacga atgtaaacga agactgtgtt gacacaagtg
5 '-  a gggcagagcc a tc ta ttg c  - 3 ’
SC MUT OP
SC MUTAS
3 1 -  acctcttcag acggcaatga eg -5 '
tagcaacctc aaacagacac catggtgcac ctgactcctg iggagaagtc tgccgttact gccctgtggg
ategttggag tt tg tc tg tg  gtaccacgtg gactgaggac icc tc ttca g  acggcaatga cgggacaccc
SC WTAS
SC W TOP
gcaaggtgaa cgtggatgaa gttggtggtg aggccctggg caggttggta tcaaggttac aagacaggtt . . .  3 
cgttccac tt gcacctactt caaccaccac tccgggaccc gtccaaccat agttccaatg ttc tg tccaa  . . .  5
Figure 4.2: Sequence of interest and primer alignments for the detection of sickle cell anaemia (NCBI Accession Number M34404) using the
fluorescent bi-directional PCR assay. Area highlighted in red represents the wild type sequence at the SNP site. The mutant allele would have a
polymorphic T  on the coding strand with a complementary ‘A’ on the non-coding strand.
5 1. . .  cagccaatgg atgccaagga gttcgaacct aaagacgtat tgcccaatgg ggatgggacc taccagggct 
3 ' . . .  gtcggttacc tacggttcct caagcttgga tttc tg c a ta  acgggttacc cctgccctgg atggtcccga
5 '-  ggct.
C282Y MUTAS 
3 '-  tggtc cacctcgtgg gtc -5 '
ggataacctt ggctgtaccc cctggggaag agcagagata tacgticcag gtggagcacc caggcctgga
cctattggaa ccgacatggg ggaccccttc tc g tc tc ta t atgcajggtc cacctcgtgg gtccggacct
. . .ggataaccttggctgta - 3 1
C282Y MUT OP C282Y WT AS
C282Y WT OP
tcagcccctc a ttg tg a tc t gggagcccta ccgtctggca ccctagtcat tggagtcatc agtggaattg . . . 3 '  
agtcggggag taacactaga ccctcgggat ggcagaccgt gggatcagta acctcagtag tcaccttaac . . . 5 '
Figure 4.3: Sequence of interest and primer alignments for the detection of the C282Y mutation in the HFE gene (NCBI Accession Number Hs.
20019). Area highlighted in red represents the wild type sequence at the SNP site. The mutant allele would have a polymorphic ‘A’ on the coding
strand with a complementary T  on the non-coding strand.
5 ' . . .  tgtttgaagc tttgggctac gtgcctcaga gcaggacctt g g tc tttcc t tgtttgaagc tttgggctac
3 ' . . .  acaaacttcg aaacccgatg cacggagtct cgtcctggaa ccagaaagga acaaacttcg aaacccgatg
5 '-  gcaggacctt g g tc tttcc t t  -3 '
H63D MUT OP
H63D MUT AS 
3 '-  ctactctcag cggcacacc -5 ' 
gtggatgacc agctgttcgt g ttc ta tg a t latgagagtc gccctgtgga gccccgaact ccatgggttt 
cacctactgg tcgacaagca caagatacta Jtactctcag cgggacacct cggggcttga ggtacccaaa
H63DW TAS
H63D W TOP
ccagtagaat ttcaagccag atgtggctgc agctgagtca gagtctgaaa gggtgggatc acatgttcac . . . 3  
ggtcatctta  aagttcggtc tacaccgacg tcgactcagt ctcagacttt cccaccctag tgtacaagtg . . .  5
Figure 4.4: Sequence of interest and primer alignments for the detection of the H63D mutation in the HFE gene (NCBI Accession Number Hs.
20019). Area highlighted in red represents the wild type sequence at the SNP site. The mutant allele would have a polymorphic ‘G’ on the coding
strand with a complementary ‘C’ on the non-coding strand.
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4.1.2 PCR am plifications
All PCR tests were a total volume of 20 pi, containing 2 pi of LightCycler™ DNA  
FastStart SYBR Green I mix, oligonucleotides, PCR grade water, a final 
concentration of 3 mM MgCI2 and 5-20 ng of human genomic DNA. Unknown DNA  
samples were received as extracted DNA samples (from blood), or were isolated 
directly from blood (Section 2.5.1) or a buccal cell swab (Section 2 .5 .2). PCR  
cycling and melt analysis protocols were performed on the LightCycler™ PCR  
instrument according to Section 2.0.2. The thermal cycling profile consisted of an 
initial denaturation step (10 min) at 95 °C, followed by 35 amplification cycles of 1 s 
denaturation at 95 °C, and 3 s annealing at 62 °C. A single fluorescence reading 
was acquired as the sample passed through 72°C. For assays designed to detect 
the C282Y and H63D mutations, the annealing time was reduced to 1 s. Product 
identification and specificity was confirmed by performing a melting curve analysis 
according to Section 2.0.3.
4.1.3 Assay Optim isation
The optimisation strategy described in Figure 4 .5 / Table 4.2 was employed to define 
optimal primer ratios for distinguishing between wild type and mutant genotypes. An 
initial magnesium titration was performed testing a range of concentrations (1, 2, 3, 
4 and 5 mM) in PCR tests directed by outer primers only. In each case, a single 
product without artefactual amplification was yielded with a final magnesium  




From sequence data (www.ncbi.nlm.nih.gov) design two 
allele-specific primers (Tm ~60°C) arranged in a bi-directional 
format around the SNP site
Set the appropriate 3' terminus for allele-specific primers according 
to genotype
Design outer primers (Tm ~60°C) that generate
small amplicons (50-150 bp) differing in Tm by at least 2°C
Order primers
OPTIMISATION SETS
Define three primer concentration levels (A, B and C) for the 
titration array (Table 4.2)
Prepare and run TWO sets of NINE PCR reactions, with primers 
aliquoted according to Table 4.2. One set should contain 
control wild type template and the other should contain control 
mutant template.
Check resulting Tm data and specificity.
Run products on gel to confirm fragment sizes.
REPEAT
using narrower range of 
primer concentration &/or 
modifying cycle parameters
QUESTION
NO — i Are two allele-specific fragments j ^ i  yE S
formed according to genotype in 
a single reaction, without 
artefactual amplification?
GENOTYPE
Figure 4.5: General optimisation strategy for defining discriminatory conditions for 
fluorescent bi-directional PCR tests.
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Rxn WT AS, /iM W T O P ,ilM M UTAS, [iM M UTO P, nM
1 A A A A
2 A A B B
3 A A C C
4 B B A B
5 B B B C
6 B B C A
7 C C A C
8 C C B A
9 C C C B
Table 4.2: Primer titration matrix. Primers were aliquoted according to this matrix, where A= 




Figure 4.6 displays gel images from optimisation sets incorporating wild type or 
mutant DNA, used to define optimal discriminatory conditions for the detection of 
the mutation associated with sickle cell anaem ia. Corresponding T m data is 
displayed in Table 4.3. Conditions of Reaction 3, Table 4 .2  (0.15 p.M each
SC _W T_A S/ SC_W T_OP, and 0.9 jiM  each SC _M U T_A S/ SC_M UT_O P) yielded a 
single product with a T m of 87.4°C  in the presence of wild type DNA, or 85.7°C with 
mutant DNA. Each melt peak had an area of 17.78 and 26.01 arbitrary fluorescence 
units, respectively. This corresponded to a single band on the agarose gel at 86 bp 
for wild type DNA and 112 bp for mutant DNA. These conditions were used in 
subsequent genotyping tests for detecting the presence of the A -»T  mutation.
Figure 4 .7  shows gel images from optimisation sets incorporating wild type or 
mutant DNA, used to define optimal discriminatory conditions for the detection of 
the C 282Y  polymorphism. Corresponding Tm data is displayed in Table 4.4. 
Conditions of Reaction 5, Table 4.2 (0.3 p.M each C 282Y_W T_A S/ C282Y_W T_OP, 
and 0.3  p.M each C 282Y_M U T_A S / C282Y_M U T_O P) yielded a product with a T m 
of 84 .15°C in the presence of wild type DNA, and 87.81 °C with mutant control DNA. 
This corresponded to a 76 bp and 72 bp fragment respectively. The larger 118 bp 
fragment amplified by outer primers was also present in Reaction 5 containing wild 
type DNA, with a melting temperature of 88.58°C.
A second round of optimisation was performed to refine conditions further (Figure 
4.8, Table 4.5). In this case, 0.25 pM each primer set was used to genotype six 
control DNA samples; two wild type, two mutant and two heterozygotes. A single 76  
bp product was formed for each wild type homozygote with a T m of 87.28 and 87.38  
°C. A single 72 bp product was formed for each mutant homozygote with a T m of 
84 .84  and 84.95 °C. Two products of both pre-defined sizes were formed with the 
heterozygous control DNA samples without artefactual amplification. These  




Figure 4.9 shows gel images from optimisation sets incorporating wild type or 
mutant DNA, used to define optimal discriminatory conditions for the detection of 
the H 63D  polymorphism. Corresponding T m data is displayed in Table 4.6. 
Conditions of Reaction 5, Table 4.2 (0.6 p,M each primer) yielded a product with a 
T m of 87.18°C in the presence of wild type DNA, or 85.08 °C with mutant DNA. Each 
melt peak had an area of 19.33 and 29.12 arbitrary fluorescence units, respectively. 
This corresponded to a band on the agarose gel at 121 bp for wild type DNA and 89 
bp for mutant DNA. A small amount of target region amplification was detected in 
the wild type sample.
A further round of optimisation was performed using a narrowed range of primer 
concentrations (Table 4.2, where A= 0.2 |iM , B= 0.25 jxM and C= 0.3 pM). Due to 
limiting volumes of control DNA samples, a heterozygous control DNA was used as 
template. Reaction 7, Table 4.2 (0.3 pM of each H 63D_W T_AS/ H63D_W T_O P and 
0.2  p M  each H 63D _M U T_A S / H 63D _M U T_O P ) amplified two allele-specific  
fragments to similar levels (Figure 4.10, Table 4 .7 ). The wild type melt peak 
(87.19°C ) had an area of 16.89 arbitrary fluorescence units, and the mutant melt 
peak (84 .1 6 °C ) had an area of 14 .38  arbitrary fluorescence units. This 
corresponded to a band on the agarose gel at 121 bp for wild type DNA and 89 bp 
for mutant DNA. To confirm the optimal nature of these conditions, all control 
sam ples w ere re-tested. Gel images are displayed in Figure 4 .11 , with 
corresponding T m data in Table 4.8. Known homozygous mutant samples were 
indistinguishable from heterozygotes, both generating identical band patterns 
containing both wild type (121 bp) and mutant (89 bp) fragments with similar T m 
values (wild type, 87.82 ±0.05°C and mutant, 85.13 ±0 .16°C).
To confirm whether the ambiguity was due to the reaction conditions or a possible 
sam ple mislabelling, the reference laboratory was contacted to disclose two 
additional DNA samples that could be used as homozygous controls. These  
samples were used as template in PCR tests using the conditions of Reaction 7 
(Table 4 .2), and fragment patterns were compared with those from the original 
mutant control. The resulting gel image and T m data is shown in Figure 4.12 and
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Table 4.9, respectively. The band profile of the original control differed from the two 
additional mutant controls. As previous, a wild type amplicon (121 bp, 87.54°C) and 
a mutant amplicon (89 bp, 84.17°C) was amplified from the original mutant control 
DNA, whilst single 89 bp amplicons (were amplified with the new control samples 
(84.70°C  and 85.18°C), confirming that the original mutant control sample was in 












86 bp ^ I
A.
158 bp
Figure 4.6: Typical gel images of optimisation titrations from the assay designed to detect the presence of the sickle cell mutation. Reactions 1 to 9 
correspond to conditions described in Table 4.2 using [A] Wild type and, [B] Mutant human genomic DNA template. The 158 bp target region was 
not amplified to a detectable level across the reaction set. Corresponding Tm data is displayed in Table 4.3 overleaf.
Gel [A] Wild type
Reaction 1 2 3 4 5 6 7 8 9
Amplicon Tm,°C Area O o Area Tm,°C Area Tm,°C Area Tm, °C Area H 3 o o Area Tm, °C Area
Oo
E
I- Area Tm,°C Area
Target region 
(158 bp)
- - - - - - - - - - - - - - - - - -
Wild type 
(112 bp)
87.25 16.86 87.48 15.69 87.36 17.78 87.06 24.57 87.19 27.82 87.21 27.64 87.16 31.76 87.17 32.94 87.13 29.41
Mutant 
(86 bp)
- - - - - - - - - - * - - - - - - -
Gel [B] Mutant
Reaction 1 2 3 4 5 6 7 8 9
Amplicon Tm, °C Area OoEI- Area f1 O o Area Tm, °C Area
Oo Area Tm, °C Area Tm, °C Area O o Area Tm ,°C Area
Target region 
(158 bp)
- - - - - - - - - - - - - - - - - -
Wild type 
(112 bp)
87.45 2.94 87.13 5.63 - - 87.20 15.66 86.79 15.98 87.23 15.57 86.52 26.79 86.64 21.96 86.85 26.09
Mutant 
(86 bp)
- - - - 85.66 26.01 - - - - 85.35 4.47 - - - - - -
Table 4.3: T m data from optimisation sets used to detect the presence of the sickle cell mutation, using [A] wild type or [B] mutant DNA template.
Corresponding gel images are shown in Figure 4.6.
Figure 4.7: Typical gel images of optimisation titrations from the assay designed to detect the presence of the C282Y mutation. Reactions 1 to 9 
correspond to conditions described in Table 4.2 using [A] Wild type and, [B] Mutant human genomic DNA template. The 118 bp target region was 
amplified to a detectable level in Reactions 8 and 9 of Set [A]. Corresponding Tm data is displayed in Table 4.4 overleaf.
Gel [A] Wild type
Reaction 1 2 3 4 5 6 7 8 9
Amplicon
ooEI- Area OOiI- Area Tm, °C Area Tm, °C Area OO Area OO Area Tm, °C Area O o Area Tm, °C Area
Target region
(118 bp)
- - - - - - - - - - • - - - 88.76 5.86 88.18 22.20
Wild type 
(76 bp)
87.97 1.19 - - - - 87.19 15.91 87.81 20.72 88.6 16.00 87.03 22.23 86.95 20.93 - -
Mutant 
(72 bp)
- - 84.45 15.39 84.13 23.81 - - - - 83.52 15.73 - - - - - -
Gel [B] Mutant
Reaction 1 2 3 4 5 6 7 8 9
Amplicon f1 O o Area
OOEI- Area Tm,°C Area Tm, °C Area OoiI- Area Tm, °C Area Oo Area Tm, °C Area O o Area
Target region 
(118 bp)
- - - - - - - - - - - - - - - - - -
Wild type 
(76 bp)
- - - - - - - - - - - - - - - - - -
Mutant 
(72 bp)
84.65 13.82 84.40 29.90 84.44 33.32 84.43 8.62 84.15 22.47 84.43 33.34 84.09 9.30 84.06 21.03 84.26 28.90
Table 4.4: Tm data from optimisation sets used to detect the presence of the C282Y mutation using [A] wild type or [B] mutant DNA template.







Figure 4.8: Typical gel images from further titrations for optimisation of the assay designed to detect the C282Y mutation. Lanes 1 and 2 contain 
wild type DNA samples; Lanes 3 and 4 contain heterozygous DNA samples; Lanes 5 and 6 contain mutant DNA samples. All DNA samples used 
were different. The 118 bp target region was not amplified to a detectable level across the reaction set. Corresponding Tm data is displayed in 
Table 4.5 overleaf.
Reaction 1 2 3 4 5 6
Amplicon Tm. °C Area Tm, °C Area Tm, °C Area Tm,°C Area Tm, °C Area OOEI- Area
Target region 
(118 bp)
- - - - - - - - - -
Wild type 
(76 bp)
87.28 2.17 87.38 2.50 87.43 1.41 87.54 1.62 - - -
Mutant 
(72 bp)
- - - 84.67 2.58 84.72 3.02 84.84 4.76 84.95 2.55







Figure 4.9: Typical gel images of optimisation titrations from the assay designed to detect the presence of the H63D mutation. Reactions 1 to 9 
correspond to conditions described in Table 4.2 using [A] Wild type and, [B] Mutant human genomic DNA template. The 169 bp target region was 
amplified to a detectable level in Reactions 2, 3, 5 and 6 of Set [A], and Reactions 5, 8 and 9 of Set [B]. Corresponding Tm data is displayed in 
Table 4.6 overleaf.
Gel [A] Wild type
Reaction 1 2 3 4 5 6 7 8 9
Amplicon Tm, °C Area Tmi °C Area Tm, °C Area Tm, °C Area Tm, °C Area Tm. °C Area Tm, °C Area OO Area Tm, °C Area
Target region 87.24 1.06 87.82 6.86 87.60 15.81 . IND _ 87.63 m
(169 bp)
Wild type - . - 86.96 17.62 87.18 19.33 . 19.25 86.57 31.86 86.48 31.88 86.67 32.05
(121 bp)
Mutant . . _ _ IND
(89 bp)
Gel [B] Mutant
Reaction 1 2 3 4 5 6 7 8 9
Amplicon Tm, °C Area Tm, °C Area Tm, °C Area Tm, °C Area Tm, °C Area Tm, °C Area OOiI- Area Tm> °C Area Tm, °C Area
Target region 
(169 bp)
- - - - - - - - - - -
Wild type 
(121 bp)
- - - 87.65 16.53 - - 87.29 31.51 87.36 33.55 88.09 8.85
Mutant 
(89 bp)
85.68 10.32 85.12 37.11 85.10 44.63 - 85.08 29.12 85.15 43.24 - - - 84.78 31.36
Table 4.6: Tm data from optimisation sets used to detect the presence of the H63D mutation using [A] wild type or [B] mutant DNA template.















Figure 4.10: A typical gel image of an optimisation titration from the assay designed to detect the presence of the H63D mutation. Reactions 1 to 9 
correspond to conditions described in Table 4.2 using heterozygous human genomic DNA template. The 169 bp target region was amplified to a 
detectable level in all reactions. Corresponding Tm data is displayed in Table 4.7 overleaf.
Reaction 1 2 3 4 5 6 7 8 9
Amplicon o11- Area OOEI- Area OOE Area H 3 o o Area
OOHg Area f1 O o Area
OO
E
1— Area OOEI- Area Tm, °C Area
Target region 
(169 bp)
- - - - IND - IND - IND - IND - IND - IND - IND -
Wild type 
(121 bp)
87.57 4.75 87.72 3.10 87.83 3.96 87.37 9.05 87.63 7.07 87.78 4.49 87.19 16.89 87.46 11.50 87.64 7.59
Mutant 
(89 bp)
84.58 22.91 84.57 27.43 84.46 30.11 84.44 17.13 84.46 25.06 84.44 28.08 84.16 14.38 84.37 21.91 84.39 28.26
Table 4.7: Tm data from a second optimisation set used to detect the presence of the H63D mutation. Corresponding gel images are shown in 
Figure 4.10.
Figure 4.11: A typical gel image using optimised conditions for the detection the H63D mutation. Lanes 1, 2 and 3 contain wild type DNA samples; 
Lanes 4 and 5 contain heterozygous DNA samples; and lane 6 contains mutant DNA samples. All DNA samples used were different. The 169 bp 
target region was amplified to a detectable level in Reactions 4, 5 and 6. Corresponding Tm data is displayed in Table 4.8 overleaf.
Reaction 1 2 3 4 5 6
Amplicon ooEI- Area Tm, °C Area Tm, °C Area Tm. °C Area Tm, °C Area OEI- Area
Target region 
(169 bp)
- - - - IND - IND - IND -
Wild type 
(121 bp)
87.54 12.76 87.51 14.79 87.48 17.80 87.76 10.83 87.86 7.75 87.83 10.45
Mutant 
(89 bp)
- - - - 85.07 12.65 85.32 10.26 85.01 14.54
Table 4.8: Tm data from control sets used to clarify the conditions established for the detection of the H63D mutation. Corresponding gel images 
are shown in Figure 4.11.
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Figure 4.12: Typical gel images using optimised conditions for the detection the H63D mutation. Lanes 1-3 contains a mutant DNA sample; lanes 
4-6 contain another mutant DNA sample; and lanes 7-9 contain the control mutant template used in previous optimisations of this assay. This 
sample has been revealed here as a heterozygote. Lanes 1, 4 and 7 contained 20 ng starting DNA concentration; lanes 2, 5 and 8 contained 
10ng; and lanes 3, 6, and 9 contained 5 ng. Less target region amplification was observed in the heterozygote sample where a lower starting DNA 
concentration was included. This will be accommodated in genotyping experiments. Corresponding Tm data is displayed in Table 4.9 overleaf.
Reaction 1 2 3 4 5 6 7 8 9
Amplicon Tm, °C Area Tm, °C Area Tm, °C Area Tm, °C Area Tm, °C Area Tm, °C Area OO£I- Area Tm,°C Area OOiI- Area
Target region 
(169 bp)
- - - - - - - IND - IND - IND -
Wild type 
(121 bp)
- - - - - - - 87.54 19.57 88.07 8.42 87.89 13.71
Mutant 
(89 bp)
84.70 28.35 85.31 23.06 85.51 21.21 85.18 26.37 85.87 13.55 85.57 19.94 84.17 15.95 85.26 14.02 84.76 17.36
Table 4.9: Tm data from control sets used to clarify the conditions established for the detection of the H63D mutation. Corresponding gel images 
are shown in Figure 4.12.
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4.1.4 SNP genotyp ing
For the sickle cell assay, forty-two DNA samples were tested in a small-blinded trial. 
Thirty-three samples generated a melt peak around 87.5°C  (±0.2°C ), five samples 
produced a melt peak at 85.7°C  (±0.2°C), and seven samples amplified both allele- 
specific fragments giving a dual-peak with maxima at 85.3°C  (±0.3°C ) and 87.6°C  
(±0 .3 °C ); thus diagnosing homozygous wild type, homozygous mutant and 
heterozygous inheritance respectively (Figure 4 .13). Cluster analysis of product T m 
values showed three unambiguous and distinct clustering regions, each  
corresponding to a particular genotype (Figure 4.14).
For the C 282Y  assay, a total of sixty-two DNA samples were genotyped. Thirty-two 
sam ples generated a melt peak around 87.2°C  (±0 .3°C ), seventeen samples 
produced a melt peak at 84.6°C  (±0.3C), and thirteen samples amplified both allele- 
specific fragments giving a dual-peak with maxima at 84.5°C  (±0.3°C) and 87.4°C  
(± 0 .2 °C ); thus diagnosing homozygous wild type, homozygous mutant and  
heterozygous inheritance respectively (Figure 4.15). Cluster analysis of product T m 
values showed three unambiguous and distinct clustering regions, each  
corresponding to a particular genotype (Figure 4.16).
For the H63D assay, sixty-two DNA samples were genotyped. Thirty-nine samples 
generated a melt peak around 87.7°C  (±0.3°C), ten samples produced a melt peak 
at 85 .3°C  (±0.1 °C), and thirteen samples amplified both allele-specific fragments 
giving a dual-peak with maxima at 85.1 °C (±0 .4°C ) and 87 .7°C  (±0.3°C); thus 
diagnosing homozygous wild type, homozygous mutant and heterozygous  
inheritance respectively (Figure 4.17). Cluster analysis of product T m values showed 
three unambiguous and distinct clustering regions, each corresponding to a 
particular genotype (Figure 4.18). For each test, ‘no template control’ samples were 
included to assess contamination and non-specific amplification by primer sets; no 
amplification occurred in these controls. If primer dimer had been formed in the 
reaction, the characteristically low T m of the artefact would ensure that points were 





Figure 4.13: Example melting profiles from diagnostic tests for the detection of the sickle cell 
mutation representing typical results from one of each possible genotype; [A] Homozygous 
wild type, [B] Homozygous mutant, and [C] Heterozygous DNA. The three genotypes are 
easily identified by visual inspection of the graphs as described in text. Actual Tm values 
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Figure 4.14: Cluster analysis to determine sickle cell genotype. The x-axis represents peaks 
within the actual Tm range of 85.4°C (±0.3°C), and the y-axis represents areas within the 
actual Tm range of 87.3°C (±0.3°C). A symbol is assigned to represent homozygous DNA 
(▲) or heterozygous DNA (O). Points lining up along either the x-axis or y-axis diagnose 
homozygous inheritance of mutant or wild type alleles, respectively. Points lying near to the 




Figure 4.15: Example melting profiles from diagnostic tests for the detection of the C282Y 
mutation representing typical results from one of each possible genotype; [A] Homozygous 
wild type, [B] Homozygous mutant, and [C] Heterozygous DNA. The three genotypes are 
easily identified by visual inspection of the graphs as described in text. Actual Tm values 














80 81 82 83 84 85 86 87 88 89
Tm 1(°C)
Figure 4.16: Cluster analysis to determine C282Y HFE genotype. The x-axis represents 
peaks within the actual Tm range of 87.2 °C (± 0.3°C), and the y-axis represents areas within 
the actual Tm range of 84.6 °C (± 0.3°C). A symbol is assigned to represent homozygous 
DNA (▲) or heterozygous DNA (O). Points lining up along either the x-axis or y-axis 
diagnose homozygous inheritance of mutant or wild type alleles, respectively. Points lying 
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Figure 4.17: Example melting profiles from diagnostic tests for the detection of the H63D 
mutation representing typical results from one of each possible genotype; [A] Homozygous 
wild type, [B] Homozygous mutant, and [C] Heterozygous DNA. The three genotypes are 
easily identified by visual inspection of the graphs as described in text. Actual Tm values 
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Figure 4.18: Cluster analysis to determine H63D HFE genotype. The x-axis represents 
peaks within the actual Tm range of 87.7 °C (± 0.3°C), and the y-axis represents areas within 
the actual Tm range of 85.3°C (± 0.1 °C). A symbol is assigned to represent homozygous 
DNA (A) or heterozygous DNA (O). Points lining up along either the x-axis or y-axis 
diagnose homozygous inheritance of mutant or wild type alleles, respectively. Points lying 
near to the x=y axes represents heterozygous inheritance.
151
Chapter Four
4.7.5 G enotype validation
For the sickle cell genotyping trial, SNP scoring by fluorescent bi-directional PCR  
was validated by restriction enzyme digestion according to the protocol described in 
Section 2 .5 .4 . PCR products directed by outer primers (S C _W T _O P  and 
SC_M UT_OP) were cut with Dde I, which has a specific cutting site of 5 ’- CTNAG -3 ’ 
(where N is G, C, A, or T; Chang and Kan, 1982). The presence of the sickle cell 
mutation abolishes the cutting site for this enzyme. A large uncut fragment was 
obtained for mutant samples, as opposed to two smaller fragments for a normal 
genotype. The presence of all three fragments diagnosed a heterozygous genotype. 
RFLP results were 100% concordant with the fluorescent bi-directional PCR assay 
(Figure 4.19).
For HH assays, the fluorescent bi-directional PCR genotyping trial was completed 
prior to receipt of actual genotypes from the source reference laboratory. The  
reference genotyping method used was a multiplex PCR followed by SSCP on a 
polyacrylamide gel at 8°C, visualised by silver staining (Unpublished method, Steve 
Keeney, Manchester Royal Infirmary, UK). Genotypes called by fluorescent bi­
directional PCR were compared for concordance. Data from the C282Y assay were 
92%  concordant with genotyping data from the reference laboratory. Results from 
the H63D  assay were 97%  concordant. Samples giving different results were 
sequenced at Bath University using Big Dye Terminator Cycle Sequencing Ready 
Reaction Kits on an ABI Prism 377 DNA Sequencer (Applied Biosystems). In each 
case, the sequence data corresponded to the fluorescent bi-directional assay.
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Figure 4.19: Genotype validation by restriction enzyme digestion. Samples A to R are displayed with a no template control sample (n).
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4.2 Discussion
The fluorescent bi-directional PCR assay described here was successfully used to 
genotype human genomic DNA sam ples for the presence of three well- 
characterised single nucleotide polymorphisms. The integration of the single tube 
bi-directional PCR (Chapter three), with SYBR Green I, melt curve analysis and 
rapid cycling has enabled favourable interactions addressing key issues facing 
developers of clinical diagnostic assays, including specificity, throughput, and cost.
The design of a bi-directional PCR test is quite simple. The resolution limits of 
current instrumentation demands that in order for two products to be accurately 
separated during melt curve analysis using a dsDNA specific binding dye, their 
melting temperatures must differ by at least 2°C  (Ririe et al., 1997). Therefore, the 
test requires the design of primer sets that satisfy this parameter. Generally, this 
can be achieved by designing smaller amplicons. Empirical formulas predict that a 
DNA duplex made up entirely of A and T  nucleotides would melt 41 °C lower than a 
100% GC duplex. Given the same GC content, a 40-base-pair primer dimer should 
melt 12°C below a 1000-bp product. Hence, the theoretical range for potential PCR  
products spans at least 50°C (Ririe et al., 1997). Using the p-globin gene sequence 
as an example, Figure 4.20 shows that in practice, this range only holds for smaller 
amplicons between 50-150 bp. Providentially, this is the range of choice for rapid 
cycling protocols due to the short extension times (Wittwer et al., 1993).
For the detection of each mutation, the GC content of the sequence surrounding the 
SNP site enabled the design of primers that amplified products with a predicted Tm 
difference of 2°C (Figures 4 .2-4.4 inclusive). Detection of the sickle cell SNP was 
aided by the high GC content downstream of the SNP site that formed the wild type 
fragment (58% ) compared to the upstream sequence that formed the mutant 
fragment (49%). Likewise, primers designed for the detection of HH mutations, was 
based on the differing GC contents of the target regions; this was 56%  upstream 
and 63%  downstream of the C 282Y  SN P site; and 49%  upstream and 53%  
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Figure 4.20: Relationship between molecular weight and product Tm of sequence 
surrounding sickle cell SNP in B-globin gene, as an example. This graph was constructed by 
sequentially measuring the Tm of different sized fragments within the (3-globin gene, using 
PrimerCalc Software Version 1.0; Q-Biogene), which employs nearest neighbour 
thermodynamic algorithms (Breslauer etal., 1986).
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The relationship between amplicon size and product Tm has consequence in other 
aspects of this assay. During bi-directional PCR, Taq  DNA polymerase will extend 
the two non allele-specific primers flanking the target region regardless of genotype, 
generating a 158, 103, or 169 bp amplicon with a calculated T m of « 88.0°C, 87.0°C, 
and 88.0°C  from sickle cell and H F E  genes (C 282Y and H63D), respectively. 
However, the melt peak from this larger fragment is indistinguishable from the 
largest allele-specific amplicon, because there can only be a small difference in 
their T m. Amplification of this fragment may lead to false results by masking allele- 
specific amplifications. By performing a two-step PCR with denaturation and  
annealing stages only, cycling conditions were adjusted to favour the amplification 
of smaller amplicons, relying on the transitional times of the kinetic PCR cycle (De  
Silva and W ittwer, 2000). This rapid protocol was effective in suppressing 
amplification of the larger target region in all assays (Figure 4.6, 4 .7-4.12 inclusive).
Rapid cycling protocols confer further advantages to A S -P C R  methods by 
improving specificity (De Silva et al., 1998). Traditionally, allele-specific PCR tests 
have been designed for Peltier-based PCR instruments requiring -3 0  s extension 
times. This increases the time for possible extension of a mismatched primer 
annealed at the expected site to occur. If the conditions have not been effectively 
optimised, an amplicon of identical size to that formed by a perfectly matched 
primer may be produced, causing failure of the genotyping test. Using air-exchange 
as the heating and cooling mechanism , faster ramp rates and improved 
temperature control can be achieved, allowing shorter extension times which have 
been shown to strongly disfavour mismatched primer extension (De Silva et al., 
1998; Wittwer et al., 1993). This is likely due to the decreased time available for a  
mismatched primer to ‘sit’ at the annealing site, reducing the chance of extending 
through. Consequently, fluorescent bi-directional PCR works effectively without 
primer modifications such as GC tails or extra mismatches near the 3 ’ end of the 
primers to improve specificity (Germer and Higuchi, 1999).
A simple optimisation strategy was used to define the conditions taking into account 
the assay dynamics described above (Figure 4.5). Since the commercial mastermix 
used contained the majority of reaction components, optimisation involved a simple
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sequential titration of Mg2+ and oligonucleotide. Discriminatory conditions were 
specified as those able to amplify allele-specific products o n ly  with similar 
efficiencies determined by melt peak height and peak area. In addition, these 
conditions should reduce or completely remove artefactual amplification (e.g. primer 
dimer). Ideally, only two oligonucleotide titration sets using wild type or mutant 
control DNA samples would be required to define optimal primer concentrations for 
allelic discrimination, and this was the case for the assay designed to detect the 
SNP causing sickle cell anaemia. Two sequential rounds of optimisation using a 
narrower range of primer concentrations or shortened cycling programs were 
necessary for both HH assays. With the use of novel chemistries such as Locked 
Nucleic Acids (Jensen et al., 2001), with the ability to improve discrimination in AS- 
PCR (as shown in Appendix V data) robustness may be further enhanced, 
eliminating the need for sequential optimisation steps. Since the true cost of 
genotyping tests is not only defined by reagent and consumable costs, but also the 
time and labour involved in reaction design and optimisation, the strategy used here 
added to overall cost effectiveness.
The power of the optimisation strategy was demonstrated by the assay designed to 
detect the H63D mutation. In this case, mislabelling of a control sample at source 
meant that conditions were being optimised for wild type and heterozygous samples 
only (Figure 4 .11). The conditions selected were able to identify that the mutant 
control was in fact heterozygous. This was confirmed by contacting the source 
laboratory to identify two more mutant samples to which the control could be 
compared, confirming that it had been correctly genotyped by fluorescent bi­
directional PCR (Figure 4.12).
The mastermix used increased the specificity of allele-specific PCR since an 
aptamer-based hot start enzyme system was incorporated (Table 3.5, pg. 90), 
preventing non-specific primer extension by T aq  DNA polymerase at ambient 
temperatures (Lin et al., 1997). In addition, the use of a commercial mastermix 
reduced the common observation of well-to-well variation in the T m of the same 
amplicon. Such variation is usually attributed to SYBR Green I concentration (Nath 
et al., 2000), salt concentration (Schildkraut and Lifson, 1965), actual product yield
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or temperature transition rates (Ririe et al., 1997). By using a commercial master 
mix with a consistent concentration of SYBR Green I, and employing optimised 
magnesium concentrations, this variation was minimised. In practice, the small 
differences observed were likely due to differences in product yield and smoothing 
mathematical algorithms and were not sufficient to cause error in fluorescent bi­
directional PCR.
In all cases, optimal conditions were defined and validated by genotyping unknown 
DNA samples for sickle cell anaemia or hereditary haemochromatosis status on the 
basis of their melting profiles alone. In each case, clearly distinct profiles were 
achieved depending upon genotype (Figures 4.13, 4 .15 and 4.17), which formed 
distinct clustering regions that may be compatible with SNP-calling software (Figure 
4.14, 4.16, 4.18). Excellent concordance levels were achieved with RFLP results in 
the detection of sickle cell anaemia (Figure 4.19). In the case of HH assays, good 
concordance was achieved (92%  and 97%). The mistyped samples were attributed 
to sample mix-ups or typographical errors.
To summarise, fluorescent bi-directional PCR is mediated through a highly efficient 
kinetic process, coupled with an accurate melt curve analysis. The rapid cycling 
satisfies the higher throughput demanded by today’s genotyping needs, and the 
introduction of homogeneity to the assay is ideal for use for diagnostic testing. The 
use of a universal dsDNA binding dye maintains the low cost of fluorescent-based 
assays. The data presented here suggests that fluorescent bi-directional PCR has 
potential as a tool for screening programmes of sickle cell anaem ia or hereditary 
haemochromatosis, particularly if coupled with informatics tools that would allow 
automation. With finer tem perature control, slower transition rates should be 
possible as well as greater sample temperature homogeneity (Ririe et al., 1997). 
This would allow greater resolution, reducing the restrictions for primer design and 
multiplexing, which represent the only drawbacks of the assay in its current form.




Bi-directional PCR Combined with 5’ Nuclease 
Fluorogenic Probes for Allelic Discrimination
5.0 Introduction
The attributes that would lead to a wider acceptance of PCR within clinical 
diagnostic applications were introduced in detail in Chapter One; the test should be 
relatively inexpensive, easy and quick to perform, with a high degree of fidelity to 
limit the likelihood of misdiagnosis (Figure 1.4, pg. 16). Real-tim e PCR probe 
technologies go someway towards fulfilling these criteria by allowing sequence 
specific detection of PCR amplicons as they are synthesised. They also have 
multiplex capabilities that enable more than one SNP to be assayed within a single 
reaction, a useful attribute where the interactions of more than one SNP contributes 
to a clinical phenotype (Taylor et al., 2001), or where a limited source of DNA is 
available. Homogenous multiplex reactions are able to eliminate the post-PCR  
processing steps, which are not only rate limiting but also increase the opportunity 
for sample mix-ups and contamination.
The success of real-time PCR probes is based on hybridisation of a short nucleic 
acid sequence to its complement; a highly specific molecular recognition event that 
adds sequence specificity to genotyping assays. Many probe configurations have 
been described (Figure 1.12, pg. 34), the majority of which utilise FRET as the 
reporting mechanism. As described in Chapter One, FRET is a distance-dependent 
interaction between the electronic excited states of two dye molecules in which 
excitation is transferred from a donor molecule to an acceptor molecule (or 
quencher) without emission of a photon (Figure 1.6D, pg. 20). The excitation energy 
is transferred to a neighbouring fluorophore, which raises the electron in the 
acceptor to a higher energy state as the photo-excited electron in the donor returns 
to ground state. If the acceptor is also fluorescent, the transferred energy can be 
emitted as a fluorescence characteristic of the acceptor. If the acceptor is not
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fluorescent, the energy is ‘quenched’ through equilibration with solvent (Didenko,
2000).
The most popular probe configuration utilising FRET for real-time PCR monitoring is 
the 5’ fluorogenic nuclease probe (commercially known as TaqMan® probe; Figure 
5.1). A TaqMan® probe consisting of an oligonucleotide specific to sequence 
between the primer annealing sites is included in the reaction. The probe is labelled 
with a reporter dye (usually FAM) and a quencher dye (usually TAMRA; 6-carboxy- 
N ,N ,N ’,N ’-tetram ethylrhodam ine), protected from extension by Taq D N A  
polymerase by phosphorylation at the 3 ’ end (Livak, 1999). In the intact probe, the 
quencher is within close enough proximity to the reporter dye to reduce the 
fluorescence signal observed by FRET. During the extension phase of a typical 
PCR run, the 5’ nuclease activity of Taq degrades the probe in the 5 ’ to 3 ’ direction, 
liberating the reporter dye from the quencher dye, disabling FRET by increasing the 
intermolecular distance beyond effective FRET limits, known as the Forster 
distance. With each additional cycle of denaturation, annealing and extension, a 
single molecule of the reporter dye is liberated from the quencher dye per PCR  
product, giving a molar increase in fluorescence signal proportional to increasing 
amplicon levels.
TaqMan® probes represent a category called ‘hydrolysis’ probes, named as such 
because the proximity of the reporter and acceptor dyes is changed by a hydrolysis 
event. The importance of specific hybridisation using TaqMan® probes is apparent 
during SNP detection where cleavage of the probe only occurs if it is specifically 
hybridised to a matched target sequence (Figure 5.2; Livak, 1999). Conventionally, 
two probes specific for each allele of a bi-allelic SNP are included in the same PCR  
test, distinguished by labelling with different reporter dyes at the 5 ’ end, emitting 
fluorescence at different detectable wavelengths. A matched template: probe 
duplex provides the optimal substrate for 5 ’ nuclease activity, which is a forked 
structure occurring at the phosphodiester bond joining the displaced region with the 
base-paired portion of the strand (Figure 1.13, pg. 38; Holland eta !., 1991). A single 





Genomic DNA Taq DNA polymerase ' *  Released reporter dye
Newly-synthesized DNA _ ►  Matched primer $  Released quencher
TaqMan probe labeled with reporter 'R' and quencher O'
Figure 5.1: Diagram of 5’ to 3’ exonuclease cleavage of labelled oligonucleotide (TaqMan®) probe. Annealing of the TaqMan® probe to a sequence 
within the PCR amplicon generates a suitable substrate for 5’-»3 ’ exonuclease activity of Taq DNA polymerase. During amplification, the 5’->3’ 
exonuclease activity degrades the probe into smaller fragments, releasing the quencher from the fluorophores. The distance between probe and 
quencher is no longer within the limits for FRET to occur, and so an increased fluorescent signal from the reporter dye is measured. The signal is 
proportional to target DNA concentration (Holland eta!., 1991).
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For a matched TaqMan® assay, fluorescence begins to increase over background 
levels during early cycles. As described previously, the fractional cycle number at 
which the fluorescence passes this fixed threshold is known as the “cycle threshold” 
(CT; Figure 1.9, pg. 26), indicating that the probe-specific target has been amplified. 
For genotyping, results are expressed as a signal ratio that reflects the differential 
hybridisation of the two oligonucleotides to the target sequence (ARn); therefore 
differences in amplification efficiency between samples do not affect interpretation 
of the genotyping results. An increase in signal from either probe will indicate the 
dominant alleles in the reaction (Figure 5.3A; Livak, 1999).
For success in conventional assays, a single base mismatch between probe and 
template has to be detected using a probe that is typically 20-30 nucleotides long. 
The reported efficacy of TaqMan® here is attributed to a number of factors including 
a thermodynamic contribution caused by the disruptive effect of a mismatch on 
hybridisation such that a mismatched probe will have a slightly lower melting 
tem perature than a  perfectly matched probe; proper choice of an annealing or 
extension temperature in the PCR can favour hybridisation of the exact match over 
a mismatched probe; and the assay is performed under competitive conditions 
given that both probes are present in the same reaction tube. The stable binding of 
a matched probe can block hybridisation of the mismatched probe (Livak, 1999).
However, amplification conditions that distinguish between probes with a single 
nucleotide difference are often difficult to establish (Sevall, 2000). A necessary 
requirem ent is that the TaqMan® probe must be bound to the tem plate at 
temperatures where Taq DNA polymerase is optimally extending primers (60-72°C). 
Probes with melting temperatures between 65°C  and 75°C are best. This usually 
requires an oligonucleotide length of 25-40 nucleotides in order to form the required 
stable hybrid. This is generally too long for most SNP detections given that the 
difference in Tm between a perfectly matched duplex 25 bp long and a similar 
duplex with a single mismatch is usually only about 3°C . Without careful 
optimisation of probe sequence and PCR conditions it is difficult to detect SNPs  
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Fig 5.2: Allelic Discrimination using fluorogenic probes and the 5’ nuclease assay. Increase in FAM signal equals homozygous for Allele 1; 











Figure 5.3 Typical read-outs. [A] Conventional allelic discrimination: Two allele-specific TaqMan® probes are incorporated, designed to anneal to 
the SNP site. TaqMan® probes are differentially labelled such that a specific signal can be assigned to a particular genotype. The signal giving the 
largest change in signal is considered the most efficient reaction, and is used to assign the genotype (Rn1-Rn2 = ARn). [B] Combined TaqMarf 
and allele-specific PCR strategies: A single probe is included in the reaction, annealing to a sequence within an allele-specific amplicon (not 
spanning the SNP site). Two separate reactions are performed containing different allele-specific primers and the same TaqMan® probe. A 
mismatch is shown to have a higher CT than a matched allele-specific PCR reaction, so the differences in cycle threshold are used as a measure 
of PCR efficiency (CT1 - CT 2= A CT).
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Consequently, several reports have been published that describe the combination 
of the TaqMan® assay with allele-specific amplification. These include TaqMAMA  
(Glaab and Skopek, 1999), TaqMan-ASA (Fujii et al., 2000), allele-specific TaqMan  
PCR assay (Mizugaki et al., 2000; Matsubara et al., 1999). In each case, a single 
“generic” probe is included in a PCR directed by an allele-specific primer and a 
common primer. The probe is designed such that it is upstream of the allele-specific 
primer, annealing between the two amplification primers. Following two separate 
tests incorporating each different allele-specific primer with the same probe, the 
genotype is inferred by comparing CT values (Figure 5.3B), as opposed to the ARn 
levels evaluated in the conventional system. The theory of this analysis is that a 
mismatched allele-specific primer generally gives a signal above threshold in later 
cycles than a matched test (i.e. it has a higher CT value than a match), attributed to 
a decrease in priming ability and PCR efficiency (Glaab and Skopek, 1999). As long 
as the CT value for a match is reproducibly lower than a mismatch, genotyping is 
possible in these systems.
Each ‘combined’ method described above has incorporated the discriminatory 
advantages of allele-specific PCR into the test, at a significant cost of returning the 
bi-allelic genotyping to a two-tube format. In a clinical assay where driving down 
genotyping costs is key, a two-tube system requiring double the amount of reagents 
than a single tube assay, and an internal control amplification, may not be 
favourable. This chapter describes an enhancem ent to the conventional allelic 
discrimination formats and allele-specific TaqMan® assays by adapting single tube 






A schematic of the bi-directional PCR/ TaqMan® probe assay is shown in Figure 
5.4, using the A -> T  mutation in codon 6 of the p-globin gene as a SNP target 
(Section 1.1). Two primer sets were included in the same single-tube PCR test; one 
designed to amplify an 86 bp amplicon in the presence of the wild type allele 
(SC_W T_AS/ SC_W T_OP), and a second designed to amplify a 112 bp product in 
the presence of a mutant allele (SC_M UT_AS/ SC_M U T_O P). SC_W T_AS has an 
‘A ’ nucleotide at the 3 ’ end matching the T  base on the coding strand of the normal 
b-globin gene. SC_M UT_AS has an ‘A’ nucleotide at the 3 ’ end, matching the T  
base on the coding strand side of the sickle cell mutation. Each primer was 
designed with a similar Tm to allow generic cycling conditions.
Two fluorescent-labelled TaqMan® probes (Appendix I), W T_FAM  and M UT_JOE, 
were designed according to manufacturers’ guidelines (Table 5.1) to lie as close as 
possible to the 3 ’ end of each corresponding allele-specific primer surrounding the 
SNP site. The wild type probe (W T_FAM) was designed as complementary to the 
sequence upstream of the wild type allele-specific primer (SC_W T_AS). FAM was 
covalently linked to the 5 ’ end of the W T_FA M  probe, quenched by TAM RA  
attached via linker arm located at the 3 ’ end of each probe. The mutant probe 
(M UT_JO E) was designed as complementary to the sequence upstream of the 
mutant allele-specific primer (SC_M UT_AS). JOE was covalently linked to the 5 ’ 
end of the MUT_JOE probe, again quenched by TAM RA. A phosphate group was 
attached to the 3 ’ end of both probes prevented extension by Taq polymerase 
during PCR (Holland eta!., 1991).
Sequences were checked using Primer Express Software (Applied Biosystems) and 
synthesised by Oswel Research Products (Southampton, UK). Figure 5.5 displays 








^  Taq DNA polymerase ^  Released quencher
_  'F-labetled' TaqMan probe with quencher O' ™  Released'F'fluorophore
Mismatched primer Genomic DNA 0
•  THabelled'TaqMan probe with quencher O' %  Released T  fluorophore
Matched pnmer i * Newly-synthesized DNA
Figure 5.4. A schematic of the combined bi-directional TaqMan® system. The sequence specific probe is designed to anneal upstream of a 
matched allele-specific primer. Two probes and two primer sets are included in the reaction; both designed to lie in a bi-directional orientation 
around the SNP site. Therefore the probes will anneal to different strands of the DNA. A matched allele-specific primer will be extended, and 
consequently the corresponding probe will be cleaved to generate a detectable signal at the appropriate wavelength. Thus, the fluorophore giving 
the maximal signal is used to assign the genotype.
5 ' . . .  agggctgggc ataaaagtca gggcagagcc a tc ta ttg c t ta c a tttg c t tctgacacaa ctgtgttcac
3 ' . . .  tcccgacccg ta tt t tc a g t  cccgtctcgg tagataacga atgtaaacga agactgtgtt gacacaagtg
5'- a gggcagagcc atctattgc -3'
SC MUT OP
3'- TAMRA gtctgtg gtaccacgtg gactgagga JOE -5' gCMUTAS
3'- acctcttcag acggcaatga eg -51 
tagcaacctc aaacagacac catggtgcac ctgactcctg Iggagaagtc tgccgttact gccctgtggg 
ategttggag tt tg tc tg tg  gtaccacgtg gactgaggac Icc tc ttcag  acggcaatga cgggacaccc
SCWTAS 5 *_ fam agaagtc tgccgttact gccctgtgg TAMRA -3
SC WT OP
gcaaggtgaa cgtggatgaa gttggtggtg aggccctggg caggttggta tcaaggttac aagacaggtt ...3' 
cgttccactt gcacctactt caaccaccac tccgggaccc gtccaaccat agttccaatg ttctgtccaa ...5'
Figure 5.5: Sequence of interest with probe alignments. SC_WT_AS has an ‘A’ nucleotide at the 3’ end matching the T  base on the coding strand
of the normal b-globin gene. SC_MUT_AS has an ‘A’ nucleotide at the 3’ end, matching the T  base on the coding strand side of the sickle cell
mutation.
Probe and primer design recommendations for TaqMan9 assays on the A B I7700 Prism SDS
Amplicons should designed within 50-150 bp range 
Primer Tm should be 58-60°C 
G/C content of probe should be within the 20-80% range 
Avoid runs of an identical nucleotide, especially guanine where runs of 4 or more G’s should be avoided
Probe Tm should be 68-70°C 
Probe should not have a G on the 5’ end 
For probe annealing, select the strand that gives the probe more C than G bases
Table 5.1: Recommendations for designing TaqMan® probes (Applied Biosystems Technical Bulletin, 2001).
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5 .1.2 Assay optimisation a n d  PCR am plifications
The combined TaqMan® and bi-directional PCR assays were performed using an 
ABI Prism 7700 Sequence Detection System (Applied Biosystems) according to 
manufacturer’s instructions. All reactions were prepared in a 96-well plate, using a 
TaqMan® Universal Master Mix (containing AmpliTaq® Gold DNA polymerase, 
AmpErase® UNG, dNTPs with dUTP, a passive reference dye, and optimised buffer 
components in a proprietary formulation; Applied Biosystems), oligonucleotides, 
250 nM each labelled probe and 5-25 ng human genomic DNA.
Primer titration was used to define primer concentrations that generated allele- 
specific amplicons according to the genotype of the template DNA. Given that the 
Mastermix contains optimised concentrations of all components apart from primers 
and probe, only a simple primer titration was necessary to define discriminatory 
conditions. Two sets of nine reactions were performed in triplicate, incorporating 
either wild type or mutant control DNA template. Primers were aliquoted according 
to Table 5.2 wherein the range of concentrations was decided empirically. The 
distribution of samples in the 96-well format is shown in Figure 5.6.
Samples were taken through a 2 min hold at 50°C for optimal AmpErase® Uracil-N- 
glycosylase (UNG) activity, followed by a 10 min hold at 95°C for AmpliTaq Gold® 
DNA polymerase activation. This was followed by a cycling program of 95 °C for 15 
s, 60 °C for 30s, for a total of 40 cycles. The fluorescence emission caused by 
cleavage of the probe upstream of an extended (matched) allele-specific primer 
was detected over the course of the run. For detection of the FAM signal, readings 
were captured within the emission wavelength range including 535 nm. For JOE, 
this range included 557 nm (Molecular Probes Handbook, 2001). The ABI Prism® 
7700 SDS software automatically normalised the fluorescence signal against non- 
PCR related fluctuations by dividing the emission intensity of the reporter dyes by 
the emission of the passive reference dye (i.e. ROX, 6-carboxy-X-rhodam ine) 
included in the reaction Mastermix. Samples were run on an agarose gel for 
clarification of fragment sizes according to Section 2.5.4.
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Figure 5.7 shows a typical set of gel image data from the primer titration sets. Table
5.3 displays corresponding ARn data for wild type and Mutant DNA template. The  
AARn data represents the difference in the ARn for each probe in the presence of 
wild type or mutant template. In the presence of wild type DNA, a large signal 
corresponding to the FAM probe was detected above the instrument threshold. 
Concurrently, the signal from the JOE probe did not rise above the threshold level. 
In the presence of mutant DNA, a large signal corresponding to the JOE probe was  
detected above a threshold, and a signal was also detected above threshold from  
FAM at a significantly lower ARn than wild type tests. The levels of detectable  
fluorescence varied according to the primer concentrations included in the test.
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Rxn WT AS, iiM WT OP, p M M U T A S .v M MUT OP, fiM
1 A A A A
2 A A B B
3 A A C C
4 B B A A
5 B B B B
6 B B C C
7 C C A A
8 C C B B
9 C C C C
Table 5.2: Primer titration matrix. Primers were aliquoted according to this matrix, where A= 
0.1 pM, B= 0.2 jllM and C= 0.6 pM. Inter-set primer concentrations were chosen empirically 
to cover a wide range of low concentrations.
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1 2 3 4 5 6 7 8 9
G 0 0 0 0 0 0 0 0 0 0 0 0
H Ntc 1 Ntc 2 Ntc 3 Ntc 4 Ntc 5 Ntc 6 Ntc 7 Ntc 8 Ntc 9 0 0 0
Figure 5.6: 96- well format for optimisation reactions. A zero indicates that wells were left 
empty. ‘Rep’ indicates that this sample is a repetition in the triplicate. WT cells contain 
control wild type DNA. MUT cells contain control mutant DNA. Ntc indicates a no template 
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158 bp 158 bp 
112 bp 
86 bp
Figure 5.7: Gel image data from optimisation sets. Note lower efficiency in these amplifications including a probe. Levels of amplification were 
sufficient for fluorescence detection.
[A] Wild Type DNA
ARn 1 2 3 4 5 6 7 8 9
FAM 1.29±0.03 0.95±0.15 0.85±0.10 1.82±0.12 1.36±0.01 0.99±0.02 1.91 ±0.09 1.57±0.02 0.96±0.09
JOE 0 0 0 0 0 0 0 0 0
AARn FAM 0.87 0.61 0.61 1.43 1.05 0.79 1.67 1.36 0.82
[B] Mutant DNA
ARn 1 2 3 4 5 6 7 8 9
FAM 0.42±0.03 0.34±0.01 0.24±0.04 0.39±0.02 0.31 ±0.02 0.20±0.02 0.24±0.02 0.21 ±0.02 0.14±0.01
JOE 0.20±0.01 0.24±0.02 0.27±0.02 0.17±0.02 0.20±0.01 0.22±0.00 0.11 ±0.01 0.13±0.00 0.15±0.02
AARn JOE 0.20 0.24 0.27 0.17 0.20 0.22 0.11 0.13 0.15
Table 5.3. Tables display typical fluorescence readings (ARn) from FAM and JOE probes during assay optimisation.
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5 .1.3 SNP genotyp ing
The conditions of Reaction 6, Table 5 .2  were used to genotype twenty-two  
randomised samples and a single control sample void of template, since both 
probes gave a large ARn value (Figure 5.8). Eight samples gave a positive FAM  
signal only (Figure 5.9A), six samples gave a positive JOE signal with a very low 
signal from FAM (Figure 5.9B), and three samples gave a measurable fluorescence 
increase from both reporter dyes (Figure 5.9C). Six samples, including the no 
template control, did not generate a measurable fluorescence signal.
The ARn value from the FAM signal (W T allele) was plotted vs. the ARn value from 
the JOE signal (M UT allele). Four distinct cluster regions were present depending 
upon genotype (Figure 5.10). Eight samples were clustered around the y-axis (FAM  
signal), six samples were clustered around the x-axis (JOE signal), and three 
samples were placed near to the x=y-axis resulting from signals from both dyes. Six 







1 . 2 0 E + 0 0
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3 . 0 0 E - 0 1
2 . 5 0 E - 0 11 . 0 0 E + 0 0
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Cycle number Cycle number
Figure 5.8: Typical data set showing [A] FAM and [B] JOE signals in the presence of wild type DNA ( )  or mutant DNA (o) under the conditions
defined by Reaction 6, Table 5.2. Reactions were run in triplicate and error bars are shown. The negative JOE signal observed in [B] is attributable
to the baseline correction used in data analysis (see Figure 1.18B, pg. 59).
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Figure 5.9: Typical fluorescence signals from FAM (left hand side) and JOE (right hand side) 
probes in the presence of [A] wild type, [B] mutant and [C] heterozygous DNA under the 











-0.1 -0.05 0 0.05 0.1 0.15 0.2 0.25 0.3
ARn M U T  allele
Figure 5.10: SNP calling. Points lying nearest to the jc-axis show homozygous mutant 
inheritance of the mutation. Points lying near the y-axis show homozygous wild type DNA, 
and the three points (o) lying near to the x  =  y  axis show heterozygous inheritance. Points 
located round the origin were control samples void of template, or mistypes.
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Combining the single tube bi-directional PCR format with fluorogenic probes for the 
specific detection of allele-specific products provides an interesting alternative to 
detecting single nucleotide changes in a DNA sequence. The test compares the 
amplification efficiency of two separate allele-specific amplicons, by incorporating 
two-sequence specific probes into a single test. An internal control is inherent since 
any successful PCR will generate an allele-specific amplicon. A simple ‘yes_no’ 
result is provided, which is ideal in a clinical setting where ambiguity should be 
eliminated to prevent misdiagnosis.
A primer titration was performed to reveal optimal conditions that gave allele- 
specific amplification without artefacts (Figure 5.7). The presence of the well- 
characterised sickle cell anaemia mutation was detected in a small trial of twenty- 
two human DNA samples, according to the magnitude of change in normalised 
fluorescence per reaction for each probe. Samples homozygous for the wild type 
allele gave a large ARn with the FAM detection probe, and a corresponding 
negligible JOE signal (Figure 5.9A). Samples homozygous for the mutant allele 
gave a large ARn with the JOE probe, and a corresponding negligible FAM signal 
(Figure 5.9B). Heterozygotes were identified by a signal from both reporter dyes, 
slightly lower than for a homozygote due to molar ratios of each allele (Figure 5.9C). 
W here a signal was detected above baseline, concordance with RFLP data was 
100% (Figure 4.19, pg. 153). Five samples failed to give a signal above baseline, 
likely due to insufficient starting DNA concentration.
The combined assay has increased flexibility in probe design compared to the 
conventional method because the target region for probe alignments is not 
restricted to the area containing the SNP site. Rather, any part of the sequence 
upstream of either allele specific primer is accessible to probe design. Primer 
design is also unrestricted since wild type and mutant primer sets can be designed 
without considering Tm constraints, as in fluorescent bi-directional PCR (Chapter 
four). Smaller amplicons (between 50-150 bp) are recommended, as with most
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protocols used today. It would be beneficial to design amplicons of a similar size to 
minimise differences in amplification efficiency. Here, amplicons of 86 bp and 112 
bp were shown to be suitable.
The most commonly used commercially available dyes for ‘two-dye’ set-ups in 
TaqMan® assays were 6-FAM and VIC (or JOE; based on an unpublished survey). 
This is due to the minimal spectral overlap between the dyes, so that separate 
signals can be attained simultaneously without significant cross talk, which would 
increase the error in the read outs from each probe. In these experiments, the 
magnitude of JOE signal was consistently lower than the FAM signal. Although the 
ABI Prism® 7700 SDS is able to excite a wide range of fluorophores using laser 
excitation (488 nm), FAM (excited at 495 nm) has a greater spectral overlap with 
the shortest excitation wavelength than JOE (excited at 525 nm). Consequently, the 
highest signal of excitation is detected from FAM, even if identical amounts of allele- 
specific amplicon are produced. The availability of different fluorophores combined 
with the ability of the instrument to monitor many dye layers makes possible the 
identification of at least two multiple targets in homogenous assays, utilised in the 
assay described here.
Other features of PCR instrumentation play a key role in the success and  
application of PCR-based assays. In particular, the throughput and speed of 
thermal cycling. Currently, real-time PCR instruments that offer integrated product 
amplification and detection, a wide excitation source for flexible multiplexing, rapid 
cycling, and greater than 32 samples per run are unavailable (Table 4.1, pg. 118). 
The combined assay described here would benefit from rapid cycling due to 
improved specificity using shorter extension times (W ittwer et al., 1993) and  
increased throughput. However, the ABI Prism 7700 SDS is based on slow Peltier 
elements for temperature cycling and is limited to maximal temperature transitions 
of around 3°C .s'1. A truncated thermal cycling program was used here in order to 
lower the assay time reducing the overall time to two hours.
The LightCycler™ instrument uses rapid air exchange as the medium for heat 
transfer and is capable of significantly faster ramp rates (20°C .s '1) such that the
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sam e test could be completed within 30 minutes. The rate-limiting step would then 
becom e the minimum annealing time for effective 5 ’ nuclease activity by Taq, 
typically in the order of 10 seconds (Holland et al., 1991). However, the 
LightCycler™ instrument is limited to 32 tests per run and does not have the same 
flexibility of dye choice as the ABI 7700 Prism SDS, due to the fixed wavelengths of 
excitation and emission wavelength detection. The blue LED of the LightCycler™ is 
able to excite fluorophores at a single wavelength (470 nm). This can efficiently 
excite the FAM fluorophore due to sufficient spectral overlap (^ex495/Xem535 nm), 
but is unable to excite JOE-labelled probes (Xex525/Xem557  nm).
Specialised FR ET probes such as wavelength shifting molecular beacons (Tyagi et 
al., 2000), or FR E T scorpion primers (Thelwell et al., 2001) could be used to 
circumvent this restriction. These nucleic acid hybridisation probes fluoresce in a 
variety of different colours (depending upon the nature of the emitter fluorophore), 
yet are excited by a common monochromatic light source (Figure 5 .11). The  
harvester fluorophore is chosen to absorb strongly in the wavelength range of the 
light source (i.e. FAM could be excited by the LightCycler™ light source) which, 
when excited will excite the emitter fluorophore, generating a characteristic 
detectable signal. The only drawback to these probes is the increased numbers of 
fluorophores required and complex design considerations, which ultimately 
increases cost.
The assay would also be compatible with other probe systems suited to rapid 
cycling. These include Resonsense® (Lee e t al., 2001), and HyBeacon® probes 
(French et al., 2001) for example. Two probes labelled with different dyes, with 
com plem entarities to regions within the non-primer sequence of either allele- 
specific amplicon could be included in a single PCR test following the protocol 
described here. Of particular interest, Resonsense® probes use a DNA intercalater 
as the donor fluorescence. This would enable the excitation of dyes compatible with 
the LightCycler™  instrument by FRET mechanisms, increasing assay speed. 
Evaluating these other probe formats would be the next stage in development of 
this assay.
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Figure 5.11: [A] Wavelength-shifting molecular beacons: Use the same principles as 
conventional molecular beacons except the beacons is labelled with two fluorophores (on 
the 5’ arm) and one quencher (at the end of the 3’ arm). A harvester fluorophore is at an 
internal location in the 5’ arm of the beacon such that it is opposite to the quencher moiety.
A reporter fluorophore lies at the distal end of the 5’ arm. The harvester fluorophore is 
chosen such that it can be excited by a monochromatic light source, and its emission 
wavelength should have spectral overlap with the excitation wavelength of the reporter 
fluorophore. In the absence of a target sequence, probes are dark because the fluorescence 
from the harvester fluorophore is quenched. In the target-bound conformation, the energy 
absorbed by the harvester fluorophore is transferred by FRET to the reporter fluorophore, 
which then releases energy as light in its characteristic colour (Tyagi etal., 2000). [B] FRET 
scorpion primers: In the closed form the quencher is able to quench fluorescence from the 
harvester fluorophore and reporter fluorophore. After extension of the scorpion primer the 
probe binds to the target separating the quencher from the two fluorophores. The han/ester 
fluorophore absorbs energy from the light source and transfers the energy by FRET to the 
reporter fluorophore. Excitation of the reporter dye occurs and an increase in its 
characteristic is observed (Thelwell etal., 2000).
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It is noted that since completing this work (Novem ber 2001), researchers have 
addressed the issue of inefficient destabilisation in the presence of a mismatch. A 
chemical modification of the fluorogenic probe with a minor groove-binding agent is 
now used to increase duplex stability. This new generation of probe incorporates 
minor groove binder (MGB) groups, to form extremely stable duplexes with single­
stranded DNA targets, allowing shorter probes to be used for hybridisation-based 
assays. The MGB probes were more specific for single base mismatches than 
standard DNA probes and produced better fluorescent signals. A larger 
destabilisation was seen with shorter probes when compared to longer conventional 
probes. In certain cases, the ATm of a matched and mismatched probe was just 
0.5°C, compared with a minimum ATm of 10°C with the MGB probe (Epoch, 2001). 
The MGB probe is now commercially available, highlighting the current acceptability 
and continuing evolution of these probes for SNP detection.
To summarise, the test returns combined AS-PCR/TaqMan® probe methods to a 
single tube format. The current limitation of this assay is the high synthesis cost of 
probes modified with fluorescent and quenching moieties, compared to dsDNA  
intercalaters. These costs are particularly acute in high throughput applications. 
Nevertheless, this has not limited the number of assays that utilise sequence- 
specific probes (as shown in Chapter One) and arguably costs may be driven down 
through competition. The continued development of innovative software and 
algorithms may help to improve automation in probe design and selection based on 




Kinetic Characterisation of PCR: Application to 
primer mismatches and quantitative PCR
6.0 Introduction
Until recently the polymerase chain reaction (Mullis et al., 1986; Saiki et al., 1985) 
has predominantly been used as a binary tool to indicate the presence or absence 
of a particular target sequence. Instruments capable of quantitative detection of 
amplification in real time (qPCR; Table 4.1, pg. 118) have enabled sensitive 
analysis of gene expression and accurate determination of copy number (Bustin, 
2000; Wittwer etal., 1997), enhancing the utility of PCR as a diagnostic.
Despite the routine use of PCR in molecular biology, enzymatic and kinetic studies 
have been limited. Early characterisation studies detailed the efficiency with which 
Taq DNA polym erase differentiates between matched and mismatched 3 ’ 
nucleotides (Kuchta et al., 1987; Petruska e ta l., 1988; Mendelman e ta l., 1990; 
Wong et al., 1991; Christopherson eta l., 1997). These considered the action of Taq 
DNA polymerase in isolation of PCR dynamics, assessing the relative extension 
efficiencies in the presence of a single dN TP  species. This significantly 
underestimates the kinetic effects known to influence reaction fidelity and efficiency, 
and limits application in the design of genotyping tests based on allele-specific PCR  
(AS-PCR).
Subsequent studies, summarised earlier (Table 3.2; pg. 87), considered the effects 
of primer 3 ’ nucleotide mismatches on primer extension by Taq DNA polymerase; 
primarily using end point amplicon yields as a measure of reaction efficiency during 
AS-PCR. The results exhibited large variability since the analysis used different 
reaction conditions and components, known to influence reaction specificity (Table 
3.3; pg. 88). Significantly, previous studies used slow Peltier-based thermal cyclers 
that have slow temperature transitions rates. The rapid cycling and short extension
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times of contemporary qPCR instruments has been shown to strongly disfavour 
mismatch extension (W ittwer e ta l. ,  1993), suggesting that abrupt transitions in 
temperature have effects that have not been previously considered.
Michaelis-Menten kinetics have been used to describe the variation of the rates of 
many enzyme-catalysed reactions as the substrate or effector concentration is 
varied (W harton and Eisenthal, 1981). There is experimental evidence from 
previous studies to show that DNA polymerase reactions obey this typical behaviour 
(Schnell and Mendoza, 1997; Goodman et al., 1993). Therefore, the Michaelis- 
Menten system can be utilised to underlie the principles of a theoretical description 
of the polymerase chain reaction and obtain quantitative predictions of enzyme 
characteristics including catalytic activity, effects of specific inhibitors, and an 
enzyme’s specificity toward a particular substrate (Cornish-Bowden, 1979).
In a steady state (referring to the situation in which the value of a particular quantity 
is constant), and for enzyme concentrations negligible to those of the substrate, the 
formation and breakdown of an enzyme-substrate complex is described by the 
relation,
E  +  S ^ E S — ^ E  +  P  (6.1)
* i
where [ £ ] ,  [S],  [PS ] and [P ] represent the concentrations of free enzyme, free 
substrate, enzyme-substrate complex and product, respectively.
The rate of product formation or initial velocity is then given by the Michaelis- 
Menten equation:
v - [ s ]
[s]+tfM (a2)




and the maximum velocity by
V ^ k j L E , ] (6.4)
where [ £ r ] represents the total enzyme concentration (Michaelis and Menten, 
1913). In this simple description of Vmax, k2 is identical to the catalytic constant, 
kcat, a fundamental quantity defining the number of substrate conversions the 
enzyme can catalyse in unit time (Cornish-Bowden, 1979).
The Michaelis-Menten equation (equation 6.2), predicts simple hyperbolic behaviour 
or saturation kinetics (Figure 6.1 A). At sufficiently low concentrations of substrate, 
[ S ], v increases linearly with [ S ]. But as [5 ] is increased, this relationship begins to 
break down and v increases less rapidly than [5 ]  until, at sufficiently high or 
saturating [5 ], v tends toward the limiting value (Equation 6.4).
For a number of different reasons, enzymes often show departure from the 
behaviour predicted by the Michaelis-Menten equation. One cause is high substrate 
inhibition, in which the formation of abortive complexes caused by an excess of 
substrate inhibits the enzyme. High substrate inhibition leads to a kinetic plot such 
as that shown in Figure 6.1 B. The curve is described by the equation,















Figure 6.1: High substrate inhibition. [A] A typical Michaelis-Menten plot showing simple 
hyperbolic behaviour described by equation 6.2; [B] A typical Michaelis-Menten plot showing 
high substrate inhibition described by equation 6.5. Plot shows a deviation at higher 
substrate concentrations from the typical behaviour shown in [A]. Based on a figure by 
Eisenthal and Danson, 2002.
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where Vmax is the maximum velocity, K M the Michaelis-Menten constant, and K i 
the inhibition constant. In this formulation an additional term, K t, is introduced into 
the denominator of the simple Michaelis-Menten equation; this term becomes 
predominant as the substrate concentration increases, resulting in inhibition of the 
observed rate (Wharton and Eisenthal, 1981). For exam ple, at low substrate 
concentration [S], (S / K (.) is insignificant compared to l  +  ( KM /S) ,  and equation 6.5 
becomes identical to the classic Michaelis-Menten equation. It follows that as S 
increases, the value of (S / K (.) increases, describing the portion of the curve where 
the rate of reaction drops rapidly (Wharton and Eisenthal, 1981).
High substrate inhibition is regularly cited as a main cause of the plateau phase in 
PCR. Therefore it is possible that the kinetics of PCR may exhibit the characteristics 
described by equation 6.5. During this chapter, the development of a kinetic model 
for PCR based on the equation for high substrate inhibition in Michaelis-Menten  
systems is described. The kinetic model is applied to rapid cycle AS-PCR (Newton 
et al., 1989), a method used to discriminate between alleles of a gene based on 
single base pair differences (see Chapter three). The model provided a method by 
which Michaelis-Menten parameters could be estimated, and the likelihood of 
misextension for a particular polymorphism could be inferred by a quantitative 
parameter.
The kinetic model was also used in the development and validation of a novel 
method for the quantification of nucleic acid using real-time quantitative PCR. 
Previously, theoretical descriptions of PCR have been put forward that apply 
different mathematical approaches to simulate various physical parameters of the 
system, mainly for quantitative-com petitive PCR application. These include 
statistical estimations of amplification rate (Peccoud and Jacob, 1998), probability of 
DNA replication (Stolovitzky and Cecchi, 1996), probability of DNA binding rates 
(Velikanov and Kapral, 1999), and derivation of expressions for amplification 
efficiency (Schnell and M endoza, 1997A; Schnell and M endoza, 1997B; 
Raeymaekers, 1993; Weiss and Haeseler, 1997). However, each of these models 




6.1.1 Allele-specific PCR Amplifications
P M _O P_98 and PM _A S_X (where X is G, C, A or T) were used to direct the 
amplification of a 98 bp allele specific amplicon from a pGEM-T® Easy Vector-based 
plasmid DNA template containing a G, C, A or T  variant nucleotide (prepared 
according to Chapter Two). All twelve possible SNP combinations (G -»C , G-»A, 
G —»T, C —»G, C—)A, C —»T, A—^ G, A—^ C, A—T ,  T —^ G, T —^ C, T —^ A) were tested in 
triplicate with a single control sample void of template,
PCR cycling and melt analysis protocols were performed on the LightCycler™ PCR  
instrument according to Section 2.0.2 except the annealing temperature was set to 
65 °C for high stringency. Critically, each PCR cycle was monitored by continual 
fluorescence acquisition throughout. Reaction specificity was confirmed by 
executing a melt curve analysis immediately after amplification according to Section 
2.0.3. In each case, a single PCR product was formed with a T m of approximately 
85.0 °C. No amplification was observed in samples void of template. Continuous 
monitoring data were exported into Microsoft Excel 2000 (Macintosh Version 9.1, 
Microsoft Corporation, USA) for further analysis.
6 .1.2 C ollection  o f ‘p e r  c y c le ' ra te  d a ta
The reaction rate v  was determined from the maximal increase in fluorescence 
signal F I  with respect to time, t, at 72°C at each cycle. The rates were estimated 
from the linear portion of the progress curve, as shown in Figure 6.2 C, according to 
the linear equation,
F l  =  Vt +  C, (6 .6)
where c is the F I  reading at time zero. The slope v  of fluorescence signal 
increase was assumed proportional to the rate of nucleotide incorporation by Taq 
DNA polymerase since this will be concomitant with the intercalation of SYBR  
Green I molecules into the newly-synthesised double-stranded DNA.
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Data points in Figures 6.3 A-D show the cycle dependence of initial rate, v, using 
template with base variant T .  Figures 6.4 A-D, 6.5 A-D and 6.6 A-D display similar 
rate data using templates with base variants ‘G \  ‘C ’ and ‘A’, respectively. During 
early and late cycles fluorescence changes were negligible. This is in contrast to 
cycles where exponential and linear amplification of target would be expected and 
where significant increases in fluorescence were observed from the real time data. 
The lag phase during early cycles was attributable to fluorescence signals that were 
below the detection limits of the optics in the LightCycler™. The length of the lag 
phase varied according to base complementation, and was generally less for a 
matched template compared to a mismatch. This lag phase was followed by a rapid 
increase in reaction velocity, which reached a maximum, then decreased as cycle 
number was increased further.
A kinetic model was developed based on the observed profile of these plots, 
described in detail during Section 6.2.1. The final kinetic model is shown below,
where v is the reaction rate, Vmax, K M , and are Michaelis-Menten parameters, 
n is cycle number, C  is a compensation factor, and a  and /  are parameters that 
define the shape and position of a sigmoid curve (Seggern, 1993). Equation 6.7  
was used in non-linear regression analysis (N L-R EG  Version 5.4; Phillip H. 
Sherrad), to fit real data from the AS-PCR tests (solid line in Figures 6 .3 -6 .6  A-D  

























Figure 6.2: Grey area highlights section of interest from a matched allele-specific PCR test 
from template containing variant nucleotide T. [A] Continuous monitoring data over 50 PCR 
cycles. [B] Temperature dependence of product accumulation over a single cycle. [C] 





















Figure 6.3: Typical graphs of rate v  vs. cycle number for base combinations (template: primer) [A] T:A, [B] T:G, [C] T:C, and [D] T:T. The solid line
represents the curve predicted by the model (Equation 6.7), and points represent data collected from real PCR tests using Equation 6.6.
















Cycle number Cycle number
Figure 6.4: Typical graphs of rate v vs. cycle number for base combinations (template: primer) [A] G:C, [B] G:G, [C] G:A, and [D] G:T. The solid
line represents the curve predicted by the model (Equation 6.7), and points are data collected from real PCR tests using Equation 6.6. Correlation







Figure 6.5: Typical graphs of rate v vs. cycle number for base combinations (template: primer) [A] C:G, [B] C:C, [C] C:A, and [D] C:T. The solid
line represents the curve predicted by the model (Equation 6.7), and points are data collected from real PCR tests using Equation 6.6. Correlation























Figure 6.6: Typical graphs of rate v vs. cycle number for base combinations (template: primer) [A] A:T, [B] A:G, [C] A:C, and [D] A:A. The solid line
represents the curve predicted by the model (Equation 6.7), and points are data collected from real PCR tests using Equation 6.6. Correlation
coefficient r2 is >0.98 in each case.
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Template Primer 3' V  K K  V I K  ’Ratio of
max M / 'm ax /JVM
Base terminus V  I K „max ■* *■ M
c 530 1300 0.002 0.408 1.000
G 448 43100 0.083 0.010 0.025
A 88.1 479000 29.2 0.000 0.004
T 302 23600 0.111 0.013 0.031
C 290 14700 0.046 0.020 0.106
G 335 1800 0.006 0.186 1.000
A 378 26100 0.093 0.015 0.078
T 271 25400 0.128 0.011 0.058
C 906 49900 0.037 0.018 0.089
G 402 32500 0.082 0.012 0.061
A 45 1720000 369 0.000 0.000
T 377 1840 0.007 0.204 1.000
C 475 17700 0.031 0.027 0.120
G 669 16700 0.015 0.040 0.180
A 245 1090 0.013 0.224 1.000
T 160 116000 2.63 0.001 0.006
Table 6.1: Predicted kinetic parameters (shown to 3 s.f.) for each base configuration. 
Matched combinations are highlighted in bold type. Constants are displayed in arbitrary 
units.
1 Ratio of specificity constants compared to a matched combination.
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The ability of the model to predict substrate concentration at each cycle was tested 
by using the values estimated for the sigmoid parameters, a  and / ,  to solve 
equation 6.8 in Microsoft Excel 2000 (Macintosh Version 9.1). The resulting sigmoid 
curve was plotted alongside the real time amplification data acquired at the end of 
each extension period at 72°C (Figures 6.7-6.10 A-D  inclusive). The differences in 
actual and predicted fluorescence readings ( F I )  values are shown in Figure 6.11. 
Larger deviations were observed in mismatch-primed PCR tests.
6 .1.3 Q uan tita tive  PCR am plifications
Four separate quantitation tests (Sets A - D )  were performed using either pGEM-T® 
Easy Vector plasmid-based DNA (see Chapter Tw o) or human genomic DNA  
template to validate the kinetic model for qPCR application. Set A included 
amplification of a 223 bp fragment by primers IC F  and ICR from plasmid DNA  
template. Set B included amplification of a 158 bp amplicon by primers SC_W T_O P  
and S C _M U T _O P  from human genomic DNA, specifically the sequence  
surrounding the most common HbS sickle cell mutation. Set C included  
amplification of a 98 bp amplicon by primers W T_A S _C  and W T_O P _98 from 
plasmid DNA (with variant nucleotide C). Set D included amplification of a 103 bp 
fragment by primers C 282Y_W T_O P and C 282Y_M U T_O P from human genomic 
DNA, specifically the sequence surrounding the C 282Y  mutation site conferring 
hereditary haemochromatosis.
PCR cycling and melt analysis protocols were performed on the LightCycler™ PCR  
instrument according to Section 2.0.2. Deviations from this protocol are summarised 
in Table 6.2. For each test, a 10x dilution series was run alongside a control test 
void of template, and three ‘unknown’ samples (Table 6.3). The ‘unknowns’ were 
selected to lie within the limits tested by external standards.
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Figure 6.7: Correlation of real time substrate accumulation (data points) with that predicted by the sigmoid function (solid line). Graphs display
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Figure 6.8: Correlation of real time substrate accumulation (data points) with that predicted by the sigmoid function (solid line). Graphs display
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Figure 6.9: Correlation of real time substrate accumulation (data points) with that predicted by the sigmoid function (solid line). Graphs display
base combinations (template: primer) [A] C:G, [B] C:C, [C] C:A, and [D] C:T.
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Figure 6.10: Correlation of real time substrate accumulation (data points) with that predicted by the sigmoid function (solid line). Graphs display
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jrence between expected fluorescence ( F I )  values, as predicted by the kinetic model, and actual fluorescence 
er™ instrument for all SNP combinations.
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Denaturation Annealing Extension
Set °C s °C S °C s Cycles
A 95 1 63 5 72 6 60
B 95 1 63 5 72 7 60
C 95 0 55 5 72 10 60
D 95 1 62 5 72 7 60
Table 6.2: Deviations of cycling protocols from that described in Section 2.0.2, used for 
quantification experiment sets where [A] represents amplifications by primer set ICF/ICR, [B] 
represents amplifications by primer set SC_WT_OP/SC_MUT_OP, [C] represents 




Reaction Sample A: total DNA, ng B: total DNA, ng C: total DNA, ng D: total DNA, ng
1 STD 20 .0 30.0 30.0 30.0
2 STD 2.0 3.0 3.0 3.0
3 STD 0.2 0.3 0.3 0.3
4 STD 0.02 0.03 0.03 0.03
5 STD 0.002 0.003 0.003 0.003
6 NEG 0.0 0.0 0.0 0.0
7 UKN 10.0 15.0 1.5 15.0
8 UKN 1.0 1.5 0.15 1.5
9 UKN 0.1 0.15 0.015 0.15
Table 6.3: Initial DNA concentrations used for quantification experiment sets where [A] 
represents amplifications by primer set ICF/ICR, [B] represents amplifications by primer set 
S C _W T_O P /S C _M U T_O P , [C] represents am plifications by primer set 




Data points showing the cycle dependency of rate v for the dilution series of 
reaction sets A to D, were collected using the method described in Section 6.1.2. 
The kinetic model (equation 6.7) was used in non-linear regression analysis to fit 
real data from the qPCR tests (Figure 6.12 A-D inclusive) to estimate informative 
kinetic parameters for each DNA concentration (Table 6.4). The position of the peak 
along the jc-axis differed according to starting DNA concentration, shifting to the 
right as DNA concentration was decreased. The apex of the curve was used as an 
independent measure of CT in the PCR test. The C j from the known standard 
dilution series was plotted vs. log known concentration to produce a standard curve; 
Figure 6.13 A-D).
An identical set of experiments was repeated and analysed using LightCycler™  
Data Analysis software (Version 3.0). The ‘Fit Points Method’ of quantification was 
used to define the cycle threshold or crossing point (Figure 1.18A, pg. 59). In the Fit 
Points method, the user manually sets a baseline above background noise. Points 
are selected from the log-linear portion of the curve, and a straight line of 
y =  mx +  c (where y  is the CT value, m is the gradient of the trend line, c is the 
intercept on the y-axis, and x  is log10 [sample]) is drawn through the points. The  
crossing point is the point at which an extrapolation of the linear curve crossed with 
the manually set threshold. Crossing point data is plotted vs. Iog10 sam ple  
concentration to produce a standard curve. Actual CT data from the kinetic model 
and LightCycler™ analyses is displayed in Table 6.5 (Set A), Table 6 .6  (Set B), 
Table 6.7 (Set C) and Table 6.8 (Set D).
For the kinetic model and LightCycler™ analyses, the linear trend line of the 
standard curve provides a function, which can be solved for x . Therefore, the 
starting concentration of unknown samples was estimated (Table 6.9).
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Figure 6.12: Kinetic model fit from real-time continuous monitoring data from amplifications directed by [A] Primer set ICF/ICR [B] Primer set 
SC_WT_OP/SC_MUT_OP; [C] Primer set PM_AS_C/WT_CP_98; [D] Primer set C282Y_WT_OP/C282Y_MUT_OP. Raw data regarding the initial 
template concentration associated with each peak is displayed in Tables 6.5 to 6.8.
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Figure 6.13: External standard peak thresholds (0) are fitted with a linear trend line to allow estimation of ‘unknown’ sample concentrations. 
Equation of trend lines and correlation coefficients are located above the relevant graph from amplifications directed by [A] Primer set ICF/ICR [B] 
Primer set SC_WT_OP/SC_MUT_OP; [C] Primer set PM_AS_C/WT_CP_98; [D] Primer set C282Y_WT_OP/C282Y_MUT_OP.
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Set [Sample], Vmax K M C  K t
ng
20 610 293 -0.627 3.50E-04
2 843 852 -0.899 8.21 E-04
0.2 1.28 186 -1.00 138
0.02 256 2463 -0.986 4.16E-02
0.002 801 8922 -0.986 1.33E-02
30 2700 2650 -0.996 0.008
3 3940 8410 -0.998 0.014
0.3 2790 19400 -0.999 0.059
0.03 1540 44400 -1.000 0.564
0.003 10.5 119000 -1 61900
20 2.96 123 -1 473
2 7610 814 -1 0
0.2 7210 2220 -0.996 0
0.02 7790 1600 -0.995 0
0.002 8900 5430 -1 0
D 30 7.81 2640 -1 1410
3 5.94 11100 -1 14300
0.3 144 25700 -1 25.2
0.03 4.13 15500 -1 65500
0.003 0.671 781000 -1 1400000
Table 6.4: Michaelis-Menten parameters estimated by the kinetic model (equation 6.9). Data 
is displayed for amplifications directed by [A] Primer set ICF/ICR [B] Primer set 




Table 6.5: CT data from amplification set A, predicted by kinetic model vs. LightCycler™ Fit 
Points Method




STD 1 20 1.30 14.11 5.66
STD 2 2 0.30 16.29 8.87
STD 3 0.2 -0.70 21.00 11.22
STD 4 0.02 -1.70 23.92 16.25
STD 5 0.002 -2.70 27.72 18.13
NTC - - - -
UKN 1 10 1.00 14.68 6.64
UKN 2 1 0.00 17.01 9.92
UKN 3 0.1 -1.00 21.46 13.58
Table 6.6: CT data from amplification set B, predicted by kinetic model vs. LightCycler™ Fit 
Points Method




STD 1 30 1.48 30.52 22.82
STD 2 3 0.48 33.81 26.29
STD 3 0.3 -0.52 36.76 29.68
STD 4 0.03 -1.52 41.02 33.57
STD 5 0.003 -2.52 47.11 51.22
NTC - - - -
UKN 1 15 1.18 32.12 23.77
UKN 2 1.5 0.18 35.45 27.64
UKN 3 0.15 -0.82 38.53 31.14
2 1 0
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Table 6.7: CT data from amplification set C, predicted by kinetic model vs. LightCycler™ Fit 
Points Method.




STD 1 20 1.30 59.63 20.7
STD 2 2 0.30 25.01 22.28
STD 3 0.2 -0.70 27.74 25.09
STD 4 0.02 -1.70 28.24 25.8
STD 5 0.002 -2.70 36.03 32.23
NTC - - 45.74 40.19
UKN 1 1 0.00 25.87 23.62
UKN 2 0.1 -1.00 28.92 26.37
UKN 3 0.01 -2.00 29.4 27.26
Table 6.8: CT data from amplification set D, predicted by kinetic model vs. LightCycler™ Fit 
Points Method.




STD 1 30 1.48 32.35 26.26
STD 2 3 0.48 36.12 29.71
STD 3 0.3 -0.52 - 33.49
STD 4 0.03 -1.52 41.4 38.75
STD 5 0.003 -2.52 60 37.42
NTC - - - -
UKN 1 15 1.18 1 28.09
UKN 2 1.5 0.18 37.92 31.01
UKN 3 0.15 -0.82 40.75 34.51
211
Chapter Six
Reaction Set Actual Kinetic model 








A 10 1.00 10.05 9.05
1 0.33 2.15 0.91
0.1 -0.94 0.11 0.70
B 15 0.97 9.25 15
1.5 -2.9E-04 1.00 1.27
0.15 -0.89 0.13 0.13
C 1 -0.19 0.65 0.55
0.1 -1.10 0.079 0.15
0.01 -1.24 0.057 0.0046
D 1.5 - 8.65
0.15 -0.29 0.51 1.70
0.015 -1.25 0.056 0.24
Table 6.9: Calculated concentrations of ‘unknown’ DNA samples using kinetic model vs. 
LightCycler™ Fit Points Method. Data is displayed for amplifications directed by [A] Primer 
set IC F /IC R  [B] Primer set SC _W T_O P/SC _M U T_O P; [C] Primer set 




6.2. 1 D e v e lo p m e n t o f Kinetic M o d e l o f PCR
Figure 6.2 A shows a typical plot of fluorescence A F I  during PCR. The observed 
transitions in fluorescence closely follow the temperature profile because of the 
strong dependency of fluorescence on temperature (Wittwer et al., 1997). As the 
sample was heated, fluorescence was high until denaturation occurs (apparent as a 
sharp drop in fluorescence). As the sample was cooled from denaturation to 
annealing tem perature, fluorescence increased rapidly, reflecting product-to- 
product annealing (Figure 6.2 B). Fluorescence also increased during extension 
whilst the temperature was held within the optimal limits for Taq  DNA polymerase 
(Figure 6.2 C). This increase was directly attributable to polymerisation and the 
accumulation of double stranded DNA, and was measured to represent the rate, v, 
of each individual cycle during the PCR.
The dependency of reaction rate, v, on substrate concentration [S'] for all PCR  
tests showed a strong departure from the hyperbolic relationship predicted by the 
Michaelis-Menten equation (Figure 6.1 A). In fact, the reaction rates generated from 
real time data closely followed the general curve predicted for high substrate 
inhibition (Figure 6.1 B; Equation 6.5).
To fit these data using equation 6 .5  directly would not provide a good  
approximation, since PCR is a non-classical enzyme system. In PCR the product 
formed in cycle n - l  is the substrate that is available for cycle n, and therefore 
cannot be represented simply using a linear scale. Under non-limiting conditions 
this should result in an exponential increase in substrate concentration over 
successive cycles described in the equation,
Sn = 2 nS0, (6.9)
where S0 is the initial template (substrate) concentration, and Sn is the substrate 
concentration after n successive cycles. It is well understood, however, that in PCR
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this model only holds for early cycles due to the changing dynamics in the plateau 
phase (Schnell and Mendoza, 1997A).
Consequently, a simplified sigmoidal function was applied to describe the 
accumulation of substrate during PCR,
5 _  1
( l  +  a * e x p w  ;) v '
where a  and /  are descriptive parameters of the sigmoid function at cycle n 
(Figure 6.15; Seggern, 1993). This function arises in many dynamical systems, 
describing simple exponential growth dynamics with a linear limiting control. Such 
systems are often called logistic growth. A similar sigmoidal function was recently 
reported as providing a good fit for the whole kinetic process of real time PCR (Liu 
and Saint, 2002).
The model was further refined by the inclusion of a compensation factor C . 
Equation 6.5 demands that at zero substrate concentration the rate of the reaction 
is zero. Since a PCR contains an initial substrate (template) concentration at cycle 
number n = 1, this compensation factor allowed the criteria of the equation to be 
satisfied, such that an artificial cycle 0 is included. The overall equation becomes,
v.
v = m ax
1+ KM
(S + C)
+ (S + C)
v *1  yj
(6.7)
where S is represented by the sigmoidal function of equation 6.8. This role of the 
compensation factor was confirmed by the consistent prediction of C  as 
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Figure 6.15: The effects of varying parameters [A] a and [B] /  on the general shape of a 
sigmoid curve. The sigmoid function was solved using the numbers shown in the legend, 
and plotted alongside each other for comparison.
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The function (S +  C ) approximated well to real-time data in these experiments 
(Figures 6 .7 -6 .10  A-D inclusive), particularly in correctly primed PCR tests (Figure 
6.11). For general applications such as quantitative PCR, this model is targeted for 
use in correctly primed PCR tests, and therefore the greater non-conformity of the 
model in the presence of a mismatch would not affect the utility of the test. The  
difference is likely due to other intrinsic factors that occur when a mismatch is 
present. These are discussed in the following section.
6.2.2 D eterm in atio n  o f kinetic constants in a lie ie-specific  PCR 
The synthesis of oligonucleotides that differ only at the 3 ’-terminal base, coupled 
with templates with a variant nucleotide at a defined position, provided a system to 
evaluate the effects of mismatches in PCR. The ability of Taq DNA polymerase to 
bind and extend terminal mismatches was dependent upon the identity of the 
mispair, inferred by the differing kinetic parameters estimated (Table 6.1).
It was assumed that ^ max represented the maximal rate of incorporation of SYBR  
into an extending DNA complex under non-limiting conditions. This provides an
arbitrary measure of maximal polymerisation or catalytic activity. Although ^ max is 
not a fundam ental property of an enzym e as it is dependent on enzym e  
concentration (Cornish-Bowden, 1979), reactions were validly compared using this 
parameter since the same total enzyme concentration, E T, was used in each PCR  
test.
For amplifications from template with a variant nucleotide G, ^ max was highest in 
the presence of a matched primer 3 ’ terminus. For all other templates at least one
of the mismatched primers gave a higher ^ max value than the match. In PCR tests
involving the transversion mispairs (template:primer) G:A, A:A and T:T, ^ max was 
lower than that found for a match. The transition mispairs C:A, A:C, T:G and




The latter observation is not surprising when one considers the consequence of 
mismatched primer extension in PCR. Certain nucleotide configurations vary in their 
affinity to bind to the enzyme and extend. However, once extension from a 
mismatched primer occurs, the resultant product and the complement synthesised 
in subsequent cycles are fully matched with both primers (Kwok et al., 1990). The  
nature of PCR means that a single copy of matched template can be amplified to 
plateau levels in just a few cycles. This causes failure in many end-point genotyping
tests by impairing discrimination. Therefore, ^max alone is insufficient to ascertain 
the true effects of a mispair in PCR.
The more dominant parameter for characterising enzymatic discrimination is the 
Michaelis constant K M , defined as the substrate concentration at which the reaction 
rate is half its maximal velocity (Cornish-Bowden, 1979). The K M is an intrinsic 
property of an enzym e reflecting the binding constant for forming the enzym e  
substrate complex, as well as the catalytic constant. In PCR, this embodies 
template affinity and the thermodynamic environment of the reaction (Schnell and 
Mendoza, 1997B). The transversion mispairs G:A, A:A, and T :T  exhibited a K M 
value between 100- to 1000-fold higher than a corresponding match. In all other 
cases, K m for a mismatch was 8- to 33- fold higher than the equivalent match. 
These data suggest that a matched conformation binds with higher affinity than a 
mismatch to the active site of the enzyme.
This is discordant with the view of Huang et al. (1992) who found that T a q  
polymerase binds with equal affinities to all base configurations. This is likely due to 
the reaction conditions employed where a single species of dNTP was used as the 
variable substrate for each template. Single-turnover kinetics is unable to reflect a 
PCR test in which all dNTPs are present at equimolar concentration and in large 
excess. In the absence of competition, similar binding affinities might be expected. 
Some groups were similarly conflicting (D ’yachenko et al., 1994; Kuchta et al., 
1987), whilst others were in agreement (Day et al., 1999; Mendelman et al., 1990; 
Petruska et al., 1988; Wong et al., 1991). The diversity of reaction conditions 
employed, enzyme source and DNA sequences may have caused this disparity.
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Importantly, the work presented during this chapter represents the kinetic 
characterisation of Taq  polymerase in a true rapid cycle PCR environm ent 
overcoming the limitations of previous findings.
The kinetic parameters displayed in Table 6.1 were used to define a value for the 
fundamental ‘specificity’ constant, kcat /K M , where kcat is the catalytic constant or 
turnover number. This specificity constant determines the ratio of reaction rates for 
enzym e acting on two competing substrates, when they are mixed together at 
equimolar concentrations. Given that it is the ratio of specificity constants that 
determines the ratio of rates of the competing reactions a and b, Vmax IK M was 
evaluated since [ E T] was identical throughout these tests (Cornish-Bowden, 1979):
The comparison of these values between matched- and mismatch-primed PCR  
expresses the enzym e’s ability to discriminate in favour of a particular base 
configuration in the presence of others (Cornish-Bowden, 1979), and consequently 
the relative extension efficiencies (Huang et al., 1992). In agreement with work by 
Kwok et al. (1990) it was found that a match was the more specific substrate for 
Taq D N A  polymerase. The relative specificity of mismatches varied according to 
each arrangement, but in general, purine:purine mispairs were harder to extend 
than other combinations. This system unequivocally demonstrates that for Taq DNA  
polymerase during rapid cycle PCR, the matched base configuration would be the 
preferred substrate in the presence of all other mismatches.
The model also provided estimate values for the inhibition constant K t , which
provides a quantitative measure of inhibitor potency (Wharton and Eisenthal, 1981). 
Values for K t are usually derived from an inhibition study of the effects of a
substance on kinetics or binding of a substrate or effectors. Such studies are 
usually performed in the presence of the true substrate (for kinetics) or ligand (for
{ V L K Y  { { v L l E AT ) K ) a  { k * J K Au )a  
{ V L  ! K Bu )b ( ( V ^ / E ? ) / K ° ) b  ( I% ,/K ° )b  
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binding) AND the inhibitor. Therefore the K. value in this model represents a
substrate inhibition constant since the substrate only is present. This could be 
interpreted as the ability of the mismatched primer to form a dead-end complex by 
binding to the active site of the enzyme without efficient extension. In addition, it 
may represent the ability of the primers to bind dystopically to a particular template, 
such that replication rate is depressed. In both cases, one might expect K M for a  
mismatched primer to be higher than that of the true primer. This is supported by 
data in which the three transversion mispairs, G:A, A:A, and T:T, exhibited a  
significantly higher K t value than all other mispairs. Consistently, K ; was lower for
a match. By considering the other param eter values associated with each  
configuration, it is proposed here that these particular mispairs bind to the enzyme 
with low affinity and extend with low efficiency, forming a stable dead-end complex 
that inhibits progression of the reaction.
Due to the complex interactions of components within a PCR (Linz et al., 1990), and 
the thermodynamics of DNA hybridisation (Petruska et al., 1988), variations in 
component concentrations or annealing temperature during the test will also alter 
the resulting kinetic constants, not just the inhibition constant. It is therefore 
important to only compare kinetic parameters obtained under identical reaction 
conditions.
6.2.3 High substrate inhibition
Factors that have been attributed to attenuation of PCR include depletion of 
substrate (dNTPs or primers), thermal inactivation or limiting concentration of DNA  
polymerase, inhibition of enzyme activity by increasing pyrophosphate production, 
reannealing of amplicon at concentrations above 10'8 M, reduction in the 
denaturation efficiency per cycle, destruction of product due to enzym e 5 ’-3 ’ 
exonuclease activity (Kainz, 2000), product to product reannealing (Wittwer et al., 
1997) or the chelation of critical metal ions by the substrate depriving the enzyme of 
a cofactor (Wharton and Eisenthal, 1981). For each theory, the characteristics of 
high substrate inhibition would be apparent.
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Previous investigations have shown that by including increasing amounts of 
“random” DNA into the PCR test from the beginning amplification could be inhibited 
(Kainz, 2000; Dimitrov and Apostolova, 1996). It was suggested that the 
accumulation of product during later cycles is more likely to inhibit the enzym e  
before the more trivial factors such as exhausting primers, metal ions or dNTPs, 
which are added in huge molar excess. This, in conjunction with the excellent fit of 
the kinetic model to real data provides compounding evidence that high substrate 
inhibition does indeed play a predominant role in curtailing amplification during the 
final cycles of a PCR.
However, one might have expected the K t for a match to be greater than or equal 
to a mismatch if we were proposing high substrate inhibition as the sole cause of 
the PCR plateau phase. These data show that in the case of a mismatch, other 
factors come into play, which further add to the magnitude of the K t value. This is 
supported by Figures 6 .7 -6 .10  A-D inclusive, in which the model’s prediction of 
substrate accumulation was more accurate for a match- than mismatch-primed 
PCR test. Figure 6.11 highlights this trend further. So although high substrate 
inhibition is the likely cause of the plateau phase in conventional PCR, it seems 
likely that the actual presence of a mismatch has an effect on the intrinsic ability of 
the enzyme to function effectively, displaying a direct inhibitory effect on the PCR.
6.2.4 PCR quan tifica tio n  using external standards
Absolute and relative quantification approaches can compare amplification of a 
target nucleic acid in samples of unknown DNA concentration, against a standard 
curve consisting of serial dilutions with known concentrations of the same target 
(homologous standards) or a reference gene. The standards are generally run in 
different reaction vessels, but within the same PCR run (external standards). For 
absolute quantification, target values are usually expressed as an absolute value 
(copy number or nanograms). In the case of relative quantification using a standard 
curve, the quantity is expressed relative to a reference/housekeeping gene, or 
calibrator. Instead of an absolute value, for all experimental samples the target 
quantity is determined from the standard curve and divided by the target quantity of
2 2 0
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the calibrator. Thus the calibrator becomes the 1x sample, and is used to 
“normalise” all other quantities, which are expressed as an n-fold difference relative 
to the calibrator.
For either method to be accurate and reliable, a single number is required that 
consistently identifies a single defined position on the curve, the CT value. The  
kinetic model was used to define the cycle threshold based on kinetic parameters. 
The peak of each kinetic curve (Figure 6.12 A-D) represents the transition point 
where the substrate concentration becomes limiting (Figure 6.16). It is assumed 
that since this is dependent on enzym e concentration and sequence only (not 
withstanding experimental error), that this point is consistent regardless of template 
concentration. The good correlation between initial template concentration and the 
calculated threshold confirmed the accuracy of the model (Tables 6.5-6.8 inclusive).
In these experiments, the cycle number at which this threshold occurred increased 
in accordance with starting tem plate concentration. A standard curve was 
constructed from these data to produce a linear trend line (Figure 6.13 A-D) from 
which the initial DNA concentrations of unknown samples were calculated (Table 
6.9). The kinetic model was directly compared with the Fit Points Method used in 
the LightCycler™  (Tables 6 .5 -6 .8  inclusive). The  software used by the  
LightCycler™ did not allow the Fit Points Method to be used with continuous 
monitoring. Therefore, deviation not only represents pipetting error and other run-to- 
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Figure 6.16: Real-time PCR data (points) overlaid by the kinetic model curve for the corresponding reaction. Figure demonstrates that the point
used to derive the CT value is consistent for each reaction.
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To summarise, a kinetic model of PCR was developed in which the PCR progress 
curve was viewed as a series of independent reactions where initial rates were 
accurately measured for each cycle. The variation of reaction rates per cycle was 
shown to closely follow the general equation for high substrate inhibition, which 
formed the foundation of the kinetic model, demonstrated here to have high 
correlation to real data. The general trends presented for matched and mismatched 
amplifications are directly applicable to the design of SNP genotyping experiments, 
providing a measure of the likely success and optimisation necessary.
This approach has also been validated for application in rapid qPCR methods in 
which accurate measurement of quantitative parameters is essential. The method 
described here can be, in principle, applied to probe detection formats as well as 
the SYBR Green I sequence non-specific detection. For example, if TaqMan®  
probes were used, an increase in reaction rate would be observed at the 
annealing/extension phase of the reaction as the 5 ’ nuclease activity is most 
effective. As the amount of cleavage is directly proportional to target DNA  
concentration, one might expect a similar curve of initial rate vs. cycle number to be 
formed as observed here. These data would be am enable to the kinetic model 
described here. This concept has not been validated, and represents an area where 
further research can be conducted.
This work forms the basis of Patent No, G B 02_21295 .9  “Improvements in or 
relating to nucleic acid amplification reactions” and was published in Biochemical 





SNP genotyping methodologies are under pressure to deliver technologies that 
work rapidly, are robust, have the potential for automation, and a reduced  
requirement for controls. Combined, these attributes will offer a decreased need to 
re-run assays, leading to cost efficiency, the major pressure for assay development. 
The successful assays of the future will need to reduce costs by utilising less 
expensive reagents and technology, but also through improving robustness and 
automation. The aim of this thesis was to develop an assay that could fulfil these 
key requirements. Ideally, the test should be suitable for use in a clinical 
environment for routine testing, involving few steps once optimised to avoid the 
potential for contamination and sample mix-ups. Understandably, low cost and high 
speed is important here.
PCR, a widely used technique in life science research, provided the ideal platform  
to satisfy these criteria. PCR is utilised in almost all genotyping techniques to 
achieve the required sensitivity and specificity, and was used as the core 
technology in the work of this thesis. Of particular relevance is the adaptation of 
PCR itself called allele-specific PCR. Although this methodology is robust, accurate, 
and the method of choice for routine screening of sickle cell anaemia for example 
(Old et al., 2000), it has been limited previously by lengthy optimisation strategies, 
the requirement of two-tubes to genotype a bi-allelic SNP, the necessity of internal 
control primers, and labour-intensive post-PCR processing using gel-based  
techniques.
Consequently, a single tube adaptation of allele-specific PCR was developed during 
this work called bi-directional PCR (presented in Chapter Three), in which allele- 
specific amplicons are separated according to size on an agarose gel. The assay  
was validated by high accuracy in blinded trials for the detection of the A -> T
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mutation in the p-globin gene linked to sickle cell anaemia. This test would likely be 
valuable in laboratories where contemporary instrumentation is unavailable, and 
throughput requirements are moderate. Current drawbacks of the assay are low- 
speed and the requirement for multiple-steps.
Bi-directional PCR was developed further, by introducing homogeneity to the test 
using a universal dsDNA specific binding dye, SYBR® Green I, to monitor specific 
product accumulation the PCR reaction mixture. This enabled real time detection of 
amplification and identification of allele-specific products using melt curve analysis. 
Figure 7.1 demonstrates how these attributes interact to address the requirements 
of the perfect assay (Figure 1.4, pg. 16). The fluorescent bi-directional PCR test 
was validated by high accuracy in blinded trials for the detection of the A -> T  
mutation in the |3-globin gene linked to sickle cell anaem ia, and the two most 
com m on m utations linked to increased  su scep tib ility  to hered ita ry  
haemochromatosis.
The fluorescent bi-directional PCR assay could be improved for more widespread 
application by introducing automation with the use of robotics systems for reaction 
set-up, and computer software for primer design. With improved tem perature  
control and measurement in PCR instruments, a slower more-controlled melt curve 
analysis could allow products differing in T m by less than 2°C  to be effectively 
discriminated. The test could be applied to TrueSNP™  primers, a phosphodiester 
primer with a LNA monomer at the 3 ’ end. This product was designed solely to 
improve specificity in allele-specific PCR tests, validated by brief experiments 
(Appendix V). The cost of TrueSNP™  primers is approximately double the cost of a 
conventional primer, but approximately one-fifth of the cost of a single real-time 
PCR probe. Since the true cost of a genotyping test is in the optimisation strategy 
as well as the test itself, additional cost benefits could be seen in optimisation, 
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Figure 7.1: A schematic representation of the four key components of the fluorescent bi­




However, where sequence specificity is of paramount importance, real-time PCR  
probes are the current tools of choice. During this work, the bi-directional PCR was 
adapted to use TaqMan® probes for allele-specific amplicon detection, as opposed 
to a universal DNA binding dye. This assay is sem i-sequence specific since a 
specific amplicon is generated following allele-specific amplification influenced by 
the enzyme and PCR conditions, not the sequence-specific probe. Therefore, of the 
three assays developed here, this adaptation conferred the fewest advantages in 
terms of speed and specificity, and incorporated additional costs and design 
considerations using real-time PCR probes.
The importance of SNP detection assays, such as those developed during this 
thesis has been realised recently. Following the sequencing of the human genomic 
project, the acceptance of genetic testing has escalated because it has been 
recognised that SNPs are linked not only to monogenic disorders of which 1600 are 
known, but also to increased susceptibility to common multifactorial disorders such 
as cancer and heart disease, and the prediction of drug efficacy and toxicity. 
Therefore, genetics and SNP testing strategies will need to be introduced into drug 
development.
Pharmacogenomic studies are already underway to look at the genes involved in 
drug metabolising enzymes or in routinely characterising the genetic variation in 
potential drug targets. Areas such as oncology would significantly benefit from a 
prediction of therapeutic affect based on genetic tests due to the multiple side 
effects and varying responses exhibited by patients administered these drugs. 
W here a typical choice of treatment exists, it would be beneficial to examine a 
patient’s response to that drug, quickly, prior to administration. The trial-and-error 
approaches used today in which sequential drugs are administered until a 
favourable response is apparent can be expensive and unacceptable to patients. 
This approach also increases the risk of cumulative side affects and non- 
compliance (Sanders, 2002). Oncology represents one of many healthcare areas 
that would potentially benefit in similar ways.
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PCR-based testing has had huge impact on other areas of diagnostic testing, such 
as the monitoring of gene expression in certain disease states, or viral load or 
bacterial particle quantification (Chapter Six). The most accurate and reproducible 
method for performing these analyses is qPCR techniques. Currently, there are a 
number of instruments available to allow real-time monitoring which has enabled 
gene quantification based on data collected from the log-linear phase of the PCR. A 
novel kinetic model developed during this work, was originally used to define useful 
kinetic parameters (including V ^ ,  K M and K t) for PCR tests primed by matched 
and mismatched primers. These data were directly applicable to the design of 
allele-specific PCR tests. Since the model was based on the internal dynamics of 
the PCR test itself, it was able to provide an accurate method for PCR quantification 
using standard curves. The model assumes that PCR becomes limited by high 
substrate, high substrate inhibition, and good degree of correlation was achieved. 
The model was also used to determine the cycle threshold in a PCR reaction curve 
to provide quantitative estimations of known and unknown template concentration. 
Therefore, this strategy can be used to analyse the PCR test, quantifying specific 
markers for disease progression. Ultimately, this will contribute to the concept of 
‘disease management’ to optimise the clinical and economical outcome.
In summary, the implementation of genetic testing in routine diagnostics is thought 
to become a standard and essential part of patient care. The large number of assay 
formats being produced suggests that soon the goal of a “perfect assay” will be met. 
Combining the assay with automated nucleic acid extraction systems, automated 
reaction set-up, and universal internal controls will significantly shorten the 
turnaround time for generating informative results used for the diagnosis and 
treatment of patients. In addition, a more thorough understanding of the molecular 
basis of disease will assist drug discovery, and ultimately allow patient care based 
on an optimised genetic profile of the individual. It still stands that this can only be 
achieved with suitable assays for the detection of genetic variation, and it is 
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Primer Sequences for PCR Amplifications
255
O lig o  N a m e # b p T j S e q u e n c e  ( 5 ' - 3 ’)
ACT BF 23 63.2 TTC CGT AGG ACT CTC TTC TCT GA
ACT BR 23 67.0 GGG GTG TTG AAG GTC TCA AAC AT
ACT BR A 34 81.0 CGG GAT CCA GAG GGG TGT TGA AGG TCT CAA ACA A
ACT BR C 34 83.1 CGG GAT CCA GAG GGG TGT TGA AGG TCT CAA ACA C
ACT BR G 34 83.1 CGG GAT CCA GAG GGG TGT TGA AGG TCT CAA ACA G
ACT BR T 34 81.0 CGG GAT CCA GAG GGG TGT TGA AGG TCT CAA ACA T
ASA 1A 15 59.5 TCG ATT CGG GAT CCA
ASA 1C 15 60.5 TCG ATT CGG GAT CCC
ASA 1G 15 61.9 TCG ATT CGG GAT CCG
ASA 1T 15 57.1 TCG ATT CGG GAT CCT
C282Y MUT AS 18 66.5 CTG GGT GCT CCA CCT GGT
C282Y MUT OP 20 67.3 GGG CTC CCA GAT CAC AAT GA
C282Y MUT OP1 22 64.8 GCC AAG GAG TTC GAA CCT AAA G
C282Y WT AS 23 64.7 GGG GAA GAG CAG AGA TAT ACG TG
C282Y WT OP 22 64.8 GGG CTC CCA GAT CAC AAT GA
H63D MUT AS 19 67.1 CCA CAC GGC GAC TCT CAT C
H63D MUT OP 21 65.5 GCA GGA CCT TGG TCT TTC CTT
H63D WT AS 23 64.6 CCA GCT GTT CGT GTT CTA TGA TC
H63D WT OP 22 66.0 ATC CCA CCC TTT CAG ACT CTG A
ICF 21 65.1 TGG CAG CAC TGC ATA ATT CTC
ICR 21 60.8 AGC GGT AAG ATC CTT GAG AGT
Oligo Name bp Tm Sequence (5’-3’)
MUT OP 267 21 61.8 GGG TTT GAA GTC CAA CTC CTA
PM A S A 19 64.7 GAA TTC GAT TCG GGA TCC A
PM A S C 19 65.3 GAA TTC GAT TCG GGA TCC C
PM AS G 19 66.4 GAA TTC GAT TCG GGA TCC G
PM A S T 19 62.7 GAA TTC GAT TCG GGA TCC T
SC MUT AS 22 67.5 GCA GTA ACG GCA GAC TTC TCC A
SC MUT OP 20 65.3 AGG GCA GAG CCA TCT ATT GC
SC W TAS 20 65.9 ATG GTG CAC CTG ACT CCT GA
SC WT OP 20 67.5 AGG GCC TCA CCA CCA ACT TC
WT CP 98 17 64.1 GCT GTC CCC AGT GGC TT
WT CP 374 31 76.3 CGG GAT CCT TCC GTA GGA CTC TCT TCT CTG A
WT OP 517 21 61.7 CCC CTT CCT ATG ACA TGA ACT
W TFAM 27 62.7 FAM AGA AGT CTG CCG TTA CTG CCC TGT GGT TAMRA
MUT JOE 27 62.7 JOE AGG AGT CAG GTG CAC CAT GGT GTC TGT TAMRA
1 Tm values are estimated at 0.1 M Na+
2 5 6
Appendix II
pGEM-T® Easy Vector System II plasmid 
sequence with cloned insert
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Cloned b-actin gene insert displayed in italic type (position 52), mutation site displayed in 
bold italic type (position 60), position of internal control fragment shown in bold type 
(position 1820 to 2047)
1 GGGCGAATTG GGCCCGACGT CGCATGCTCC CGGCCGCCATGGCGGCCGCG
51 GGAATTCGATT- (cloned insert)
C G G G A T C C G G A G G G G T G T T G A A G G T C T C A A A C A T G A T C T G T A A G G C A G A G A T G C A C C A T G T
C A C A C T G G G G A A G C C A C T G G G G A C A G C C A G G C C A G A C G G G G G A C A T G C A G A A A G T G C A A A
G A A C A C G G C T A A G T G T G C T G G G G T C T T G G G A T G G G G A G T C T G T T C A G A C C T A C T G T G C G C C
T A C T T A A T A C A C A C T C C A A G G C C G C T T T A C A C C A G C C T C A T G G C C T T G T C A C A C G A G C C A G T
G T T A G T A C C T A C A  C C C  A  C A  A C  A C  T G  T C T C A  G A  C A  C C  T A  G  T C A  G A G A G A C A A A C A  C C A  G A A A A
A G A G C T C A T C T G G G A A A A A G C A A A T A G A A C C T G C A G A G T T C C A A A G G A G A C T C A G G T C A G A
G A A G A G A G T C C T A C G G A A G G A T C C C G A A -  (end of cloned insert)
52 ATCACTAGTG AATTCGCGGC CGCCTGCAGG TCG ACC ATAT
101 GGGAGAGCTC CCAACGCGTT GGATGCATAG CTTGAGTATT CTATAGTGTC 
151 ACCTAAATAG CTTGGCGTAA TCATGGTCAT AGCTGTTTCC TGTGTGAAAT 
201 TGTTATCCGC TCACAATTCC ACACAACATA CGAGCCGGAA GCATAAAGTG 
251 TAAAGCCTGG GGTGCCTAAT GAGTGAGCTA ACTCACATTA ATTGCGTTGC 
301 GCTCACTGCC CGCTTTCCAG TCGGGAAACC TGTCGTGCCA GCTGCATTAA 
351 TGAATCGGCC AACGCGCGGG GAGAGGCGGT TTGCGTATTG GGCGCTCTTC 
401 CGCTTCCTCG CTCACTGACT CGCTGCGCTC GGTCGTTCGG CTGCGGCGAG 
451 CGGTATCAGC TCACTCAAAG GCGGTAATAC GGTTATCCAC AGAATCAGGG 
501 GATAACGCAG GAAAGAACAT GTGAGCAAAA GGCCAGCAAA AGGCCAGGAA 
551 CCGTAAAAAG GCCGCGTTGC TGGCGTTTTT CCATAGGCTC CGCCCCCCTG 
601 ACGAGCATCA CAAAAATCGA CGCTCAAGTC AGAGGTGGCG AAACCCGACA 
651 GGACTATAAA GATACCAGGC GTTTCCCCCT GGAAGCTCCC TCGTGCGCTC 
701 TCCTGTTCCG ACCCTGCCGC TTACCGGATA CCTGTCCGCC TTTCTCCCTT 
751 CGGGAAGCGT GGCGCTTTCT CATAGCTCAC GCTGTAGGTA TCTCAGTTCG 
801 GTGTAGGTCG TTCGCTCCAA GCTGGGCTGT GTGCACGAAC CCCCCGTTCA 
851 GCCCGACCGC TGCGCCTTAT CCGGTAACTA TCGTCTTGAG TCCAACCCGG 
901 TAAG AC ACG A CTTATCGCCA CTGGCAGCAG CCACTGGTAA CAGGATTAGC 
951 AGAGCGAGGT ATGTAGGCGG TGCTACAGAG TTCTTGAAGT GGTGGCCTAA 
1001 CTACGGCTAC ACTAGAAGAA CAGTATTTGG TATCTGCGCT CTGCTGAAGC 
1051 CAGTTACCTT CGGAAAAAGA GTTGGTAGCT CTTGATCCGG CAAACAAACC
2 5 8
1101 ACCGCTGGTA GCGGTGGTTT TTTTGTTTGC AAGCAGCAGA TTACGCGCAG 
1151 AAAAAAAGGA TCTCAAGAAG ATCCTTTGAT CTTTTCTACG GGGTCTGACG 
1201 CTCAGTGGAA CGAAAACTCA CGTTAAGGGA TTTTGGTCAT GAG ATTATC A 
1251 AAAAGGATCT TCACCTAGAT CCTTTTAAAT TAAAAATGAA GTTTTAAATC 
1301 AATCTAAAGT AT ATATG AGT AAACTTGGTC TGACAGTTAC CAATGCTTAA 
1351 TCAGTGAGGC ACCTATCTCA GCGATCTGTC TATTTCGTTC ATCCATAGTT 
1401 GCCTGACTCC CCGTCGTGTA GATAACTACG ATACGGGAGG GCTTACCATC 
1451 TGGCCCCAGT GCTGCAATGA TACCGCGAGA CCCACGCTCA CCGGCTCCAG 
1501 ATTTATCAGC AATAAACCAG CCAGCCGGAA GGGCCGAGCG CAGAAGTGGT 
1551 CCTGCAACTT TATCCGCCTC CATCCAGTCT ATTAATTGTT GCCGGGAAGC 
1601 TAGAGTAAGT AGTTCGCCAG TTA AT AG TTT GCGCAACGTT GTTGCCATTG 
1651 CTACAGGCAT CGTGGTGTCA CGCTCGTCGT TTGGTATGGC TTCATTCAGC 
1701 TCCGGTTCCC AACGATCAAG GCGAGTTACA TGATCCCCCA TGTTGTGCAA 
1751 AAAAGCGGTT AGCTCCTTCG GTCCTCCGAT CGTTGTCAGA AGTAAGTTGG 
1801 CCGCAGTGTT ATCACTCATG GTTATGGCAG CACTGCATAA TTCTCTTACT 
1851 GTCATGCCAT CCGTAAGATG CTTTTCTGTG ACTGGTGAGT ACTCAACCAA 
1901 GTCATTCTGA GAATAGTGTA TGCGGCGACC GAGTTGCTCT TGCCCGGCGT 
1951 CAATACGGGA TAATACCGCG CCACATAGCA GAACTTTAAA AGTGCTCATC 
2001 ATTGGAAAAC GTTCTTCGGG GCGAAAACTC TCAAGGATCT TACCGCTGTT 
2051 GAGATCCAGT TCGATGTAAC CCACTCGTGC ACCCAACTGA TCTTCAGCAT 
2101 CTTTTACTTT CACCAGCGTT TCTGGGTGAG CAAAAACAGG AAGGCAAAAT 
2151 GCCGCAAAAA AGGGAATAAG GGCGACACGG AAATGTTGAA TACTCATACT 
2201 CTTCCTTTTT CAATATTATT GAAGCATTTA TCAGGGTTAT TGTCTCATGA 
2251 GCGGATACAT ATTTGAATGT ATTTAGAAAA ATAAACAAAT AGGGGTTCCG 
2301 CGCACATTTC CCCGAAAAGT GCCACCTGAT GCGGTGTGAA ATACCGCACA 
2351 GATGCGTAAG GAGAAAATAC CGCATCAGGA AATTGTAAGC GTTAATATTT 
2401 TGTTAAAATT CGCGTTAAAT TTTTGTTAAA TC AG CTC ATT TTTTAACCAA 
2451 TAGGCCGAAA TCGGCAAAAT CCCTTATAAA TC AAA AG AAT AGACCGAGAT 
2501 AGGGTTGAGT GTTGTTCCAG TTTGGAACAA GAGTCCACTA TTAAAGAACG 
2551 TGGACTCCAA CGTCAAAGGG CGAAAAACCG TCTATCAGGG CGATGGCCCA 
2601 CTACGTGAAC CATCACCCTA ATCAAGTTTT TTGGGGTCGA GGTGCCGTAA 
2651 AGCACTAAAT CGGAACCCTA AAGGGAGCCC CCGATTTAGA GCTTGACGGG 
2701 GAAAGCCGGC GAACGTGGCG AGAAAGGAAG GGAAGAAAGC GAAAGGAGCG 
2751 GGCGCTAGGG CGCTGGCAAG TGTAGCGGTC ACGCTGCGCG TAACCACCAC
2 5 9
2801 ACCCGCCGCG CTTAATGCGC CGCTACAGGG CGCGTCCATT CGCCATTCAG 
2851 GCTGCGCAAC TGTTGGGAAG GGCGATCGGT GCGGGCCTCT TCGCTATTAC 
2901 GCCAGCTGGC GAAAGGGGGA TGTGCTGCAA GGCGATTAAG TTGGGTAACG 




Single tube genotyping of sickle cell 
anaemia using PCR-based SNP analysis
261
© 2001 Oxford University Press Nucleic Acids Research, 2001, Vol. 29, No. 23 e l 19
Single tube genotyping of sickle cell anaemia using 
PCR-based SNP analysis
Christy M. Waterfall* and Benjamin D. Cobb
Molecular Sensing pic, Unit 3, Challeymead Business Park, Bradford Road, Melksham, Wiltshire SN12 8LH, UK 
Received August 31, 2001; Revised and Accepted October 9, 2001
ABSTRACT
Allele-specific amplification (ASA) is a generally 
applicable technique for the detection of known 
single nucleotide polymorphisms (SNPs), deletions, 
insertions and other sequence variations. Convention­
ally, two reactions are required to determine the 
zygosity of DNA in a two-allele system, along with 
significant upstream optimisation to define the 
specific test conditions. Here, we combine single tube 
bi-directional ASA with a ‘matrix-based’ optimisation 
strategy, speeding up the whole process in a reduced 
reaction set. We use sickle cell anaemia as our model 
SNP system, a genetic disease that is currently screened 
using ASA methods. Discriminatory conditions were 
rapidly optimised enabling the unambiguous identi­
fication of DNA from homozygous sickle cell patients 
(HbS/S), heterozygous carriers (HbA/S) or normal 
DNA in a single tube. Simple downstream mathematical 
analyses based on product yield across the optimisation 
set allow an insight into the important aspects of 
priming competition and component interactions in 
this competitive PCR. This strategy can be applied to 
any polymorphism, defining specific conditions 
using a multifactorial approach. The inherent 
simplicity and low cost of this PCR-based method 
validates bi-directional ASA as an effective tool in 
future clinical screening and pharmacogenomic 
research where more expensive fluorescence-based 
approaches may not be desirable.
INTRODUCTION
The successful implementation of single nucleotide polymorphism 
(SNP) screening for clinical research and the administration of 
medicine tailored to an individual’s genotype, so-called 
‘personalised medicine’ , lies in the ability to deliver highly 
reliable, accurate and inexpensive assays that can discriminate 
between key DNA polymorphisms. Biotechnology and 
pharmaceutical companies have addressed this challenge with 
the development o f methodologies including single-strand 
conformation polymorphism analysis, heteroduplex analysis 
and denaturing gel electrophoresis. Each of these techniques 
relies on conformation-induced gel mobility changes (1). 
Simple homogeneous assays based on fluorescence resonance
energy transfer, mass spectrometry or direct sequencing of 
PCR products have also been shown to be effective tools for 
SNP detection (2). Implementation of these methods can 
require specific reagent synthesis and downstream purification, 
making them complicated and expensive.
However, assays based on PCR for SNP diagnosis have 
broad potential in clinical diagnostics because o f their inherent 
simplicity and potential low cost. Established PCR-based 
methodologies include certain ligation assays (3,4), genetic bit 
analysis (5), arrayed primer extension (6) and restriction 
fragment length polymorphisms (7), and use of sequence- 
specific fluorescent probes (8).
PCR has also been adapted for the detection of well-characterised 
SNPs using allele-specific amplification (ASA); oligonucleo­
tides complementary to a given DNA sequence except for a 
mismatch at their 3'-hydroxyl residue w ill not function as 
primers in the PCR under appropriate conditions. A typical 
ASA test consists of two complementary reactions, each 
containing a common primer, an allele-specific primer and Taq 
DNA polymerase lacking 3 '—>5' proofreading activity. The 
first reaction contains a primer specific for the normal (or wild- 
type) DNA sequence and refractory to amplification from 
mutant DNA at a given locus. Similarly, the second reaction 
contains a mutant-specific primer unable to amplify wild-type 
DNA. Molecular conformation is achieved by analysis of the 
resulting PCR amplicon profiles. A  normal individual w ill 
generate product in the first reaction only; a heterozygote 
amplifies products in both reactions; and a homozygous 
mutant individual does so only in the mutant-specific reaction. 
Internal control amplification is necessary, providing a 
positive control for the PCR test (9).
More recently, single tube adaptations have been introduced 
for known SNP detection in a two-allele system including 
competitive oligonucleotide priming (10), multi-coloured 
fluorescent oligo labelling systems (2), tetra-primer PCR (11) 
and overlapping PCR strategies (12,13). The latter both use bi­
directional primer arrangements in which common ‘outer’ 
primers define the size of each allele-specific fragment 
allowing simple identification using electrophoretic methods.
Maintaining the integrity of all ASA techniques, particularly 
for diagnostic application, requires the optimisation of many 
experimental parameters. The literature suggests that a magnesium 
and oligonucleotide titration is sufficient to obtain discriminatory 
conditions. Generally, further mismatches are incorporated at 
the 3'-end o f the allele-specific primer to weaken hydrogen 
bonding between the primer and template, increasing the like­
lihood o f discrimination (14). However, these conventional
*To whom correspondence should be addressed. Tel: +44 1225 706245; Fax: +44 1225 700056; Email: christy.waterfall@molecular-sensing.com
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approaches are simplistic considering the complex component 
interactions in a PCR reaction and prove time consuming and 
expensive. This has limited the applicability of PCR-based 
SNP diagnosis for routine clinical application. In particular, b i­
directional systems require significant optimisation due the 
effects o f primer competition caused by multiple primer sets in 
the PCR amplification.
Here, we modify current systems at a number of levels with 
the application o f a multifactorial optimisation procedure to 
single tube bi-directional ASA. Our strategy enables the rapid 
identification o f component ratios favouring ASA in a greatly 
reduced experiment set using unmodified oligonucleotides. 
This low cost optimisation strategy combined with a single 
tube genotyping system introduces improvements to PCR-based 
SNP screening.
SNP model
We demonstrate our system by detecting the single base pair 
mutation that causes the autosomal recessive disease sickle cell 
anaemia (GenBank accession no. M34058). A single A —>T 
transversion in the sequence encoding codon 6 of the human 
(3-globin gene causes the substitution of amino acid glutamine 
by valine, forming a mutant globin chain termed HbS. Haemo­
globin S is freely soluble when fully oxygenated, but under 
conditions of low oxygen tension the erythrocytes assume an 
irregular ‘sickle’ shape, leading to aggregation and haemo­
lysis. The sickled erythrocytes become trapped in the micro­
circulation, depriving organs of essential oxygen, causing pain 
and chronic anaemia (15). Homozygous HbS is a serious 
haemoglobinopathy found almost exclusively in the Black 
population. About 8% of American Blacks are carriers and 
-0.2% are affected. In the UK sickle cell disease affects 
-10 000 people (actionresearch.co.uk/camp/sick.html). Hetero­
zygotes (sickle cell carriers) are clinically normal, although 
their red cells w ill sickle when subjected to very low oxygen 
pressure in vitro (genelink.com/technical/sickle.html). PCR-based 
techniques for prenatal diagnosis of sickle cell disease were 
introduced in 1989 following the invention o f the amplification 
refractory mutation system (9) and are still the method o f 
choice in clinical research laboratories (16). A single tube 
adaptation of conventional ASA would add significant benefits 
to routine testing for sickle cell disease.
MATERIALS AND METHODS
Reagents
PCR reagents (Taq DNA polymerase, HS TaQUANT-OFF, 
lOx Mg-free Taq buffer, 25 mM MgCl2) were obtained from 
Q-Biogene (CA), except for dNTPs (2 mM each dATP, dCTP, 
dGTP and d'lTP), which were from Promega (UK). Primer 
selection was accomplished using the PrimerCalc® software 
package (Q-Biogene). For standard gel electrophoresis, molecular 
biology grade agarose was used (Q-Biogene) in 0.5x TBE 
buffer (45 mM Tris, 45 mM borate, 1 mM Na2EDTA, pH 8.3). 
Double deionised water (18 MQ) was used for all buffers and 
solutions for electrophoresis and PCR amplifications. 
Homozygous HbS human genomic DNA and heterozygous 
HbA/S DNA were a generous gift from the National Haemo- 
globinopathies Reference Service (Oxford, UK).
Bi-directional allele-specific PCR amplifications
WT-AS (5'-ATG GTG CAC CTG ACT CCT GA-3') and 
WT-CP517 (5'-CCC CTT CCT ATG AC A TGA ACT-3') 
were designed for amplification of a 517 bp fragment from the 
normal |}-globin gene (wild-type primer set). MUT-AS (5'-CAG 
TAA CGG CAG ACT TCT CCA-3') and MUT-CP267 (5'-GGG 
TTT GAA GTC CAA CTC CTA-3') were designed for ampli­
fication of a 267 bp fragment from homozygous mutant DNA 
(HbS/S) conferring sickle cell disease (mutant primer set). A ll 
reactions were performed in a volume of 25 p i containing 
10 ng total human genomic DNA template, lOx PCR reaction 
buffer, 1 U pi-1 Taq DNA polymerase and water. The wild-type 
primer set, mutant primer set, MgCl2 and dNTP concentrations 
are shown in Table 1 and were aliquoted according to an 
orthogonal array (Table 2) (17). Amplification was performed 
using an MJ Thermal Cycler (GRI, UK) through an initial 
denaturation at 95°C for 2 min, followed by 30 cycles o f dena- 
turation at 95°C for 30 s, primer annealing at 60°C for 30 s and 
extension at 72°C for 35 s. A  small blind trial was performed 
in which 14 human genomic DNA samples of mixed zygosity 
were used as substrate DNA under discriminatory conditions 
that were considered optimal (reaction 9, Tables 1 and 2). The 
exact template concentration o f each sample was not specified, 
varying between 5 and 25 ng pi-1.
Analysis of PCR products
An aliquot (10 pi) of each PCR product was loaded with 6x 
loading buffer (Promega) onto a 2% agarose gel and run in
0.5x TBE buffer at 30 mA constant current. Amplification 
products were visualised by UV transillumination (305 nM)
Table 1. Concentration levels of components used in a multifactorial array for 
the identification of discriminatory reaction conditions for bi-directional ASA
Level A B C
WT-AS/WT-CP517 (pM) 0.2 0.4 0.8
MUT-AS/MUT-CP267 (pM) 0.2 0.4 0.8
MgCl2 (mM) 0.5 1 2
dNTPs (mM) 80 120 200
Table 2. An orthogonal array for testing four reaction parameters, each at 
three different levels





1 A A A A
2 A B B B
3 A C C C
4 B A B C
5 B B C A
6 B C A B
7 C A C B
8 C B A C
9 C C B A
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Figure 1. Schematic representation of bi-directional allele-specific PCR. The wild-type primer set is shown in green and the mutant primer set in pink. Three 
possible fragments can be formed depending upon substrate DNA zygosity, as well as enzyme system and cycling parameters. The green amplicon defines the 
allele-specific product formed when only the wild-type primers are extended and the pink amplicon defines the allele-specific product formed when only the 
mutant primers are extended. A heterozygote is identified by the presence of both PCR products. The target region amplified by non-allele-specific outer primers 
is shown in pale grey. Our selected enzyme system was inefficient at amplifying longer sequences and in the presence of competition from a smaller fragment 
insufficient target region was amplified for visualisation on a stained gel.
after staining with SYBR Gold (Molecular Probes, UK) for 
30 min. The agarose gels were photographed and analysed by 
gel imaging software to obtain maximum band optical density 




A schematic of bi-directional ASA is shown in Figure 1. A 
wild-type allele-specific primer is designed as complementary 
to the non-coding strand of the wild-type allele terminating at 
the known polymorphic site. This primer w ill be extended in 
the presence of wild-type DNA only under appropriate PCR 
conditions. A further allele-specific primer is included in the 
reaction, designed as complementary to the coding strand of 
the known mutant allele, again terminating at the SNP site. 
This primer w ill be extended in the presence of the mutant 
allele only, as it is refractory to extension of wild-type DNA 
due to a single base pair mismatch at the 3'-end. Two ‘outer 
primers’ are placed on the opposite strand at a pre-defined 
number of bases from their allele-specific pair in order that 
molecular confirmation can be achieved by analysis of the 
resulting amplicon profiles using gel-based methods. A differ­
ence of at least 100 bp is preferable to increase electrophoretic 
separation.
Taq DNA polymerase w ill extend both outer primers in all 
reactions as they are non-allele-specific, but the yield of the 
large amplicon spanning the whole target region is subject to 
variation according to the enzyme system and cycling 
parameters employed. The HotStart enzyme system used in 
this study was less efficient at amplifying larger fragments and 
in the presence o f competition from a smaller fragment did not 
amplify sufficient DNA for the larger band spanning the whole 
target region to be visualised on an agarose gel.
We designed two 20/21 mer allele-specific primers, WT-AS 
and MUT-AS, complementary to the normal P-globin or sickle 
cell genes, respectively, arranged in a bi-directional orientation 
such that both primers terminate at the mutation site. Primer
WT-AS has a single A nucleotide at the 3'-end, matching the T 
nucleotide on the non-coding strand of the normal P-globin 
gene. Primer MUT-AS has a single A nucleotide at the 3'-end, 
matching the T base on the coding strand of the sickle cell 
gene. The wild-type outer primer (WT-CP517) was positioned 
517 bp downstream on the opposite strand of WT-AS. The 
mutant outer primer (MUT-CP267) was placed 267 bp 
upstream of MUT-AS. Unlike normal ASA, this assay has an 
inherent PCR control, as at least one allele-specific fragment 
should be yielded per reaction under optimised conditions. 
This negates the need for a distant pair of primers to direct the 
amplification of an internal control fragment.
Optimisation strategy for discrimination between the 
normal and sickle cell alleles
Inclusion of multiple allele-specific primer sets in a single 
reaction tube requires the consideration of many experimental 
factors. For typical multiplex reactions, the key parameter for 
optimisation is primer concentration. At equimolar concentrations, 
amplification by the two primer sets may be weak or strong at 
a given locus, an event dependent upon primer stabilities, 
binding efficiencies, priming competition, product size and 
concentration of other reaction components (18). Normally, 
primer ratios are individually optimised for each reaction, 
however, an adjustment in primer concentration has associated 
implications considering the complex interactions between 
other components in a PCR. Unique to this assay, each primer 
is complementary to a different part of the DNA sequence, 
introducing additional variability to the reaction.
MgCl2 and dNTPs have been shown to affect the efficiency 
of priming and extension by altering the kinetics of association 
and dissociation of primer-template duplexes at annealing and 
extension temperatures. These components also alter the 
efficiency with which the polymerase recognises and extends 
such duplexes. Of particular relevance to allele-specific PCR 
methods, the concentration of MgCl2 and dNTPs required for 
optimal amplification depends largely on the target and primer 
sequences. The presence of excess magnesium in a reaction 
may result in the accumulation of non-specific amplification 
products and insufficient concentrations reduce product yield.
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Figure 3. Gel image data from a small blind trial. Fourteen human DNA 
samples of varying zygosity were selected and amplified under conditions 
specified by reaction 9 (Table 2). Diagnosed template zygosity is shown on the 
gel image. Three normal samples were identified by amplification of the 517 bp 
product only. Six heterozygous samples were identified by amplification of 
both the 267 and 517 bp fragments. For heterozygotes, the 267 bp band was 
slightly more intense than the 517 bp band, likely due to staining disparity 
between optimisation sets A and B. Five homozygous sickle cell samples were 
identified by amplification of the 267 bp amplicon only.
Figure 2. Gel image data of PCR amplifications. Outer lanes contain 100 bp 
ladders. Reactions 1-9 according to the matrix (Table 2) are labelled accordingly. 
Set A represents reactions in which wild-type template DNA was the substrate. 
Set B represents reactions in which HbS/S template DNA was included. The 
517 and 267 bp allele-specific fragments were generated in each set, respectively. 
Product yield varied across each reaction set. Table 3 represents maximal 
optical density (OD) of the amplicon bands, used as a representation of product 
yield/reaction score.
It has also been demonstrated that dNTPs quantitatively bind 
Mg2+, so that any modification of dNTP concentration will 
require a compensatory adjustment of MgCl2 (17). Additionally, 
Taq polymerase requires free Mg2+ as a cofactor so any excess 
of dNTPS can have a detrimental effect on product yield by 
chelating cofactor ions (19). Standard approaches to multiplex 
or allele-specific PCR optimisation are unable to account for 
these multiple interactions, as they are largely based on trial- 
and-error strategies.
We applied a multi factorial optimisation strategy in which 
optimal component concentrations for allele discrimination 
were identified in a single trial with few reactions. The wild- 
type primer set, mutant primer set, MgCl2 and dNTPs were 
selected as four critical parameters, the interactions of which 
are most likely to affect the outcome of bi-directional PCR. 
The concentrations of these components were varied according 
to an orthogonal array and differences in product yield across 
the reaction set were used for two purposes, qualitatively in the 
identification of diagnostic reaction conditions and quantitatively 
to study the individual effect of each parameter on the assay.
Optimal conditions for zygosity determination
Figure 2 shows gel image data from reaction sets A and B. Both 
sets are identical in component ratios and cycling conditions, 
containing normal and HbS/S DNA templates, respectively. 
Although product yield varied considerably across the reaction 
sets, only the appropriate allele-specific amplicon was generated 
according to template zygosity. Set A amplified the 517 bp 
amplicon and set B generated the 267 bp fragment only. The 
larger fragment spanning the whole target region was not
amplified in all cases using our enzyme system and cycling 
parameters.
Diagnostic conditions were selected by qualitative analysis 
of PCR yields from set A (WT DNA) and set B (HbS/S DNA). 
Optimal conditions for zygosity determination are those that 
amplify each allele-specific amplicon at similar efficiencies, as 
measured by band intensity from the gel. In this study, the 
conditions and interactions of reaction 9 (Table 2) satisfied 
these criteria, producing 517 and 267 bp bands with maximum 
OD values of 160.67 and 165.93 units, respectively. The optimal 
nature of these conditions was confirmed unambiguously in a 
small blind trial of 14 DNA samples of different zygosity 
(Fig. 3). Reactions generating the 517 bp fragment identified a 
normal genotype. Amplification of the 267 bp fragment 
confirmed a homozygous mutation and sickle cell carriers 
(HbA/S) were identified by the amplification of both the 517 and 
267 bp bands, diagnostic of heterozygous inheritance. The 
robustness of the optimised reaction conditions was demon­
strated by the ability to amplify from a range of unknown template 
concentrations without compromising the allele specificity of the 
system.
Effect of each parameter on specificity
A quantitative analysis was performed in which the actual 
product yield for each reaction was used to estimate the effects 
of individual components on amplification in bi-directional 
PCR. Signal-to-noise (SNL) ratios were calculated using the 
maximal optical density (max OD) of the allele-specific PCR 
products (Table 3) to represent product yield (y) in the quadratic 
loss function,
SNL = -10 log(l/nZni = |l/y j2)
assuming that variable y denotes the performance of the system 
measured for a particular combination of factor settings in a 
given experiment (total of n repeated measurements per 
experiment) (17). Reactions giving non-allele-specific fragments 
or no amplification at all were given a score of 1. The effects of 
reaction components on the SNL ratio were determined by 
regression analysis for both normal and HbS/S DNA templates
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Table 3. Maximal optical density (max OD) measurements of band intensities from amplification sets A and B in Figure 2
Reaction
1 2 3 4 5 6 7 8 9
Set A, max OD wild-type 5.13 90.83 80.30 63.40 63.70 1 132.27 1 160.67
Set B, max OD mutant 113.6 172.53 169.20 108.73 161.13 183.67 144.80 1 165.93
All values are in arbitrary units.
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Figure 4. Normal DNA. Effects of reaction components on the SNL ratios for the amplification of a wild-type 517 bp amplicon from normal DNA. Increased SNL 
value represents a larger effect on product yield than a low SNL.
(Figs 4 and 5, respectively), using calculated SNL values 
(Table 4).
We were able to demonstrate the significance of priming 
competition and component interaction on the outcome of 
bi-directional ASA reactions. The SNL analysis revealed that 
the optimal magnesium requirement for the generation of 
maximal product yield without compromising specificity was 
1.5 mM. This value did not vary according to template 
zygosity, which is in accordance with the multiple roles of 
magnesium in PCR. Likewise, the optimal concentration of 
dNTPs in sets A and B were similar, with lower levels being 
favoured. The quantitative binding of magnesium ions by 
dNTPs may account for this observation, as excess dNTPs may 
chelate the magnesium cofactor ions of Taq, decreasing 
processivity or simply reducing the yield and specificity.
The regression profiles of primer sets generated by normal 
and mutant DNA samples were quite different, demonstrating 
differences in primer stabilities, efficiencies and competition. 
For normal DNA the aim is to direct amplification o f the 
517 bp fragment only. The lower concentration of the wild- 
type primer set tested gave the largest SNL value relating to 
product yield. Intermediate concentrations decreased the SNL 
and the upper concentration showed an incremental increase in 
SNL. An identical profile was observed with the mutant primer 
set, optimally redundant in the presence of wild-type DNA. It 
is possible that at lower concentrations of both primer sets,
i.e. conditions of minimal competition, the wild-type pair is able 
to direct allele-specific amplification of the 517 bp fragment.
When the mutant allele is present, the aim is to direct ampli­
fication of the 267 bp amplicon only. The optimal concentration 
of the mutant primer set was predictably at the upper level.
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Figure 5. HbS/S DNA. Effects of reaction components on the SNL ratios for the amplification of a mutant 267 bp amplicon from HbS/S DNA. An increased SNL 
value represents a larger effect on product yield than a low SNL.
Likewise, the inclusion of lower concentrations of the wild- 
type primer allowed maximal optimal amplification of the 
mutant fragment, as the wild-type set thereby exhibited least 
competition with the mutant primer set. We have observed 
similar trends using other SNP models, confirming that primer 
interactions have a significant role in determining the outcome 
of bi-directional amplifications.
DISCUSSION
We have successfully demonstrated the use of bi-directional 
ASA for single tube genotyping of the SNP responsible for 
sickle cell anaemia. Our simple matrix optimisation strategy 
offers advantages over conventional methods, allowing the 
determination of specific test conditions in a greatly reduced 
reaction set. Combined with single tube bi-directional allele- 
specific PCR, rapid diagnosis of normal, homozygous and 
heterozygous template DNA can be achieved simply and 
applied to the screening of any known SNP. Bi-directional 
ASA is based on the recent adaptation of ASA methods, using 
a single tube for the diagnosis of a two-allele system, differing 
from other protocols described in which modified oligonucleo­
tides or cycling parameters are generally required to maintain 
specificity.
We found that the A:A or T:T mismatches designated by the 
sickle cell polymorphism were completely refractory to ampli­
fication under the optimised conditions. This is discordant with
a report by Kwok et al. (20) in which only A:G, G:A and C:C 
mismatches reduced overall PCR product yield significantly. 
Other combinations required the incorporation of additional 
mismatches near the 3'-end to increase discrimination. This 
difference may be due to improvements in the process of oligo­
nucleotide synthesis and the use of recombinant Taq DNA 
polymerases. In particular, the use of hot start systems was seen 
to improve the specificity of our allele-specific amplifications. The 
optimisation system used and the increased priming competition 
in our bi-directional assay w ill have positively contributed to 
the absolute discrimination.
The implementation of an orthogonal array in our optimisation 
system generated product yield data from two small reaction 
sets that served a dual purpose in our experiments. Firstly, we 
were able to use product yield data qualitatively to identify 
conditions under which both allele-specific fragments were 
amplified to similarly maximal efficiencies according to 
template zygosity. Secondly, reaction ‘scores’ were used 
quantitatively in a simple regression analysis, allowing the 
effects of ‘control factors’ influencing reaction performance to 
be assessed simultaneously. This provided an insight into the 
component interactions and priming competition that dominate 
bi-directional allele-specific amplifications.
The conditions selected for the blind trial were 0.8 pM for 
each primer from the wild-type and mutant sets, 1 mM magnesium 
ions and 80 pM dNTPs. This is unlikely to be in accordance 
with optimal component levels calculated by SNL values
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because of the different objectives of each enquiry. The theoretical 
target of the SNL analysis is to define conditions producing the 
maximum yield of each product. This differs from the practical 
target o f specifying diagnostic conditions under which each 
allele must be amplified specifically and at equal efficiencies 
enabling a heterozygous mutation to be identified without a 
gross over-amplification of one allele over another. Thus, to 
achieve this objective, sub-optimal conditions for the amplifica­
tion o f one allele may be combined with optimal conditions for 
the amplification of another by a less efficient primer set, as in 
this study.
Two further variables that have an effect on reaction 
outcome are the enzyme system and instrumentation used for 
amplification. The HotStart Taq DNA polymerase used in this 
study was extremely accurate, amplifying allele-specific products 
with only minimal spurious products. Additionally, the 
HotStart system was inefficient at amplifying larger fragments 
(>600 bp) when in competition with a smaller fragment, thus 
the non-allele-specific fragment spanning the whole target 
region was not amplified in this case. In similar studies, this 
larger fragment has been designated an internal control 
amplification, avoiding the incorporation of a distant primer 
pair conventionally required for diagnostic tests (12). 
However, any successful bi-directional ASA reaction w ill 
yield a fragment serving as an internal positive control for the 
PCR. Thus we favour our system where the processivity o f Taq 
is expended generating allele-specific products only. We tested 
a conventional enzyme system in similar experiments and 
found that the larger fragment was generally produced at the 
expense of the allele-specific fragment, with decreased specificity 
(data not shown). Application to other thermal cyclers may 
require further optimisation, since different reaction vessels 
and heating/cooling methods can dramatically change the 
dynamics of a PCR.
Here, genotyping was simply based on size discrimination of 
the resulting allele-specific PCR products, visualised by agarose 
gel electrophoresis. With the emergence of qPCR technologies, 
offering rapid thermal cycling and on-line product detection, 
our system can be adapted to detect PCR products based on 
their specific melting temperature using non-specific DNA-binding 
dyes. This would address high throughput issues whilst 
maintaining the advantages of low cost and the use of simple 
chemistries associated with the gel-based assay.
The technique described could be modified to detect more 
than one SNP simultaneously with the combination o f our 
optimisation strategy and accurate primer design. It has 
recently been suggested that the grouping and interaction of 
several SNPs in haplotypes may be more important than single 
SNPs in the identification of drug response and disease 
susceptibility of individuals (21). The commercial applications 
of this are widespread, as the development o f reliable, cost- 
effective tests w ill be considerably more complex i f  haplotypes 
need to be determined rather than single SNPs.
In conclusion, we have described various factors that have a 
combined influence on the outcome of bi-directional PCR 
amplifications. We have demonstrated the technique by identifying 
accurate conditions for determining the zygosity of sickle cell 
patients and carriers, a technique that can be simply applied to 
the detection o f any known genetic mutation.
Table 4. Signal-to-noise ratios (SNL) for reaction components used for the 
amplification of (A) the 517 bp wild-type allele-specific fragment and (B) the 





(A) Normal DNA template
WT-AS/WT-CP517 18.94 4.77 4.77
MUT-AS/MUT-CP267 18.95 4.77 4.77
Mg2+ 1.68 39.95 38.12
dNTP 18.94 4.77 4.77
(B) HbS/S DNA template
WT-AS/WT-CP517 43.12 42.93 4.77
MUT-AS/MUT-CP267 41.01 4.77 44.73
Mg2+ 4.77 42.88 43.94
dNTP 42.94 44.32 4.77
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SNP Genotyping Using 
Single tube SNP Fluores­
cent Bidirectional PCR
BioTechniques 33: - (July 2002)
Table 1. Primer Titration Matrix
Reaction SCF-WT WT-CP 86 SCF-MUT MUT-CP112
1 A A A A
2 A A B B
3 A A C C
4 B B A A
5 B B B B
6 B B C C
7 C C A A
8 C C B B
9 C C C C
Primers were aliquoted according to this matrix, where A = 0.15 pM, B = 0.3 jxM, 
and C = 0.9 pM. Inter-set primer concentrations were chosen empirically to cover 
a wide range.
ABSTRACT
SNP genotyping is a well-populated 
field with a large number o f assay formats 
offering accurate allelic discrimination. 
However, there remains a discord between 
the ultimate goal o f rapid, inexpensive as­
says that do not require complex design 
considerations and involved optimization 
strategies. We describe the first integration 
o f bidirectional allele-specific amplifica­
tion, SYBR Green® I, and rapid-cycle PCR 
to provide a homogeneous SNP-typing as­
say. Wild-type, mutant, and heterozygous 
alleles were easily discriminated in a single 
tube using melt curve profiling o f PCR 
products alone. We demonstrate the effec­
tiveness and reliability o f this assay with a 
blinded trial using clinical samples from in­
dividuals with sickle cell anemia, sickle cell 
trait, or unaffected individuals. The tests 
were completed in less than 30 min without 
expensive fluorogenic probes, prohibiting 
design rules, or lengthy downstream pro­
cessing fo r  product analysis.
INTRODUCTION
Although PCR was described nearly 
two decades ago (11), it still remains a 
core enabling technology for many di­
agnostic procedures. More recently, 
there has been renewed interest in the 
use of PCR for detecting SNPs since it 
has the potential to offer rapid and in­
expensive diagnosis. SNP genotyping 
has witnessed a progression from plat­
forms requiring secondary analysis of 
PCR products [e.g., RFLP (2), single­
strand conformational polymorphism 
(8), and DNA sequencing (14)] to rapid 
homogeneous genotyping with se­
quence-specific detection (10,20). This 
evolution has largely been accom­
plished through the availability of PCR 
instruments that combine amplification 
and product detection. Continued im­
provement of instrumentation in terms 
of speed and detection sensitivity sug­
gests that PCR may be an effective plat­
form on which to base SNP-typing as­
says for diagnostic application.
To this end, a number of different 
fluorescent chemistries have been de­
veloped that provide sequence-specific 
probes for real-time PCR. These typi­
cally employ fluorescence resonance 
energy transfer (FRET) between two 
fluorophores, with one quenching the 
fluorescence of the other (3,17,21,22). 
The design, synthesis, and purification 
of these probes are both difficult and 
expensive, which limits their commer­
cial suitability.
A widely used method for mutation 
detection that does not use fluorescent 
probes is allele-specific amplification 
(ASA) (12,15) and is based on the ob­
servation that a mismatch between tem­
plate and PCR primer reduces or pre­
vents amplification by Taq DNA 
polymerase. This process is assisted by 
the lack of a 3'—>5' proofreading activi­
ty in the enzyme. Two allele-specific 
primers complementary to the wild- 
type and mutant sequence are used to 
amplify target DNA in a pairwise 
manner with a single common primer. 
The presence or absence of PCR prod­
uct in each reaction mixture indicates 
whether the normal or mutant allele is 
present in the target. Typically, two re­
actions are required to genotype a two- 
allele system, and internal control am­
plification is necessary to provide a 
positive control for the PCR test (19).
More recently, we introduced a sin­
gle-tube adaptation called bidirectional 
ASA (23), in which two allele-specific 
primer pairs are included in a single
PCR test. Like similar methods pub­
lished independently [e.g., PCR-CTPP 
(5), SB-ASA (6), bidirectional AS- 
PCR (7), bi-PASA (9), SAS-PCR (16), 
tetra primer PCR (27), and tetra primer 
ARMS PCR (28)], this strategy has 
benefits in terms of reducing reagents 
and consumable costs, yet requires a 
secondary analysis for product identifi­
cation by gel electrophoresis or chro­
matography, which decreases overall 
throughput.
We describe a new assay format 
called fluorescent bidirectional PCR, 
which represents the first integration of 
bidirectional PCR with detection of 
specific PCR products according to 
their Tm. This introduces homogeneity 
to a previously heterogeneous system 
and takes advantage of contemporary 
PCR instruments, which offer in­
creased speed and cost-effectiveness. 
The test is compatible with rapid-cycle 
PCR, decreasing the time taken for 
bidirectional PCR methods from 4 h to 
35 min. In addition, specificity is im­
proved since shorter extension times 
strongly disfavor mismatched primer 
extension (17,25). The use of a single 
generic DNA binding dye, in this in­
stance SYBR Green® I, has enabled in­
expensive characterization of the am­
plification profile, which offers an 
interesting, more rapid alternative to 
the Tm-shift genotyping assay previ­
ously described (4).
Critically, fluorescent bidirectional 
PCR does not require any additional 
primer modifications such as GC tails 
(4) or additional mismatches near the 3' 
end of the primers to improve specifici­
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ty and utilizes a commercially available 
reaction mixture w ith  no additional 
reagents to those normally employed for 
a standard PCR assay. Since the true 
cost o f a genotyping test is defined by 
not only reagent and consumable costs 
but also time and labor for design and 
optimization, our simplified strategy 
adds to overall cost-effectiveness. To op­
timize any new PCR effectively, a mag­
nesium and oligonucleotide titration is 
usually performed, and once conditions 
have been established for a particular 
SNP, re-optimization is unnecessary.
We demonstrate the efficiency and 
re liab ility  o f the assay by detecting the 
single-base-pair mutation that causes 
the autosomal recessive disease, sickle 
cell anemia. Here, a single A —>T trans­
version in the sequence encoding 
codon 6 o f the human P-globin gene 
expresses itse lf as an amino acid substi­
tution o f glutamine to valine, forming a
mutant globin chain (HbS) (26). In this 
study, a set o f clinical D N A  samples 
was genotyped to validate fluorescent 
bidirectional PCR as an interesting and 
cost-effective alternative to other SNP 
genotyping methodologies.
MATERIALS AND METHODS 
Fluorescent Bidirectional PCR 
Primers
Oligonucleotides were designed 
using PrimerCalc® software (Q-Bio- 
gene, CA, USA) and synthesized by 
Sigma-Genosys, w ith a reverse-phase 
cartridge purification step. Each primer 
was designed with a Tm o f 60°C to 
allow generic PCR cycling conditions. 
SCF-WT (5'-ATGGTGCACCTGACT- 
CCTGA-3') and WT-CP86 (5'-AGGG- 
CCTCACCACCAACTTC-3') direct the
amplification o f an 86-bp product from 
the normal p-globin gene, w ith a calcu­
lated Tm o f 87°C (wild-type primer set). 
SCF-MUT (5'-GCAGTAACGGCAGA- 
CTTCTCCA-3') and M UT-CP112 (5'- 
AG G G C A G A G C C A TC TA TTG C -3 ') 
amplify a 112-bp fragment from homo­
zygous mutant DNA, with a calculated 
Tm o f 85°C (mutant primer set). Product 
melting temperatures were predicted us­
ing PrimerCalc software, which em­
ploys nearest neighbor thermodynamic 
algorithms fo rT m calculations (1).
Fluorescent Bidirectional PCR
Assay
Reactions were performed in a total 
volume o f 20 |J.L, containing 2 (J.L 
LightCycIer™ D N A  FastStart SYBR 
Green I mixture (Taq D NA polymerase, 
reaction buffer, deoxynucleoside tr i­
phosphate mixture, and SYBR Green I
SCF-MUT WT-CP86 SCF-MUT WT-CP86
MUT-CP112 SCF-WT MUT-CP112 SCF-WT
A. Wild type allele B. Mutant allele
Figure 1. Schematic of fluorescent bidirectional PCR. In a single reaction with two allele-specific primer sets, genomic DNA (■ ) will be amplified by either 
set depending on template zygosity, yielding allele-specific PCR products (■). Straight arrows indicate complementarities between primer and template, where­
as upward-/downward-facing arrows represent a single-base mismatch at the 3' end of the allele-specific primer. (A) Samples homozygous for the wild-type al­
lele will be amplified by SCF-WT and WT-CP86, giving a product with a predefined Tm of 87°C. (B) Samples homozygous for the mutant allele will generate 
a product with a predefined Tm of 85°C. Heterozygous inheritance will amplify both allele-specific PCR products. Internal control primers are not necessary 




Figure 2. Gel images from primer titrations. Reactions 1-9 correspond to conditions described in Table 1 using (A ) wild-type and (B) mutant human genom­
ic DNA template. Samples void of template are denoted by “n”. Actual product T m values for the 86-bp product were 87.1°C (±0.3°C), and 85.7°C for the 112- 
bp fragment. The 158-bp target region was not amplified to a detectable level across the reaction set.
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dye; Roche Applied Science, Lewes, 
U K ), a final concentration o f 3 mM 
M gC l2 and 20 ng human genomic 
D N A. For primer optim ization sets, 
oligonucleotides were aliquoted ac­
cording to Table 1, w ith  control D N A  
templates. For the blinded trial, optimal 
primer ratios, as defined by reaction 3, 
Table 1, were used (0.15 p M  each w ild - 
type Primer, and 0.9 p M  each mutant 
primer) w ith 45 D N A  samples o f un­
known genotype.
PCR Cycling and Melt Curve 
Analysis
PCR cycling and melt analysis pro­
tocols were performed on the L igh t- 
C ycler PCR instrument (Roche A p ­
plied Science). Am plifications were 
completed in approximately 30 min, in ­
cluding a 10-min Taq D N A  polymerase 
activation step at 95°C, 35 PCR cycles 
o f denaturation at 95°C fo r 1 s, primer 
annealing at 62°C fo r 3 s, and primer 
extension for 0 s at 72°C. A ll tempera­
ture transition rates were set to 20°C/s 
and a single fluorescence acquisition 
was made at 72°C fo r each cycle. Fluo­
rescence gains (used to set sensitivity 
o f detection) for the L ightCycler were 
F I -2 throughout.
Product identification and specifici­
ty was confirmed by executing a melt­
ing curve analysis immediately after 
amplification in the same closed capil­
lary tube. An in itia l denaturation at 
95°C fo r 0 s was fo llowed by a cooling 
step to 67°C (5°C above primer anneal­
ing, ensuring all fluorescence from 
dsDNA originates from  product-to- 
product re-annealing) and a slow denat­
uration phase to 95°C at a rate o f 
0. l°C /s, w ith continual fluorescence 
acquisition. Product denaturation was 
observed as a rapid loss o f  fluorescence 
near the calculated T m. This data was 
converted into melting peaks by L igh t­
Cycler software, plotting the first nega­
tive derivative o f fluorescence loss w ith 
respect to temperature (-d (F l)/dT  vs. 
T). The apex o f the m elt peak repre­
sents product T m.
Genotype Validation by Restriction 
Digestion
To validate genotype scoring by flu ­
orescent bidirectional PCR, conven­
tional PCR was performed using the 
DNA samples o f unknown genotype, 
followed by restriction enzyme diges­
tion with D de I. Each PCR was a total 
volume o f 25 pL, containing 20 ng 
template D NA, 0.5 pM  each outer 
primer (WT-CP86 and M UT-CP112), 
and 10 pL  PCR Master M ix  (Promega) 
containing Taq DNA polymerase, 
dNTPs, M gC l2, and reaction buffers at 
optimal concentrations fo r efficient am­
plification. A ll reactions were per­
formed using an MJ Thermal Cycler 
(GRI, U K) through an in itia l denatura­
tion at 95°C fo r 2 min, followed by 30 
cycles o f denaturation at 95°C for 30 s,
primer annealing at 60°C for 30 s, and 
extension at 72°C fo r 35 s. A  10-pL 
aliquot o f the reaction was mixed w ith 
20 U Dde I (Promega) and 3 pL  One- 
Phor-All Plus buffer (Amersham Phar­
macia, L ittle  Chalfont, U K), made up 
to 30 p L  w ith PCR-grade water. The 
solutions were incubated at 37°C fo r 1 
h, followed by an enzyme inactivation 
step at 65°C fo r 15 min. Digestion 
products were separated according to 
size on a 2.5% agarose gel (Q-Biogene) 
and visualized by staining w ith ethidi- 
um bromide. This protocol was used 





Figure 3. Example melting profiles from diagnostic tests representing one of each possible geno­
type. (A) Homozygous wild-type (sample 4); (B) homozygous mutant (sample 6); and (C) heterozygous 
DNA (sample 10). The three genotypes are easily identified by visual inspection of the graphs as de­
scribed in text. Actual Tm values were slightly higher than calculated in most cases.
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RESULTS AND DISCUSSION 
Assay Design
The principle o f the fluorescent b id i­
rectional PCR assay is shown schemat­
ica lly in Figure 1. A  key requirement o f 
the test is the ab ility  to design appropri­
ate primer pairs that amplify allele-spe­
c ific  PCR products w ith  a predicted T m 
difference o f 2°C, allowing adequate 
discrim ination by m elt curve analysis. 
This can be accomplished by defining 
primer T m value and searching fo r out­
er primers that generate products be­
tween 50 and 150 bp. Smaller products 
are recommended, g iving the widest 
variation in m elt temperature, as well 
as being the size o f choice for rapid cy­
cling protocols (18,24). The thermal 
profile  employed in our experiments 
can be transferred between assays fo l­
low ing these guidelines, and a slower, 
more-controlled temperature transition 
during melting may enhance T m dis­
crim ination further (13).
We chose the sequence surrounding 
the sickle cell mutation site to demon­
strate the applicability o f the test, aided 
by the high GC content downstream o f 
the SNP site that formed the w ild-type
fragment (58%) compared to the up­
stream sequence that formed mutant 
fragment (49%). As w ith all genotyp­
ing assays, the actual SNP position and 
surrounding sequence is nonvariable, 
meaning that under rare conditions the 
assay may not be appropriate. Howev­
er, using the described procedure, we 
have successfully designed primer sets 
to detect a range o f sequence polymor­
phisms using conventional primer de­
sign software.
Cycling conditions were manipulat­
ed to favor smaller products by reduc­
ing the extension time to 0 s, relying on 
the transitional times o f the kinetic 
PCR cycle to amplify the shorter prod­
ucts (16). Taq D N A polymerase ex­
tends the two primers flanking the tar­
get region regardless o f genotype, 
generating a 158-bp product w ith a cal­
culated T m o f approximately 88°C. The 
melt peak from this larger fragment 
would be indistinguishable from the 
wild-type product, which has a slightly 
lower T m o f 87°C. Thus, amplification 
o f this fragment may lead to false re­
sults by masking ASAs. Very rapid cy­
cling combined w ith internal competi­
tion from smaller fragments and a 
high-fidelity enzyme system totally
suppressed amplification o f this region 
throughout our experiments (Figure 2).
Assay Optimization
We specify optimal discrim inatory 
conditions as those able to am p lify  al­
lele-specific products only w ith sim ilar 
efficiency as determined by m elt peak 
height and peak area (13). In addition, 
these conditions should reduce or com­
pletely remove artifactual amplification 
in the form o f primer dimers. We used a 
strategy that would normally be applied 
to new PCR optim ization, m odified to 
accommodate oligonucleotide pairs. 
An in itia l magnesium titration was per­
formed using “ outer”  primers to direct 
amplification. Maximum specificity 
and product yie ld  was achieved w ith 3 
mM magnesium (data not shown). Two 
oligonucleotide titration sets using con­
trol DNAs o f known genotype under 
rapid cycling conditions defined opti­
mal primer set concentrations fo r allel­
ic discrim ination. The ratios and inter­
actions o f reaction 3 gave optimal 
results, yie ld ing single products w ith a 
T m o f 87.4°C w ith wild-type D N A  and 
85.7°C w ith mutant DNA. Each melt 
peak had a height o f approximately 10 
fluorescence units and sim ilar peak ar­
eas. The size o f corresponding products 
was confirmed by gel electrophoresis 
(Figure 2).
SNP Genotyping
The fluorescent bidirectional PCR 
assay was validated using optimized 
discriminatory conditions to genotype 
45 unknown samples for sickle cell sta­
tus based on their melting profiles 
alone. In each case, clearly distinct pro­
files were achieved depending on geno­
type (Figure 3). Thirty-three samples 
generated a melt peak around 87.5°C 
(±0.2°C), five samples produced a melt 
peak at 85.7°C (±0.2°C), and seven 
samples amplified both allele-specific 
fragments, g iving a dual-peak with 
maxima at 85.3°C (±0.3°C) and 87.6°C 
(±0.3°C), thus diagnosing homozygous 
wild-type, homozygous mutant, and 
heterozygous inheritance, respectively. 
Cluster analysis o f product T m values 
showed three unambiguous and distinct 
clustering regions, each corresponding 




Figure 4. Cluster analysis to determine sickle cell genotype. The x-axis represents peaks within the
actual Tm range o f  85.4°C (±0.3°C), and the y-axis represents areas within the actual Tn1 range of 87.3°C 
(±0.3°C). A symbol is assigned to represent homozygous DNA (A) or heterozygous DNA (O). Points 
lining up along either the x- or y-axis diagnose homozygous inheritance of mutant o r wild-type alleles, 
respectively, and points lying near to the x = y axes diagnoses heterozygous inheritance of the sickle cell 
mutation.
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each test, “no template control” samples 
were included to assess contamination 
and nonspecific amplification by primer 
sets; no amplification occurred in these 
controls. If  primer dimer had been 
formed in the reaction, then the Tm of 
the artifact would ensure that points 
were well away from profiles generated 
by actual template amplifications.
Experienced users of melt curve 
analysis will acknowledge that there 
can be well-to-well variation in the ac­
tual Tm of PCR products. Such varia­
tion is usually attributed to SYBR 
Green I concentration, salt concentra­
tion, or actual product yield (13). By 
using a commercial master mixture 
with a consistent concentration of 
SYBR Green I and employing opti­
mized magnesium concentrations, this 
variation was minimized. In practice, 
the deviations observed were likely due 
to differences in product yield and did 
not cause error in our tests. Melt peak 
data was 100% concordant with restric­
tion digestion band patterns (data not 
shown), validating our assay entirely.
In summary, fluorescent bidirection­
al PCR is mediated through a highly ef­
ficient kinetic process, coupled with an 
accurate melt curve analysis. The data 
presented here suggest that it has poten­
tial as a tool for screening programs of 
sickle cell anemia, particularly if cou­
pled with informatics tools that would 
allow automation. While we appreciate 
that for clinical use a more thorough 
evaluation of the test would be appro­
priate, our trial has adequately demon­
strated the potential of this method for 
use in SNP research. It provides a 
rapid, single-tube format, with internal 
control and sequence validation for 
SNP screening, in particular for near 
patient testing where the cost-effective- 
ness of the assay is the main driver. We 
believe that this will prompt a revival in 
an interest in allele-specific PCR for 
SNP detection.
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Appendix V
Locked Nucleic Acids as enhancers of 
allele-specific PCR
2 76
This brief report summarises experiments comparing the alieie-specificity of PCR 
amplification directed by conventional DNA oligonucleotides or LNA TrueSNP™ 
primers (Proligo LLC, Boulder, USA).
Assay design
Four plasmid DNA tem plates were employed for the PCR tests, each identical in 
sequence apart from a single variant nucleotide (G, C, A or T) at position 11 of a 
cloned p-aetin gene insert. To assess specificity across a range of starting tem plate  
concentrations, three dilutions were tested in each case (1 ng, 0.1 ng and 0.01 ng). 
Four allele-specific DNA primers (W T _A S _X ) and a universal common prim er 
(W T_O P_98) directed the amplification of a 98 bp amplicon with a Tm  of 85 °C. For 
LNA experim ents, equivalent TrueS N P ™  primers replaced allele-specific DN A  
primers. Previously optimised reagent concentrations and cycling protocol w ere  
used for PCR amplifications on the LightCycler™. Melt peaks were obtained at the 
end of each cycle, and peak area  was used to represent product yield. Each  
experiment was run in triplicate, and is displayed as an average across the set.
Results a n d  Summary
T hese data  represen t am plifications prim ed by the 4 possible m atched  
prim er/tem plates and 12 m ism atched prim er/tem plates, over a range of D N A  
concentrations. The data clearly shows a significant im provem ent in specificity  
using LNA primers compared to DNA primers at all tem plate concentrations. W hen  
DNA oligos were used, m ism atched amplifications w ere apparent in nearly all 
cases. LNA primers rarely extended a mismatched primer, and then only at the  
highest starting tem plate  concentration, dem onstrating their effectiveness in 


















0.1 ng 0.01 ng
LNA 
0.01 ng
DNA DNA LNA LNA LNA
0.1 ng 0.01 ng 1 ng 0.1 ng 0.01 ng
120
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0.1 ng 0.01 ng 1 ng 0.1 ng 0.01 ng
DNA DNA
1 ng 0.1 ng
DNA LNA LNA
0.01 ng 1 ng 0.1 ng
LNA
0.01 ng
DNA concentration DNA concentration
Amplifications primed by allele-specific primer with a 3’ terminal ‘C’ is shown in , ‘G’ is , ‘A’ is red, and T  is dark red.
Appendix VI
Kinetic characterisation of primer 
mismatches in allele-specific PCR: A 
quantitative assessment
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Kinetic characterisation of primer mismatches in allele-specific PCR: 
a quantitative assessment
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Abstract
A novel method of estimating the kinetic parameters of Taq DNA polymerase during rapid cycle PCR is presented. A model was 
constructed using a simplified sigmoid function to represent substrate accumulation during PCR in combination with the general 
equation describing high substrate inhibition for Michaelis-Menten enzymes. The PCR progress curve was viewed as a series of 
independent reactions where initial rates were accurately measured for each cycle. Kinetic parameters were obtained for allele- 
specific PCR (AS-PCR) amplification to examine the effect of mismatches on amplification. A high degree of correlation was ob­
tained providing evidence of substrate inhibition as a major cause of the plateau phase that occurs in the later cycles of PCR.
© 2002 Elsevier Science (USA). All rights reserved.
Keywords: Kinetic model; Allele-specific PCR; Michaelis-Menten; Substrate inhibition; Sigmoid function
ACADEMIC
PRESS
The polymerase chain reaction (PCR) enables repli­
cation of nucleic acid in vitro through the action of a 
thermally stable D N A  polymerase [1,2]. Until recently it 
has been used predominantly as a binary tool to indicate 
the presence or absence of a particular target sequence. 
Instruments capable of quantitative detection of ampli­
fication in real time (qPCR) have enabled sensitive 
analysis of gene expression and accurate determination 
of copy number [3,4], enhancing the utility of PCR as a 
diagnostic tool.
Despite the routine use of PCR in molecular biology, 
enzymatic and kinetic studies have been limited. Early 
characterisation studies detailed the efficiency with 
which Taq D N A  polymerase differentiates between 
matched and mismatched 3' nucleotides [5-15]. These 
analyses used end-point methods that considered the 
action of Taq in isolation of PCR dynamics. This sig­
nificantly underestimates the kinetic effects known to 
influence reaction fidelity and efficiency, and limits ap­
plication in designing genotyping tests. Furthermore,
* Corresponding author. Fax: +44-0-1225-700-056.
E-mail address: cjiristy.waterfalliu-molecular-sensing.com (C.M. 
Waterfall).
the rapid cycling of contemporary qPCR instruments 
has been shown to strongly disfavour mismatch exten­
sion [16], suggesting that abrupt transitions in temper­
ature have effects that have not been previously 
considered.
Several theoretical descriptions of PCR have been put 
forward that apply different mathematical approaches 
to simulate various physical parameters of the system. 
These include statistical estimations of amplification 
rate [17], probability of DNA replication [18], proba­
bility of DNA binding rates [19], and derivation of ex­
pressions for amplification efficiency [20-23]. Each 
model has yet to be evaluated using real PCR data.
Michaelis-Menten kinetics have been used to de­
scribe the variation of the rates of many enzyme-catal­
ysed reactions as the substrate or effector concentration 
is varied. There is experimental evidence to show that 
D N A  polymerase reactions obey this typical behaviour
[24]. Therefore, the Michaelis-Menten system can be 
utilised to underlie the principles of a theoretical de­
scription and obtain quantitative predictions of enzyme 
characteristics including catalytic activity, effects of 
specific inhibitors, and an enzyme’s specificity toward a 
particular substrate [25].
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We describe a mathematical model based on the 
Michaelis-Menten framework that enables the kinetic 
characterisation of PCR. In particular, we apply this 
model to rapid cycle allele-specific PCR (AS-PCR) that 
is used to discriminate between alleles of a gene based on 
single base pair differences. AS-PCR relies on the ability 
of Taq D N A  polymerase to extend a primer only when 
its 3' end is perfectly complementary to the template. 
The allele of the target DNA can be inferred by the 
presence or absence of amplicon [12]. These data would 
be directly applicable to designing single nucleotide 
polymorphism (SNP) detection experiments for disease 
and pharmacogenomic analysis [26].
In our experiments, PCR was shown to follow the 
general equation for high substrate inhibition. In this 
formulation an additional term is introduced into the 
denominator of the simple Michaelis-Menten equation; 
this term becomes predominant as the substrate con­
centration increases, resulting in inhibition of the ob­
served rate [27]. This formed the foundation of our 
model, which was used to represent PCR kinetically 
using a single equation that considers each cycle of PCR 
as a defined enzymatic reaction. A simple sigmoidal 
function was used to represent changing substrate con­
centration over the course of the reaction. A high degree 
of correlation was obtained, suggesting that PCR is 
sensitive to substrate during the plateau phase of the 
amplification.
Materials and methods
Plasmid DNA model system. All oligonucleotides were designed 
using PrimerCalc software (Q-Biogene; Carlsbad, USA) and synthe­
sised by Sigma-Genosys (Cambridgeshire, U K ) with a reverse-phase 
cartridge purification step. A  374 bp insert from the P-actin gene was 
amplified from human genomic D N A  (Sigma-Aldrich; Dorset, U K ) 
directed by primers BF (5'-TTC CGT AGG ACT CTC TTC TC T G A ­
S') and BR2 (5'-GGG G TG  T T G  AAG  GTC TCA AAC AT-3'). The 
resulting amplicon was purified using Wizard PCR Purification Kit 
(Promega; Madison, W l). Mutagenic primers, BFR (5'-CGG G AT  
CC TTC CG T AGG A C T C TC  TTC TCT GA-3') and BR2X (5'-CGG  
G AT CC XG A  G GG G TG  T T G  AAG  GTC TCA AAC AT-3' where 
X is G, C, A, and T) were used to re-amplify the purified PCR product 
introducing a 5' tail containing a variant nucleotide. The re-amplified 
products were ligated into plasmid D N A  using a pGEM -T Easy 
Vector System I Kit (Promega), following manufacturer’s protocol. 
Competent Escherichia coli cells (Q-Biogene) were transformed with 
the ligation mixes and resulting clones were screened colorimetrically 
to confirm transformation. Plasmid Minipreps (Qiagen; Sussex, U K )  
were used to purify the plasmid D N A  following manufacturer’s pro­
tocol. Plasmid preparations were sequenced to confirm the presence 
and position of the variant nucleotide. Preparations were quantified by 
measuring absorbance at 260 nm using a Cary-100 UV-Visible Spec­
trophotometer (Varian; Surrey, UK). Plasmid templates were used to 
model a “susceptibility gene” covering all base configurations.
Allele-specific PCR amplifications. PMOP98 (5'-GCTGTCCCCAG  
TGGCTT-3') and PMASX (5'-GAATTCGATTCGGGATCCX-3' 
where X  is G, C, A, or T ) directed amplification of a 98 bp allele- 
specific amplicon from the plasmid D N A  template. The 3'-terminus of 
primer PMASX was designed to anneal to the single polymorphic base
within the plasmid sequence. Product melting temperatures were pre­
dicted as 85.0 °C using PrimerCalc software, which employs nearest 
neighbour thermodynamic algorithms for Tm calculations [28],
Reactions were performed in a total volume of 20 pi containing 2 pi 
LightCycIer D N A  FastStart SYBR Green I  mixture ( Taq D N A  
polymerase, reaction buffer, dNTPs, and SYBR Green I dye; Roche 
Applied Science, Lewes, U K ), a final concentration of 3 mM MgCl2, 
and PCR-grade water. Forward and reverse primers were present at 
0.5 M  each with lOOpg plasmid template. Each forward primer 
(PMASX) with PMOP98 was used to direct amplification from four 
plasmid templates (containing G, C, A, or T  variant nucleotide) testing 
all 16 base combinations. Reactions were performed in triplicate with a 
single control sample void of template.
Continuous PCR monitoring and melt curve analysis. PCR cycling 
and melt analysis protocols were performed on the LightCycIer PCR  
instrument (Roche Applied Science). Amplifications were completed in 
approximately 40 min, including a 10-min Taq D N A  polymerase ac­
tivation step at 95 °C, 50 PCR cycles of denaturation at 95 °C for 1 s, 
primer annealing at 65 °C for 5 s, and primer extension for 5 s at 72 °C. 
A ll temperature transition rates were set to 20 °C/s and each PCR cycle 
was monitored by continual fluorescence acquisition. Fluorescence 
gains (used to set sensitivity of detection) for the LightCycIer were F l-  
1 throughout. These continuous monitoring data were exported into 
Microsoft Excel 2000 for further analysis.
Reaction specificity was confirmed by executing a melt curve 
analysis immediately after amplification in the same closed capillary 
tube. An initial denaturation at 95 °C was followed by a cooling step to 
70 °C (5 °C above primer annealing) and a slow denaturation phase to 
95 °C at a rate of 0.1°C/s, with continual fluorescence acquisition. 
Product denaturation was observed as a rapid loss of fluorescence near 
the calculated Tm, and converted to a melt peak by plotting the first 
negative derivative of fluorescence loss, FI, with respect to tempera­
ture, T  (-d (F l)ld T  vs 7). A  single peak at the predicted Tm confirms 
the optimal nature of the reaction conditions and the absence of 
contamination in control samples. A broad peak at a significantly 
lower Tm than PCR product identifies primer dimer amplification [29].
Collection o f  'per cycle' rate data. The reaction rate v was deter­
mined from the maximal increase in fluorescence signal F I  with respect 
to time, t, at 72 °C at each cycle. The rates were estimated from the 
linear portion of the progress curve, as shown in Fig. 1C, according to 
the linear equation,
F l  =  vt +  c, (1)
where c is the F l  reading at time zero. The slope v o f fluorescence 
signal increase was assumed proportional to the rate of nucleotide 
incorporation by Taq D N A  polymerase since this will be concomitant 
with the intercalation of SYBR Green I  molecules into the newly 
synthesised double-stranded D N A .
Results and discussion
Kinetic data
Fig. 1A shows a typical plot of fluorescence AFT 
during PCR. The observed transitions in fluorescence 
closely follow the temperature profile because of the 
strong dependency of fluorescence on temperature [4]. 
As the sample is heated, fluorescence is high until de­
naturation occurs (apparent as a sharp drop in fluores­
cence). As the sample cools from denaturation to 
annealing temperature, fluorescence increases rapidly, 
reflecting product-to-product annealing (Fig. IB). Flu­
orescence also increases during extension whilst the
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Fig. 1. Grey section highlights area o f interest from a matched allele-specific PCR test from template containing variant nucleotide T. (A) Continuous 
monitoring data over 50 PCR cycles. (B) Temperature dependence of product accumulation over a single cycle. (C) Product accumulation during the 
extension phase (72 °C) only.
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temperature is held within the optimal limits for Taq 
DNA polymerase (Fig. 1C). This increase is directly 
attributable to polymerisation and the accumulation of 
double-stranded DNA. During early and late cycles 
fluorescence changes over this period were negligible. 
This is in contrast to cycles where exponential and linear 
amplification of target would be expected and where 
significant increases in fluorescence were observed from 
the real-time data.
Mathematical model
The rate of reaction at each cycle was calculated from 
the slope of the linear F l  portion in Fig. 1C. Data points 
in Figs. 2A-D show the cycle dependence of rate v using 
template with base variant T \  The lag phase during 
early cycles was attributable to fluorescence signals that 
were below the detection limits of the optics in the 
LightCycIer. The length of the lag phase varied ac­
cording to base complementation and was generally less 
for a matched template compared to a mismatch. This 
lag phase was followed by a rapid increase in reaction 
velocity, which reached a maximum, and then decreased 
as cycle number was increased further.
The dependency of reaction rate on substrate con­
centration shows a strong departure from the hyperbolic 
relationship predicted by the Michaelis-Menten equa­
tion, and appears to be characteristic of high substrate
inhibition in which the formation of abortive complexes 
inhibits the enzyme. The reaction rates generated from 
real-time data closely followed the general curve pre­
dicted for high substrate inhibition,
v
 _______________r m ax_______________
' [ 1  +  (Km /S ) +  (S/Ki) ] '  1 j
where Vmax is the maximum velocity, KM is the Micha­
elis-Menten constant, and K\ the inhibition constant. At 
low substrate concentration S, (S /K x) is insignificant 
compared to 1 + (K M/S ) and Eq. (2) becomes identical 
to the classic Michaelis-Menten equation. It follows 
that as S increases, the value of {S/K,) increases to be­
come the significant term in the denominator and, as 
observed in our experiments, the value of v decreases 
[27].
Since we fit this equation to data generated from 
PCR, a non-classical enzyme system, S must be repre­
sented appropriately. In PCR the product formed in 
cycle n -  1 is the substrate that is available for cycle n. 
Under non-limiting conditions this should result in an 
exponential increase in substrate concentration over 
successive cycles described Eq. (3),
Sn =  2" So, (3)
where So is the initial template (substrate) concentration 
and S„ is the substrate concentration after n successive 
























Fig. 2. Graphs o f rate v vs. cycle number for base combinations (template: primer) (A ) T:A, (B) T:G , (C) T:C, and (D ) T:T. The solid line represents 
the curve predicted by the model (Eq. (5)) and points are data collected from real PCR tests using Eq. (1). Correlation coefficient r2 is >0.99 in each
case.
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where 5 is represented by the sigmoidal function of Eq.
(4).
Determination o f kinetic constants in allele-specific PCR
The synthesis of oligonucleotides th a t differ only at 
the 3/-terminal base, coupled with templates with a 
variant nucleotide at a defined position, provided a 
system to evaluate the effects of mismatches on PCR. 
Non-linear regression (NL-REG Version 5.4; Phillip H. 
Sherrad) was used to estimate informative kinetic pa­
rameters for each base configuration using Eq. (5). The 
ability of Taq DNA polymerase to bind and extend 
terminal mismatches was dependent upon the identity of 
the mispair (Table 1).
We assumed that Fmax represented the maximal rate 
of incorporation of SYBR into an extending DNA 
complex under non-limiting conditions. This provides 
an arbitrary measure of maximal polymerisation or 
catalytic activity. Although Vmax is no t a fundamental 
property o f an enzyme as it is dependent on enzyme 
concentration [25], we were able to com pare reactions 
using this param eter since the same to ta l enzyme con­
centration was used in each PCR test.
For amplifications from template with a variant nu­
cleotide G, ffnax was highest in the presence of a matched 
primer 3' terminus. For all other templates at least one 
of the mismatched primers gave a higher Fmax value than 








o 20 30 40 SO
Cycle number Cycle number
Fig. 3. Correlation of real-time substrate accumulation (data points) with that predicted by the sigmoid function multiplied by final fluorescence 
reading (solid line). Graphs display base combinations (template: primer) (A ) T:A, (B) T:G , (C ) T:C, and (D ) T:T. Arrows indicate the larger de­
viations from predicted values in the presence o f a mismatch.
model holds only for early cycles [20]. We applied a 
simplified sigmoidal function to describe the accumula­
tion of substrate during PCR,
(1 +  aexpG/*)) ^
where a and /  are descriptive parameters of the sigmoid 
function at cycle n [30]. This function arises in many 
dynamical systems, describing simple exponential 
growth dynamics with a linear limiting control. Such 
systems are often called logistic growth. A similar sig­
moidal function was recently reported as providing a 
good fit for the whole kinetic process o f real-time PCR 
[31]. The inclusion o f  Eq. (4) as a substrate function 
approxim ated well to real-time data in our experiments 
(Figs. 3A -D ), particularly in correctly primed PCR 
tests.
Our model was further refined by the inclusion of a 
compensation factor C. Eq. (2) demands that at zero 
substrate concentration the rate of the reaction is zero. 
Since a PCR contains an initial substrate (template) 
concentration at cycle number n =  1, this compensation 
factor allows the criteria of the equation to be satisfied, 
such that an artificial cycle 0 is included. The overall 
equation becomes,
v  [1 +  ( K m /( S  +  C ) )  +  +
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Table 1
Predicted kinetic parameters (shown to 3 s.f.) for each base configuration
Template base Primer 3' 
terminus
vr max K, I 'm  ax /  KM Ratio of
G C 530 1300 0.002 0.408 1 . 0 0 0
G 448 43100 0.083 0.010 0.025
A 88.1 479000 29.2 0 . 0 0 0 0.004
T 302 23600 0 . 1 1 1 0.013 0.031
C C 290 14700 0.046 0.020 0.106
G 335 1800 0.006 0.186 1 . 0 0 0
A 378 26100 0.093 0.015 0.078
T 271 25400 0.128 0.011 0.058
A C 906 49900 0.037 0.018 0.089
G 402 32500 0.082 0.012 0.061
A 45 1720000 369 0 . 0 0 0 0 . 0 0 0
T 377 1840 0.007 0.204 1 . 0 0 0
T C 475 17700 0.031 0.027 0.120
G 669 16700 0.015 0.040 0.180
A 245 1090 0.013 0.224 1 . 0 0 0
T 160 116000 2.63 0.001 0.006
a Ratio of specificity constants compared to a matched combination. Matched combinations are highlighted in bold type. Constants are displayed 
in arbitrary units.
mispairs (template:primer) G:A, A:A, and T:T, Vmax was 
lower than that found for a match. The transition mi­
spairs C:A, A:C, and T:G and transversion mispairs 
A:G and T:C exhibited equal or higher Vmzx than a 
matched combination.
The latter observation is not surprising when one 
considers the consequence of mismatched primer ex­
tension in PCR. Certain nucleotide configurations vary 
in their affinity to bind to the enzyme and extend. 
However, once extension from a mismatched primer 
occurs, the resultant product and the complement syn­
thesised in subsequent cycles are fully matched with 
both primers [6]. The nature of PCR means that a single 
copy of matched template can be amplified to plateau 
levels in just a few cycles. This causes failure in many 
end-point genotyping tests by impairing discrimination. 
Therefore, Vmax alone is insufficient to ascertain the true 
effects of a mispair in PCR.
The more dominant parameter for characterising 
enzymatic discrimination is the Michaelis constant, K m , 
defined as the substrate concentration at which the re­
action rate is half its maximal velocity [13]. The K m is an 
intrinsic property of an enzyme reflecting the binding 
constant for forming the enzyme substrate complex, as 
well as the catalytic constant. In PCR, this embodies 
template affinity and the thermodynamic environment 
of the reaction [20]. The transversion mispairs G:A, 
A:A, and T:T exhibited a K m value between 100- and 
1000-fold higher than a corresponding match. In all 
other cases, K m for a mismatch was 8- to 33-fold higher 
than the equivalent match. These data suggest that a 
matched conformation binds with higher affinity than a 
mismatch to the active site of the enzyme.
This is discordant with the view of Huang et al. [5] 
who found that Taq polymerase binds with equal af­
finities to all base configurations. This is likely due to the 
reaction conditions employed where a single species of 
dNTP was used as the variable substrate for each tem­
plate. Single-turnover kinetics is unable to reflect a PCR 
test in which all dNTPs are present at equimolar con­
centration and in large excess. In the absence of com­
petition, similar binding affinities might be expected. 
Some groups were similarly conflicting [10,14], whilst 
others were in agreement [7,9,13,15]. The diversity of 
reaction conditions employed, enzyme source, and D N A  
sequences may have caused this disparity. Importantly, 
this report represents the kinetic characterisation of Taq 
in a true rapid cycle PCR environment overcoming the 
limitations of previous findings.
The kinetic parameters displayed in Table 1 were 
used to define a value for the fundamental ‘specificity’ 
constant, kca{/K M, where kcat is the catalytic constant or 
turnover number. This specificity constant determines 
the ratio of reaction rates for an enzyme acting on two 
competing substrates, when they are mixed together at 
equimolar concentrations. Given the fact that it is the 
ratio of specificity constants that determines the ratio of 
rates of the competing reactions a and b, we evaluated 
Knax/^w since [Zst] was identical throughout our tests
[25]
(if E°T =  Ej ) . ( 6 )
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The comparison of these values between matched- 
and mismatch-primed PCR expresses the enzyme’s 
ability to discriminate in favour of a particular base 
configuration in the presence of others [25], and conse­
quently, the relative extension efficiencies [5]. In agree­
ment with work by Kwok et al. [6] we found that a 
match was the more specific substrate for Taq poly­
merase. The relative specificity of mismatches varied 
according to each arrangement, but in general, pu- 
rine:purine mispairs were harder to extend than other 
combinations. Our system unequivocally demonstrates 
that for Taq D N A  polymerase during rapid cycle PCR, 
the matched base configuration would be the preferred 
substrate in the presence of all other mismatches.
Finally, this model estimated values for the inhibition 
constant K\, which provides a quantitative measure of 
inhibitor potency [27]. Values for K\ are usually derived 
from an inhibition study of the effects of a substance on 
kinetics or binding o f a substrate or effectors. Such 
studies are usually performed in the presence of the true 
substrate (for kinetics) or ligand (for binding) AND the 
inhibitor. Therefore, the K\ value in this model repre­
sents a substrate inhibition constant since the substrate 
only is present. This could be interpreted as the ability of 
the mismatched primer to form a dead-end complex by 
binding to the active site of the enzyme without efficient 
extension. In addition, it may represent the ability of the 
primers to bind dystopically to a particular template, 
such that replication rate is depressed. In both cases, one 
might expect Km for a mismatched primer to be higher 
than that of the true primer. This is supported by data in 
which the three transversion mispairs, G:A, A:A, and 
T:T, exhibited a significantly higher K, value than all 
other mispairs. Consistently, K\ was lower for a match. 
By considering the other parameter values associated 
with each configuration, we propose that these particu­
lar mispairs bind to the enzyme with low affinity and 
extend with low efficiency, forming a stable dead-end 
complex that inhibits progression of the reaction.
High substrate inhibition
Factors that have been attributed to attenuation of 
PCR include depletion of substrate (dNTPs or primers), 
thermal inactivation or limiting concentration of DNA  
polymerase, inhibition of enzyme activity by increasing 
pyrophosphate production, reannealing of amplicon at 
concentrations above 10-8 M, reduction in the dena­
turation efficiency per cycle, destruction of product due 
to enzyme 5'-3' exonuclease activity [32], product-to- 
product reannealing [4] or the chelation of critical metal 
ions by the substrate depriving the enzyme of a cofactor 
[27], For each theory, the characteristics of high sub­
strate inhibition would be apparent.
Other investigations have shown that by including 
increasing amounts of “random” DNA into the PCR
test from the beginning amplification could be inhibited 
[32,33]. It was suggested that the accumulation of 
product during later cycles is more likely to inhibit the 
enzyme before the more trivial factors such as exhaust­
ing primers, metal ions or dNTPs, which are added in 
huge molar excess. In conjunction with the excellent fit 
of our model to real data (Figs. 2A-D), we provide 
compounding evidence that high substrate inhibition 
does indeed play a predominant role in curtailing am­
plification during the final cycles of a PCR.
However, one might have expected the Kx for a match 
to be greater than or equal to a mismatch if we were 
proposing high substrate inhibition as the sole cause of 
the PCR plateau phase. Our data show that in the case 
of a mismatch, other factors come into play, which 
further add to the magnitude of the K x value. This is 
supported by Figs. 3A -D  in which the model’s predic­
tion of substrate accumulation was more accurate for a 
match- than mismatch-primed PCR test. So although 
high substrate inhibition is the likely cause of the pla­
teau phase in conventional PCR, we demonstrate that 
the actual presence of a mismatch has an effect on the 
intrinsic ability of the enzyme to function effectively, 
displaying a direct inhibitory effect on the PCR.
In summary, we report for the first time kinetic pa­
rameters that have been estimated in a real-time rapid 
PCR system. These data represent the enzyme’s activity 
under optimal reaction conditions. Due to the complex 
interactions of components within a PCR [34], and the 
thermodynamics of D N A  hybridisation [13], variations 
in component concentrations or annealing temperature 
during the test will alter the resulting kinetic constants. 
It  is, therefore, important to only compare kinetic pa­
rameters obtained under identical reaction conditions.
The general trends shown here are directly applicable 
to the design of SNP genotyping experiments, providing 
a measure of the likely success and optimisation neces­
sary. We expect this novel approach to PCR charac­
terisation to be utilised in other applications, especially 
rapid qPCR methods in which accurate measurement of 
quantitative parameters is essential.
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